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Abstract 
Structural and Functional Studies of Caveolae in the Femoral Artery 
 
Caveolae are important microdomains found in the plasma membrane, which act as 
signalling hubs in endothelial cells (ECs) and smooth muscle cells (SMCs). Thus, 
disruption of caveolae by membrane cholesterol depleting agents such as methyl β-
cyclodextrin (M-β-CD) has various functional effects on arteries, including 
impairment of endothelium-dependent relaxation and augmentation of smooth 
muscle cell contraction independently of the endothelium.  
The aim of this study was to test the hypotheses that caveolae modulate contractility 
in rat femoral artery, and more specifically the response to BKCa channel activity.  
Different methods were used in the study including; transmission electron 
microscopy (TEM), immunohistochemistry, immunocytochemistry and Western 
blot, and myography. M-β-CD was used in this work to disrupt caveolae from the 
plasma membranes of SMCs and ECs of rat femoral artery.   
TEM examination showed that caveolae were present throughout the plasma 
membrane of the SMCs and ECs in femoral artery. TEM examination also showed 
that treatment of the artery with M-β-CD, causes removal of caveolae from most of 
plasma membrane of the SMCs and ECs. Immunohistochemistry and 
immunocytochemistry results showed that cav-1, cav-3 and BKCa channels are co-
expressed in SMCs, and cav-1 and BKCa channels are present in ECs. The presence 
of these proteins in femoral artery tissue lysate was confirmed by Western blot. 
Femoral artery contraction studies using myography showed that caveolar disruption 
by M-β-CD caused a significant increase in the contraction in endothelium-intact 
artery rings in response to 20 mM K
+
 and 100 nM BayK-8644 (20 K/ Bay K). In 
endothelium-denuded artery rings and/or after incubation of endothelium-intact 
artery rings with L-NAME (an eNOS inhibitor), there was a non-significant increase 
in the contraction in response to 20K/ BayK.  Incubation of endothelium-intact artery 
rings with TEA
+
 or IBTX, both BKCa channel inhibitors, caused a significant 
increase in the contraction to 20 K/ Bay K.  Incubation of endothelium-intact artery 
rings with L-NAME, reduced the contraction to TEA
+
 and IBTX. These results 
provide evidence that contraction of rat femoral artery is inhibited by basal nitric 
oxide release from the endothelium, and BKCa channels in the SMCs might have a 
role in this vasorelaxation. 
Further femoral artery relaxation studies showed that the integrity of caveolae was 
important for the vasorelaxation of arteries (pre-contracted with 20 K/ Bay K) when 
BKCa channels were directly activated by NS-1619. In contrast, vasorelaxation by  
isoproterenol and forskolin in endothelium-denuded artery was not significantly 
altered after caveolae were disrupted.      
These data together suggest that caveolae are an important factor in maintaining Ca
2+
  
homeostasis in SMCs in rat artery femoral due to regulation of contractile activation.  
1 
 
Chapter 1 Introduction 
The vascular system consists of vessels of varying size and function designed to 
transport blood, hormones, oxygen, vitamins, glucose, minerals and waste (Mulvany 
and Aalkjaer, 1990). There are three major types of blood vessel: arteries, veins and 
capillaries (Aaronson and Ward, 2007). Arteries are further divided into three types 
according to their size: elastic conducting arteries, muscular distributing arteries and 
resistance arteries/arterioles. Elastic conducting arteries include the largest artery, the 
aorta, and the most important characteristic of these arteries is their low resistance 
due to their large diameter (0.3 cm to 1 cm) (Mulvany and Aalkjaer, 1990, Mulvany 
and Halpern, 1977). They are richer in elastin and collagen fibers than any other type 
of vessel to allow them to withstand high pressure (Aaronson and Ward, 2007). 
Muscular distributing arteries such as femoral arteries are the second largest arteries. 
The most important function of these arteries is the delivery of blood to target 
organs. These arteries are important in vasoconstriction and vasodilation as they 
have a lot of smooth muscle. Finally, resistance arteries and small arterioles are the 
smallest arteries that deliver blood to capillaries. Control of blood flow through 
capillary beds is achieved by changing the lumen size of arterioles (Mulvany and 
Aalkjaer, 1990). Blood flow through a given blood vessel depends directly on the 
pressure difference between the two ends of the blood vessel, and indirectly on the 
resistance to blood movement. Blood flow to tissues is regulated by the ability of 
arteries to constrict (vasoconstriction) or dilate (vasodilation). This property is 
dependent on the state of contraction of the smooth muscle cells within the arterial 
wall (Mulvany and Aalkjaer, 1990, Mulvany and Halpern, 1977). Maintained 
contraction of arterial smooth muscle (smooth muscle tone) causes a sustained 
2 
 
alteration in arterial diameter. Vascular smooth muscle tone is regulated by a diverse 
range of mechanisms including neuronal, hormonal, biochemical and bioelectrical 
stimuli (Mulvany and Aalkjaer, 1990, Mulvany and Halpern, 1977). Many of these 
signals ultimately influence free intracellular Ca
2+
 concentration within the smooth 
muscle cells (SMC), leading to contraction or relaxation of arteries.  
I selected the femoral artery to study as it is an important artery that supplies blood 
to the groin and thigh area to allow walking, running and other everyday activities. It 
is also relevant as it susceptible to peripheral arterial disease, mainly through an 
atherosclerotic process (Dieter et al., 2002). 
1.1 Anatomy of the femoral artery  
The femoral arteries receive blood from the external iliac artery (Ohayon et al., 
2012). The femoral artery is located a little beneath the groin area and continues 
down along the front of the thigh (Ohayon et al., 2012). Once it crosses the middle of 
the thigh it merges to become the popliteal artery. The femoral artery is one of 
muscular distributing arteries with a large lumen, and therefore offers little resistance 
to the flow of blood. The femoral artery walls are made up of three layers: tunica 
intima, tunica media and tunica adventitia (figure 1.1). The intimal layer (tunica 
intima) is composed of a single layer of endothelial cells (ECs) which have a 
squamous structure and form fenestrations (Zhang, 1999). The medial layer (tunica 
media) is made up of SMCs embedded within a matrix of elastin and collagen fibres. 
The tunica media is bound by the internal and external laminae and provides the 
vessel with the ability to contract. For this reason, this layer has the ability to stretch 
up to 1.5 times its length and back to their normal length when not under tension 
(Zhang, 1999). The adventitial layer (tunica adventitia) in the arteries is mainly made 
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of connective tissue (collagen and elastin), macrophages, mast cells, fibroblasts and 
Schwann cells and nerve axons (Mulvany and Aalkjaer, 1990), which are mainly 
adrenergic nerves. 
  
 
 
Figure ‎1.1. A histological preparation of a rat femoral artery showing the three layers; 
tunica intima (TI), which include ECs; tunica media (TM), which include SMCs; and the 
tunica adventitia (TA). The internal elastic lamina (IEL) and external elastic lamina (EEL) 
are also shown. The lumen diameter (L) is about 190 µm. Haematoxylin and eosin staining, 
X400 magnification. 
 
1.2 Caveolae 
1.2.1 Initial discovery  
In the 1950s, morphologically-identified caveolae were first described using electron 
microscopy as flask-shaped, 50-100 nm diameter invaginations in the plasma 
membrane of endothelial cells (Palade, 1953). After that, Yamada in 1955 observed 
similar ‘cave-like’ structures in the epithelial cells of the gall bladder of a mouse 
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(Yamada, 1955). Caveolae are classically described as small omega-shaped 
invaginations (50-100 nm diameter) in the plasma membrane (figure 1.2 A and B)  
(Palade, 1953, Yamada, 1955). Later studies revealed that caveolae are a special type 
of a lipid raft, highly enriched in cholesterol and sphingolipids (Brown and London, 
1998, Simons and Toomre, 2000). Further investigations identified caveolae in most 
mammalian cell types with notable abundance in adipocytes (Fan et al., 1983, 
Scherer et al., 1996), endothelial cells (Feron et al., 1996) and smooth muscle cells 
(Forbes, 1979).   
Forty years later, researchers have identified the most important structural protein of 
caveolae, known as caveolin (Glenney and Soppet, 1992). Caveolin was re-classified 
to caveolin-1 (cav-1) after the discovery of two additional members of the caveolin 
gene family, caveolin-2 (cav-2) and caveolin-3 (cav-3) (Glenney and Soppet, 1992, 
Way and Parton, 1995, Scherer et al., 1996). Over the course of several years, 
different studies showed that caveolae are implicated in cellular cholesterol 
homeostasis, endocytosis, transcytosis, potocytosis, cell signalling and tumour 
suppression (Razani et al., 2002). More recent studies investigated caveolin-
deficiency and how it can cause diseases such as diabetes, cancer, muscular 
dystrophies and cardiovascular disease (hypertension and atherosclerosis) (Cohen et 
al., 2004). 
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Figure ‎1.2. Transmission electron micrographs of intact rat femoral artery. A, 
Endothelial cell.  Caveolae (Cav) cover most of the EC membrane.  Caveosomes (C) are also 
abundant. B, Smooth muscle cell. Omega-shaped caveolae cover most of the SMC 
membrane. Also shows the peripheral SR. 
1.2.2 Lipid rafts 
In 1972, Singer and Nicolson first proposed the fluid-mosaic model to describe the 
construction of plasma membranes (Singer and Nicolson, 1972). In this model, they 
suggested that proteins were “floating” within the lipid bilayer like a “liquid” surface 
cell membrane (figure 1.3) (Singer and Nicolson, 1972). Although it is a useful 
conceptualisation, this model had limitations in explaining several function of the 
plasma membrane including signal transduction. Additionally, this model ignored 
the presence of caveolae in the plasma membrane. This model was expanded by 
Henderson and Unwin in 1975 where they proposed the presence of integral 
membrane proteins within the cell membrane (Henderson and Unwin, 1975). They 
also alternated hydrophobic and hydrophilic parts of trans-membrane loops of these 
proteins. Additionally, they suggested that glycoprotein carbohydrate groups were on 
the extracellular surface. 
In 1997, Simon and Ikonen proposed the modern concept of cell membrane 
structure. They explained that the plasma membrane is composed of a combination 
of protein receptors and glycosphingolipids organised in glycolipoprotein 
microdomains, known as lipid rafts (Simons and Ikonen, 1997). The movement of 
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the clustering of sphingolipids and cholesterol laterally or sideways within the fluid 
bilayer leads to raft formation. They also suggested that the rafts function as 
platforms for the attachment of proteins to allow movement in the membranes 
laterally or sideways, and to facilitate signal transduction. Plasma membranes have 
also been re-described by more recent studies on the standard lipid bilayer and lipid 
rafts within them (figure 1.4) (Alberts 2002). Lipid rafts are more tightly-packed 
than the standard lipid bilayer (Korade and Kenworthy, 2008) and can float freely in 
the membrane bilayer (Simons and Ehehalt, 2002).   
The original concept of rafts was used as an explanation for several cell membrane 
functions such as the embedding of macromolecules in the phospholipid matrix, the 
transport of proteins selectively included or excluded in lipid rafts, the regulation of 
neurotransmission, and receptor trafficking for signal transduction (Korade and 
Kenworthy, 2008, Pike, 2009). 
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Figure ‎1.3. The original fluid-mosaic model of the plasma membrane (Singer and 
Nicolson, 1972). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1.2.3 Caveolae structure  
Caveolae can be described as a cholesterol-rich and clathrin-free invaginated    
microdomain in the cell membrane (Anderson, 1998) (figure 1.5 A). 
Morphologically, caveolae have been shown to be a flask-like membrane structure. 
However, this shape can be changed according to the physiological condition of the 
cells (Razani and Lisanti, 2001b, Simionescu et al., 1975). Originally, caveolae were 
identified as a sub-type of lipid raft. However in contrast with lipid rafts, caveolae 
contain a family of small proteins called caveolins and another family of proteins 
(2) (1) 
Figure ‎1.4. The new concept of lipid raft organisation. Area (1) is the standard lipid 
bilayer, whereas area (2) is a lipid raft. Adapted from Alberts (2002). 
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called cavins. It has been shown that each caveola contains of approximately 140-
150 caveolin molecules (Pelkmans and Zerial, 2005). In addition, caveolae are rich 
in cholesterol, sphingolipids, receptors and ion channels as well as lipid raft (Lisanti 
et al., 1994a, Anderson, 1998). 
1.2.3.1 Caveolins  
Caveolins are considered to be the main structural protein units of caveolae. They are 
a family of small proteins (18-24 kDa) that are embedded in the cell membrane with 
both N- and C-terminals reside in the cytosol. Caveolins are comprised of three 
types: cav-1, cav-2 and cav-3 (Lisanti et al., 1994a, Anderson, 1998). Caveolins are 
synthesised in the rough endoplasmic reticulum (ER) and subsequently trafficked via 
the Golgi complex to the cell surface (Hayer et al., 2010).     
Caveolins are essential in mediating the invagination of caveolae. Furthermore, 
caveolins can be oligomerised into a complex of 14-16 subunits and become larger 
mega-complexes (Minami et al., 1995, Sargiacomo et al., 1995). It is believed that 
the high affinity of caveolins for cholesterol, oligomerisation and the oligomer-
oligomer interactions may facilitate the formation of the 50-100 nm caveolar 
invaginations (Sargiacomo et al., 1995). A 33 amino acid hydrophobic domain of 
each caveolin is believed to anchor the protein in the cell membrane (Anderson, 
1998). 
1.2.3.1.1 Caveolin scaffolding domains 
Various studies have identified a 20 amino acid domain that is located in the 
membrane side of the cytosolic N-terminal domain of caveolin, termed the caveolin 
scaffolding domain (CSD) (Table 1) (Couet et al., 1997). One of the most important 
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functions of CSDs is their interaction with several binding partners such as G protein 
α-subunits and Src family kinases (Cohen et al., 2004). Through CSDs, caveolins are 
able to bind and regulate caveolin-associated signalling proteins. Couet et al. 
identified the possible binding motifs in these caveolin-associated proteins using a 
glutathione S-transferase-fusion protein containing the CSD to screen a peptide 
phage display library (Couet et al., 1997). In this study, the researchers found a high-
binding affinity of a selected group of peptides to the CSD, with the sequences of 
these motifs as following: ΦXΦXXXXΦXXΦ, ΦXΦXXXXΦ and ΦXXXXΦXXΦ 
where Φ is an aromatic residue (Phe, Tyr, or Trp) and X is any amino acid (Couet et 
al., 1997).  
 
           Table 1. Scaffolding domain sequences and residues of caveolin 1, 2 and 3. 
Caveolin                            CSD sequence                            Residues 
     Cav-1       D G I W K   A S F T T F T V T K      Y W F Y R       82-101 
             Cav-2       D K V W I   C S H A L F E I S K       Y V M Y K      54-73 
             Cav-3      D G V W R   V S Y T T F T V S K     Y W C Y R       55-74 
 
1.2.3.1.2 Caveolin-1 
Cav-1 was originally identified by Glenney and co-workers as a component of 
caveolae in Rous sarcoma virus-transformed chicken fibroblasts (Glenney and 
Soppet, 1992). Cav-1 has two isoforms, cav-1α (178 amino acid peptide) and cav-1β 
(147 amino acid peptide); both isoforms have been reported to show overlap with 
slight differences in their distribution in mammalian cells (Scherer et al., 1995), 
where cav-1α is the predominant isoform (Hnasko and Lisanti, 2003). The 
expression of cav-1 is reported in most cell types of the vascular system (Bernatchez 
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et al., 2005). 
Cav-1 has been implicated in a wide range of signal transduction processes (Razani 
et al., 2002). This protein has a major role in physiological mechanisms that regulate 
vascular reactivity. In this regard, cav-1 has been shown to be co-expressed with 
endothelial nitric oxide synthase (eNOS) and has a negative regulatory role in eNOS 
activity. Consequently, cav-1 association inhibits the release of nitric oxide (NO) 
(Sowa et al., 2001).  
1.2.3.1.3 Caveolin-2 
Caveolin-2 (162 amino acid peptide) was identified for the first time in adipose 
tissue by Scherer et al. using microsequencing of adipocyte-derived caveolin-
enriched membranes (~20 kDa) (Scherer et al., 1996). Cav-2 has multiple isoforms: 
cav-2α, cav-2β and cav-2γ (Hnasko and Lisanti, 2003), and it has been shown that 
cav-2 co-express with cav-1 in caveolae. The interactions of cav-2 with G proteins in 
adipose tissue is different from that of cav-1, and maybe explains why cav-1 and 
cav-2 are co-expressed within a single cell (Scherer et al., 1996).  
1.2.3.1.4 Caveolin-3 
Caveolin-3 (or M-caveolin) was identified as a muscle-specific isoform through an 
analysis of a cDNA library screening for cav-1 homologous genes (Way and Parton, 
1995). The cav-3 protein (151 amino acid peptide) is organised by two coding exons 
(Anderson, 1998, McMahon et al., 2009) and is split into four parts: N-terminus (1–
53 amino acids), CSD (54–73 amino acids), transmembrane (74–106 amino acids), 
and C-terminus (107–151 amino acids) (Parton, 1996, Galbiati et al., 2001). 
1.2.3.1.5 Caveolin distribution 
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Tissue expression profile studies have shown expression of both cav-1 and cav-2 in 
several cell types, with the highest level in adipocytes, endothelial cells, 
pneumocytes and fibroblasts. Cav-3 expression is limited to muscle (cardiac, skeletal 
and smooth muscle cells) (Scherer et al., 1994, Scherer et al., 1996, Anderson, 
1998). Cav-1 and cav-3 have been shown to be co-expressed in the smooth muscle 
cells of some specific tissues (Glenney and Soppet, 1992, Razani and Lisanti, 2001b, 
Razani et al., 2002, Scherer et al., 1996). Furthermore, in other studies, it has been 
shown that  CSDs of both cav-1 and cav-3 bind with same caveolin biding motifs of 
partner proteins (Okamoto et al., 1998). Expression of both of cav-1 and cav-3 might 
explain their contribution in the formation of distinct caveolae in smooth muscle 
cells (Kogo et al., 2006). 
1.2.3.1.6 Cavins 
Cavins modulate caveolin function and organization by acting as scaffolding proteins 
and by regulating the availability of caveolins (Chidlow and Sessa, 2010). Four 
cavin isoforms have been discovered: cavin-1, cavin-2, cavin-3 and cavin-4. Cavins 
are closely related in primary structure and possess a highly conserved N-terminal 
domain. Moreover, cavins are distributed in different tissues (Chidlow and Sessa, 
2010) suggesting that each member regulates tissue-specific caveolae function.  
1.2.3.1.6.1    Cavin-1  
Cavin-1, also known as polymerase transcript release factor, is one of the proteins 
that supports caveolin as it plays an important role in the regulation of caveolin 
expression and caveolae formation and organisation (caveolae morphology) (Liu and 
Pilch, 2008, Chidlow and Sessa, 2010). The importance of cavin-1 in caveolae 
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formation has been demonstrated in adipose tissue (Aboulaich et al., 2004). The co-
expression of cavin-1 with cav-1 has been demonstrated in lipid rafts (Aboulaich et 
al., 2004). Importantly, the interaction between cavin-1 and cav-1 seems indirect as 
loss of caveolae disrupts the association of cavin-1 and cav-1. The role of cavin-1 
appears to be stabilizing shape of caveolae by acting as its molecular anchor to 
cytoskeletal proteins (Liu and Pilch, 2008). Moreover, the importance of cavin-1 for 
the stability of cav-1 has been confirmed in vitro as over-expression of cavin-1 has 
been shown to cause increased levels of cav-1 (Hill et al., 2008).  
These findings were further supported by Hayer et al. using live-cell imaging to 
demonstrate that cav-1 scaffolds are trafficked to the plasma membrane 
independently from cavin-1. The trafficking of cav-1 alone to the plasma membrane 
without cavin-1, suggest that the interaction between cavin-1 with cav-1 might only 
assist in the formation of caveolae (Hayer et al., 2010). 
1.2.3.1.6.2    Cavin-2 
Cavin-2, also known as a serum deprivation-response protein, has been demonstrated 
to directly bind with cavin-1 and recruit it to the plasma membrane (Hansen et al., 
2009). It has also been shown that cavin-2 is necessary for the expression of cav-1 
and cavin-1 proteins in the cell membrane and subsequent formation of caveolae 
(Hansen et al., 2009). Over-expression of cavin-2 in vitro has been reported to cause 
the formation of elongated tubular caveolae that might be involved in channel 
formation (Gustincich et al., 1999, Hansen et al., 2009). These studies also 
highlighted the importance of cavin-2 in caveolae signalling and 
compartmentalisation of PKC to caveolae. Cavin-2 has also been shown to be 
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important for pleckstrin (a protein found in platelets), a platelet PKC substrate when 
bound to cavin-2 (Baig et al., 2009). 
1.2.3.1.6.3    Cavin-3 
It has been shown that cavin-3 is expressed only when cav-1 is expressed in the same 
cells although the expression of cav-1 was detected alone without cavin-3 in some 
tissues. This suggests that the expression of cavin-3 might be linked to the 
expression of cav-1 (McMahon et al., 2009). Furthermore, it has been shown that 
down-regulation of cavin-3 occurs as a result of depletion of cav-1. This also 
indicates that cav-1 is necessary for cavin-3 stability (McMahon et al., 2009). 
Another study demonstrated the presence of cavin-3 in caveolae and endocytic 
vesicles (Mundy et al., 2002), and that it traffics with cav-1 to different places in the 
cell (McMahon et al., 2009). This might indicate that cavin-3 plays an important role 
in caveolae budding or movement of the endocytic vesicles beside microtubules. On 
the other hand, intracellular trafficking has been impaired when cavin-3 was absent. 
Together, these results suggest that cavin-3 is important for caveolae budding to 
form vesicles (Izumi et al., 1997). 
1.2.3.1.6.4   Cavin-4 
Cavin-4 has been shown to be expressed in muscle, with an extremely high 
expression in skeletal and cardiac muscle (Tagawa et al., 2008, Bastiani et al., 2009). 
Bastiani et al. (2009) have shown that cavin-4 is localised with cav-3  and interacts 
with cavin-2. Furthermore, cavin-4 may influence the differentiation of skeletal 
muscle, and so it may play a role in caveolae-associated muscle disease (Bastiani et 
al., 2009).  
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1.2.4 Formation of caveolae 
The formation and function of caveolae has mainly been attributed to the caveolin 
family (Rothberg et al., 1992) (figure 1.5 B). Cav-1 and cav-2 are expressed in non-
muscle and smooth muscle tissues (Parolini et al., 1999). However, cav-3 is 
specifically expressed in cardiac, skeletal and vascular smooth muscle (Tang et al., 
1996). Cav-1 and cav-3 have been shown to be essential in the formation of caveolae 
in muscle. Deleting cav-1 or cav-3 in mice was shown to result in a loss of caveolae 
(Drab et al., 2001, Galbiati et al., 2001). Moreover, it has been shown that 
introducing the expression of cav-1 in cells in which caveolae or caveolins are not 
normally detectable results in de novo formation of caveolae in these cells (Fra et al., 
1995). The importance of caveolin in the biogenesis of caveolae has also been 
demonstrated in a prokaryotic host lacking any intracellular membrane system. In 
this simple model system, introducing recombinant caveolins induced the formation 
of caveolae-like structures (Walser et al., 2012). Although cav-2 is associated with 
cav-1 in various cell types and is a component of caveolae structure, it is redundant 
in caveolae formation, and thus its role is still elusive (Scherer et al., 1996). The 
recent model of caveolae biogenesis proposes that assembly is linked to the 
biosynthetic trafficking of cav-1(Kirkham et al., 2008). Cav-1 is synthesised and 
oligomerised in the endoplasmic reticulum. After the transportation of the cav-1 
oligomers to the Golgi complex, they form larger complexes and associate with 
cholesterol (Hayer et al., 2010). Following trafficking of caveolin complexes to the 
plasma membrane, cavins are recruited to stabilise the caveolin oligomers. Loss of 
cavin-1 in cultured cells was shown to cause depletion of caveolae (Hill et al., 2008). 
Deleting cavin-1 in mice resulted in caveolae loss and reduced levels of caveolins 
(Liu and Pilch, 2008). Therefore, cavin-1 is a crucial component for caveolae 
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generation and maintenance. Cavin-2 has been shown to be an important element in 
the formation of the caveolar membrane curvature (Hansen et al., 2009). However, 
the precise roles of other cavins have not yet been elucidated. 
 
 
 
 
1.2.5 Roles of caveolae/caveolins  
Since their discovery in 1953, several functional roles have been attributed to 
caveolae and caveolins in numerous cell types. In this section, I will focus on the 
most important functional roles of caveolae and caveolins.  
1.2.5.1 Vesicular transport 
At the level of the vascular endothelium, most molecules internalise through 
endocytosis. Endocytosis can be mediated via three different pathways: clathrin-
coated pits (receptor mediated); pits (fluid-phase); and caveolae-vesicles system 
transport (receptor mediated) (Moore, 2006). The endocytosis by clathrin-coated pits 
Figure ‎1.5. Schematic diagram; A. Main features of caveolae and caveolins. B. Caveolae 
formation and membrane trafficking of cav-1. Figure B is modified from Hayer et al. (2010). 
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and/or pits (fluid-phase) might lead to the transfer of materials to endosomal and/or 
lysosomal compartments whereas the caveolae-vesicles system can transport 
macromolecules into the cell (endocytosis) to the endoplasmic reticulum and/or 
Golgi apparatus complex, or across it through the cell (transcytosis) (Schnitzer, 
2001, Razani et al., 2002). In addition to the use of the caveolae-vesicles system for 
cellular entry, it allows macromolecules to avoid classical digestion in the cell by 
enzymes in the endosomal and lysosomal compartments (Pelkmans and Helenius, 
2002, Na et al., 2003, Panyam et al., 2003). Furthermore, several studies have shown 
that the caveolae-vesicles transcytosis/endocytosis system transfers macromolecules 
such as albumin (Ghitescu et al., 1986), insulin (King and Johnson, 1985), low-
density lipoproteins (LDL) (Frank et al., 2009), and chemokines (Ge et al., 2008) 
from the lumen of blood vessels to the sub-endothelial space. Generally, the 
caveolae-vesicles system can transport molecules through three different pathways: 
transcytosis, endocytosis and potocytosis. 
1.2.5.2 Transcytosis  
Transcytosis is considered to be one of the most important functions of the 
endothelial caveolae where macromolecules from the luminal surface are transferred 
to the abluminal surface through trans-endothelial channels. These channels might be 
formed as a result of the connection of free vesicles (caveosomes) to each other and 
ultimately to caveolae at the other surface (Clough and Michel, 1981) (figure 1.6 A). 
This mechanism might allow macromolecules to completely and rapidly cross the 
artery wall via caveolae.  
Transcytosis via caveolae is exploited by various viral pathogens as shown in 
nanotechnology experiments where labelled ‘tracer’ serum proteins were used to 
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track their dynamic interaction with endothelial cells using electron microscopy 
(Razani et al., 2002). Furthermore, in another study, antibodies were used to label 
specific proteins in the capillary lumen. Results of this experiment showed that 
pathogens completely and rapidly crossed the capillary wall directly via caveolae 
(Schnitzer, 2001). These studies suggest that caveolae have the ability to select 
specific proteins to be transported via the transcytosis pathways (Razani et al., 2002).  
1.2.5.2.1 Endocytosis 
Endocytosis is a process where small and large molecules are taken up by cells from 
artery lumen and then transported into the intracellular compartments ER and/or 
Golgi apparatus complex. This occurs exclusively by caveosomes rather than 
clathrin-coated pits (Razani et al., 2002) (figure 1.6 B). Caveolae also contain 
dynamin (Henley et al., 1998), a GTPase that mediates the internalisation of caveolar 
vesicles. Although the complete mechanism of endocytosis is still not clear, several 
findings suggest that the activation of tyrosine kinases is key in this process 
(Pelkmans and Helenius, 2002). Certainly, activation of this kinase through 
phosphorylation leads to active endocytosis through caveolae. Also, the binding of 
several pathogenic agents, which have receptors in caveolae, leads to the activation 
of kinase signalling pathways (Norkin, 2001, Norkin et al., 2002). These properties 
might provide a mechanism to inhibit several pathogens by blocking pathogenesis 
receptors which are present in caveolae.  
1.2.5.3 Potocytosis 
It has been shown that caveolae are involved in cellular drinking (solute uptake), also 
known as potocytosis (Anderson et al., 1992). Through this pathway, the 
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endothelium can transport small molecules without having to use 
endosomal/lysosomal compartments, allowing them to avoid classical digestion in 
the cell (Anderson et al., 1992, Razani and Lisanti, 2001b).  
1.2.5.4 Cholesterol homeostasis  
Cholesterol homeostasis is attributed to the ability of cav-1 to bind cholesterol in the 
ER and transport it to caveolae at the plasma membrane. At this stage, the 
cholesterol molecules can be transferred to extracellular (abluminal surface) 
lipoproteins or be used for building the plasma membrane. Cav-1 can repeat this 
cycle through return to the ER/Golgi compartments (Razani and Lisanti, 2001b) 
(figure 1.6 C). Further analysis found that each cav-1 molecule forms a complex 
with ~1-2 cholesterol molecules in vitro (Murata et al., 1995). Later, a similar result 
was reported in vivo (Thiele et al., 2000). Additionally, cav-1 has been shown to 
transport cholesterol from the ER directly to caveolae, which subsequently flowed to 
a non-caveolae membrane region (Smart et al., 1996). Moreover, the scavenger 
receptor B1 (responsible for the influx of LDL particles into the endothelium) has 
been identified to co-express with cav-1 in caveolae (Graf et al., 1999). These results 
might indicate a wide and varied interrelationship between cav-1/caveolae and 
cholesterol in the endothelium. 
1.2.5.5 Tumour suppression    
The association between caveolins and tumour suppression was first investigated in 
1989 by Glenney (1989). He demonstrated that cav-1 is a predominant 
phosphoprotein in v-src-transformed embryonic chicken fibroblasts. For example, 
cav-1 was highly expressed, as detected using immunohistochemical and Western 
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blot analysis, in a non-tumorigenic human fibroblast cell line (IMR-90). On the other 
hand, in human fibrosarcoma cells (HT-1080), cav-1 expression is greatly reduced. 
Cav-1 is up-regulated in HT-1080 cells when the mitogen activated protein kinase 
signalling pathway is inhibited by PD 98059 (Wiechen et al., 2001). 
Cav-1 has also been investigated to act as a scaffold for several proteins with a 
capacity to interact and inhibit various signalling pathways which could activate 
oncogenes (Razani et al., 2002). Cav-1 has been shown to have suppressor effects on 
oncogenes such as c-Neu and c-Myc (Engelman et al., 1998a, Park et al., 2001). 
Further work reported that cav-1 can have similar inhibitory effects on several other 
receptor tyrosine kinases such as EGFR, Her2/Neu, and PDGF receptor tyrosine 
kinases, which are localised to caveolae and may act as pro-proliferative/anti-
apoptotic signals (Razani et al., 2002). Therefore, cav-1 may be a critical member of 
cellular tumour suppressors that inhibit the action of tumorigenic signals. 
1.2.5.6 Signal transduction  
Under control conditions, caveolin binds with other protein molecules in caveolae. 
Additionally, caveolae can serve to compartmentalize signal transduction molecules 
in order to influence the function of other proteins (Razani and Lisanti, 2001b) 
(figure 1.6 D). In this regard, there are several proteins, such as receptor tyrosine 
kinases, G protein-coupled receptors and ion channels that have been shown to 
localise to caveolae, as reviewed by (Razani and Lisanti, 2001b). This observation 
led other authors to suggest that cav-1 might serve to compartmentalise certain 
signalling molecules within caveolae, focusing on the localisation of these elements 
within the cell with possibility of selectively modulating cell signalling events 
(Lisanti et al., 1994a). Therefore, caveolae may serve as a platform for various 
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receptors and proteins that have a role in signal transduction. When activated by 
ligand binding, they could be recruited to caveolae.  
This suggestion was confirmed by several studies showing the GTPase activity of G 
protein α-subunits could be inhibited by a 20-amino acid peptide derived from the 
cav-1 N-terminal domain (residues 82-101, CSD, see Table 1) (Li et al., 1995). 
Further work confirmed the interaction between cav-1 and other proteins including 
Src family tyrosine knases, PKC isoforms and eNOS (Engelman et al., 1998a, 
Okamoto et al., 1998, Smart et al., 1999). This confirmed that cav-1 interacts with 
other proteins through this CSD. 
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Figure ‎1.6. Schematic diagram illustrating the physiological functions of caveolae and 
the caveolins. Modified from Razani and Lisanti (2001). A. Transcytosis-transport of 
proteins from the luminal side to the abluminal surface through trans-endothelial channels. 
These channels might be formed as a result of the connection of free vesicles (caveosomes) 
to each other and ultimately to caveolae at the other surface. B. Endocytosis is a process for 
uptake of small and large molecules and their subsequent transport into the intracellular 
compartments ER and/or Golgi apparatus from the artery lumen exclusively by caveosomes. 
C. Cholesterol homeostasis is attributed to the ability of cav-1 to bind cholesterol in the ER 
and transport it to caveolae at the plasma membrane. Caveolin can repeat this cycle through 
return to the ER/Golgi compartments. D. Signal transduction; caveolin under control 
conditions binds with other protein molecules in caveolae. Additionally, caveolae can serve 
to compartmentalize signal transduction molecules in order to regulate other proteins 
function. 
 
 
1.2.5.7  Regulation of endothelial nitric oxide synthase (eNOS) 
Caveolae are the key organiser of vascular relaxation via modulation of eNOS 
activity (Chidlow and Sessa, 2010). eNOS is an isoform of the NOS enzyme and is 
localised to the caveolae domain at the plasma membrane of endothelial cells (Xu et 
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al., 2008). The association between cav-1 and eNOS leads to inhibition of eNOS 
activity and therefore of NO release (Chidlow and Sessa, 2010). 
eNOS is targeted to caveolae through co-translocation, N-myristoylation and post-
translocation palmitoylation (Ju et al., 1997, Okamoto et al., 1998). eNOS has two 
binding sites (oxygenase and reductase) which facilitate the direct interaction with 
the two cytoplasmic domains of cav-1 to form an eNOS-caveolin heteromeric 
complex (Garcia-Cardena et al., 1997). The caveolin binding motifs (CBMs) of 
eNOS (FXAAPFXXW) that recognises the CSD of cav-1 is in the oxygenase 
domain (Garcia-Cardena et al., 1997). The interaction of cav-1 with eNOS causes  
inhibition of the NO signal until there is an increase in the influx of Ca
2+
, resulting in 
formation of the Ca
2+
-calmodulin complex. The interaction between cav-1 and eNOS 
is regulated by this Ca
2+
-calmodulin complex (Michel et al., 1997). Ca
2+
-calmodulin 
triggers dissociation of eNOS from cav-1, leading to the oxidisation of L-arginine to 
generate NO and L-citrulline (Fleming and Busse, 2003, Minshall et al., 2003). NO, 
in combination with other vasodilatory factors, regulates vascular tone and maintains 
normal blood vessel function and integrity (Rosselli et al., 1998). Generation of NO 
by eNOS is regulated by three possible mechanisms: direct interaction of the 
heteromeric complex of caveolin and Ca
2+
-calmodulin with eNOS, reversible 
phosphorylation, and differential localisation of the eNOS-isoenzyme within the 
endothelial cells. Subcellular eNOS distribution is mediated by lipid modification, 
for example, myristoylation and dual palmitoylation have the ability to induce the 
association of the enzyme with the Golgi and cell membrane, respectively (Govers 
and Rabelink, 2001). 
Xu et al. found that disruption of caveolae in the aorta of rats by cholesterol 
depleting agents, such as methyl-β-cyclodextrin (M-β-CD) and filipin, caused an 
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impairment of NO function in acetylcholine-induced relaxation (Xu et al., 2007). 
The reduced NO-mediated relaxation after caveolae disruption might be due to an 
enhanced “scavenging” of eNOS by cav-1 freed from caveolae, possibly 
accompanied by internalisation (endocytosis) (Michel, 1999). eNOS and cav-1 
translocation from plasma membrane caveolae to the endoplasmic reticulum or Golgi 
apparatus occurs in cholesterol depleted cells (Blair et al., 1999). eNOS internalises 
in association with caveolin without the usual agonist-stimulated activation events 
occurring  (Michel, 1999). These results suggest that alterations in plasma membrane 
cholesterol might alter caveolin–eNOS activity, and subsequently cause endothelial 
dysfunction. The results from this model show the importance of caveolae in 
maintaining appropriate regulation of eNOS activity, and therefore NO production. 
1.2.5.8 Regulation of ion channel function  
Several types of ion channels localise to caveolae and associate with caveolins (Dart, 
2010). Cholesterol depletion from lipid rafts, including caveolae, can alter the 
function of the ion channels that are localised to caveolae, and therefore have an 
effect on the physiological function of these channels, as summarised in Table 2. 
Cholesterol depletion by cholesterol depleting agents led to altered ion channel 
function in vascular tissue in response to several types of agonists (Dreja et al., 2002, 
Prendergast et al., 2010). 
1.2.5.8.1 Regulation of large conductance Ca2+-activated K+ (BKCa) channel 
function  
In vascular SMCs, BKCa channels are considered to be the key regulator of artery 
tone through their inhibitory effect on L-type Ca
2+ 
channels. Opening of BKCa 
channels reduces L-type (voltage-dependent) Ca
2+ 
channel (VDCC) opening, and 
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therefore decreases Ca
2+
influx into SMCs, causing vasodilation (Dopico et al., 
2012). BKCa channels belong to a family of Ca
2+
-dependent K
+
 channels in vascular 
SMCs and have been investigated by biophysical techniques and primary sequence 
analysis (Cui et al., 1997, Horrigan and Aldrich, 1999).  
In vascular SMCs, BKCa channels can be activated (opened) by several factors, such 
as locally produced Ca
2+ 
transients (sparks) from ryanodine-sensitive Ca
2+
 releasing 
receptors (RyR) in the sarcoplasmic reticulum (SR) see, Bolton and Imaizumi 
(1996), agonist stimulation (Ganitkevich and Isenberg, 1990), phosphorylation by 
protein kinase G (PKG) activation by NO (through the activation of sGC) (Mistry 
and Garland, 1998) or direct interaction of NO with BKCa channel proteins (Bolotina 
et al., 1994). Furthermore, BKCa channels have been reported to have a large number 
of potential phosphorylation sites, so regulation could be exerted through the channel 
phosphorylation by a number of protein kinases (including PKA, PKG, PKC and 
Src), as reviewed in Hill et al. (2010). 
Activation of voltage-dependent Ca
2+
 channels (VDCCs) by depolarization of the 
SMC cell membrane by high extracellular potassium ion (K
+
) concentration or by 
direct binding by the Ca
2+
 channel agonist Bay K 8644 (Prendergast et al., 2010) can 
increase bulk cytosolic [Ca
2+
]i, consequently causing SMCs contraction (Levick, 
2010). In contrast to the action of bulk changes in cytosolic [Ca
2+
]i, local, sub-
membrane [Ca
2+
]i increases can result in relaxation. Thus, Ca
2+ 
sparks through local 
release of micromolar concentrations of Ca
2+
 from SR via RyR receptors, result in a 
local increase in Ca
2+
. The sparks are distributed in regions of close apposition of the 
plasma membrane to the SR membrane. The distance between the plasmalemma and 
the superficial SR is about 20 nm in SMCs (Somlyo et al., 1978). SMC contraction 
does not occur as a result of Ca
2+
 sparks as amount of Ca
2+
 released is insufficient to 
25 
 
raise global Ca
2+
. Rather, Ca
2+
 sparks activate BKCa channels in the spark 
microdomain, thus generating spontaneous transient outward currents (STOCs), 
inducing membrane hyperpolarisation (the membrane potential becomes more 
negative), thereby closing VDCCs and causing relaxation (Lacinova, 2005). This 
mechanism is very important in vascular reactivity and the reduction of myogenic 
tone (Fallet et al., 2001, Gschwend et al., 2003). Several immunostaining studies 
have shown that mammalian BKCa channels are co-expressed with cav-1 and cav-3 
(Wang et al., 2005, Riddle et al., 2011). Furthermore, inhibition of BKCa channels by 
blockers causes membrane depolarisation, leading to vasoconstriction (Wulf et al., 
2009).  
In mouse cerebral artery SMCs, BKCa channels, L-type Ca
2+
channels and RyR form 
a functional unit that regulates smooth muscle contractility (Cheng and Jaggar, 
2006). Under control conditions, Ca
2+
 influx through L-type Ca
2+
channels causes 
release of Ca
2+
 from a cluster of RyRs (a Ca
2+
 spark) resulting activation of BKCa 
channels (figure 1.7 A) (Sones et al., 2010). Cheng and Jaggar demonstrated that the 
genetic ablation of cav-1 abolishes caveolae and decreases BKCa channel opening 
frequency (Cheng and Jaggar, 2006). Disrupting caveolae in SMCs of the cerebral 
artery by M-β-CD also leads to decreased spark frequency and amplitude (Lohn et 
al., 2000). These results suggest that the changes in Ca
2+
 sparks and transient BKCa 
channel current might be due to the disruption of the local coupling between BKCa 
channels and RyR channels (figure 1.7 B). Similar results have been reported in 
another paper (Sones et al., 2010). The authors reported that the disruption of 
caveolae by M-β-CD leads to an inhibition of BKCa channels in murine portal vein 
myocytes using patch clamp technique. They found that the application of paxilline 
(a BKCa channel blocker) caused inhibition of outward BKCa channels current and 
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depolarisation of the cell membrane. A similar result was found when they applied 
M-β-CD. These results suggest that BKCa channels in vascular myocytes are inhibit 
indirectly by caveolar disruption by cholesterol depletion. 
The effect of cholesterol depletion in regulating ion channels has been studied by 
Prendergast et al.(Prendergast et al., 2010). The effects of M-β-CD and cholesterol 
oxidase (to replenish cholesterol) on Ca
2+
signals were examined in rat coronary 
artery myocytes in response to high K
+
 solution (KPSS), caffeine (to activate SR 
Ca
2+
 release) and agonist-induced Ca
2+
 signals. Agonists included 5-HT, endothelin-
1 and phenylephrine. Bay K 8644 was also used to stimulate L-type Ca
2+
 channels. 
Ca
2+
 transients were measured from single SMCs of the coronary artery in response 
to 5-HT, endothelin-1 and phenylephrine. The authors concluded: (i) application of 
KPSS, Bay K-8644 or agonists led to an increase in [Ca
2+
]i in the SMCs before 
cholesterol manipulation. (ii) The Ca
2+
 signals generated in response to KPSS or 
with caffeine were not altered by cholesterol depletion. (iii) Ca
2+
 signals generated 
by endothelin-1, phenylephrine and 5-HT were significantly decreased after 
cholesterol depletion. (iv) Application of cholesterol oxidase on M-β-CD treated 
cells led to a recovery of agonist-induced Ca
2+
 signals.  
In the same study, the effect of cholesterol depletion on BKCa channel function was 
examined (Prendergast et al., 2010). To examine the effect of M-β-CD on BKCa 
channel function, three selective K channel blockers were used before and after 
incubation with M-β-CD: iberiotoxin (IBTX) to block BKCa channels, TRAM-34 to 
block intermediate conductance K channels (IKCa), and apamin to block small 
conductance K channels (SKCa). Results showed that increase in outward current 
observed with M-β-CD was significantly inhibited by IBTX but not by TRAM-34 or 
apamin. These results suggest that cholesterol extraction and caveolae disruption by 
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M-β-CD caused a selective alteration of ion channel function, with L-type Ca2+ 
channel activity unchanged while BKCa channel activity was positively altered. 
These results suggest that contraction is a result of a wide range of signalling 
proteins that are associated with caveolae (Prendergast et al., 2010). 
 
 
 
Figure ‎1.7. Schematic diagram illustrating the physiological role of BKCa channels in 
vascular SMCs and activation of these channels by SR-mediated Ca
2+
 sparks. A; in 
vascular SMCs, BKCa channels are within the caveolae microdomains. L-type Ca
2+
 channels 
can activate transient Ca
2+
 rises in the form of Ca
2+
 sparks from the SR via ryanodine-
sensitive mechanisms. Presence of SR near to Cav microdomains allows Ca
2+
 sparks to 
activate BKCa channels. The efflux of K
+
 ions subsequently inhibits L-type Ca
2+
  channels. 
This promotes SMC relaxation. B; Cav depletion by M-β-CD leads to re-distribution of 
BKCa channels away from peripheral SR. Consequently, abolishing the inhibitory effect of 
BKCa channels on L-type Ca
2+
 channel, resulting from the absence of activation of BKCa 
channels by Ca
2+
 sparks. 
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Table 2. Vascular ion channels associated with caveolae. +: yes; -: not shown; TRPC1: transient receptor potential channel 1; EDHF: 
endothelium-derived hyperpolarising factor. 
Channel Tissue 
Biochemic
al  
isolation 
Electron     
microscope 
Associatio
n    
caveolin 
Functional effect References 
TRPC1 
Endothelium- 
denuded  
caudal artery 
+ + + 
Cholesterol depletion inhibits the TRPC1-store 
operated Ca
2+
  signal. (Bergdahl et al., 2003) 
L-type 
Ca
2+
 
Cerebral 
artery 
+ + - 
Cav-1 ablation attenuates the coupling between 
L-type Ca
2+
channels and RyR channels. 
 
(Cheng and Jaggar, 2006) 
BKCa 
Endothelial 
(cell lines) 
+ - + 
BKCa channels are inactive under control 
conditions but can be activated by cholesterol 
depletion or knockdown of cav-1. 
 
(Wang et al., 2005) 
BKCa Aorta - - + 
Under normal conditions, cav-1 limits the 
contribution of the BKCa channels to EDHF-
mediated relaxation. Reduced expression of 
cav-1 leads to greater channel activity to the 
EDHF- mediated response, which seems 
essential for maintained coronary dilation.   
 
(Feher et al., 2010) 
Kir6.1 
Vascular 
smooth 
muscle cells; 
HEK293 cells 
+ 
- 
+ 
- 
+ 
- 
Cholesterol depletion eliminates cAMP/PKA-
dependent regulation of channel. PKC-
mediated caveolin-dependent internalisation. 
 
(Jiao et al., 2008) 
BKCa 
Gracilis 
artery 
endothelium 
+ - + 
BKCa channels are inactive under control  
conditions but can be activated by cholesterol 
depletion or exposure of the tissue to chronic 
hypoxia.    
(Riddle et al., 2011) 
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1.2.5.8.2 Role of caveolae in regulation of artery contraction 
A large number of signalling molecules are associated with caveolin as discussed 
above (Shaul and Anderson, 1998, Razani and Lisanti, 2001b). Furthermore, other 
molecules that are important in vascular physiology including eNOS, Ca
2+
-ATP-ase, 
and the endothelin receptor (Fujimoto et al., 1998) may be regulated by caveolins. 
For example, the impaired endothelin receptor-induced vascular contractility in cav-
1 knockout (KO) mice  shows further support for a role of caveolae and caveolins in 
GPCRs signalling.  
Normally, but not exclusively, artery contraction occurs as a response to graded 
membrane depolarisation which induces elevation of intracellular Ca
2+
 concentration 
in SMCs by opening of VDCCs (Klabunde, 2004). In contrast, there are a number of 
negative feedback mechanisms that decrease Ca
2+
 concentration in SMCs including 
the activation of BKCa channels (Hill et al., 2010). For example NO, which is 
released by endothelial cells and diffuses to SMCs, can activate BKCa channels and 
consequently decreases Ca
2+
 influx through VDCCs through the inhibitory effect of 
BKCa channels on VDCCs. However, several studies have shown that the cholesterol 
depletion from lipid rafts including caveolae is associated with impairment of both 
NO and Ca
2+
 signalling in the cardiovascular system, causing aberrations in 
endothelium dependent-relaxation and contractility, and consequently defects in 
myogenic tone, as summarised in Table 3. 
The effects of caveolae disruption by cholesterol depletion agents (such as filipin or 
M-β-CD) on endothelium-dependent relaxation in different vascular beds have been 
studied by Xu et al. using an organ bath technique (Xu et al., 2007). They reported 
that caveolae disruption in the rat aorta, small renal arteries and mesenteric arteries 
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caused impaired endothelium-dependent relaxation and reduced release of NO and 
endothelium-derived hyperpolarising factor (EDHF). Consequently, there was 
decreased NO-dependent relaxation after treatment by either filipin or M-β-CD (Xu 
et al., 2007). In the same experiment, the inhibition of NOS was examined by N
G
-
monomethyl-L-arginine) (L-NMMA). In the aorta, treatment with either filipin or M-
β-CD only inhibited the NO component, whereas in the renal artery both NO and 
EDHF pathways were affected. In contrast, in mesenteric arteries, filipin treatment 
only reduced EDHF-dependent response.  
The functional inhibition of caveolae in SMCs by cholesterol depletion with M-β-
CD has provided insights to the regulation of arterial contractility. Dreja et al. 
provided a useful model to explain why contraction was increased after M-β-CD 
treatment (Dreja et al., 2002) using rat tail artery devoid of endothelium. 
Contractions were induced using calyculin A (an inhibitor of myosin light chain 
phosphatase), KPSS (60 mM K
+
 to depolarize the cell membrane), cirazoline (α1-
adrenergic agonist), 5-HT (serotonin receptor 5-HT2A agonist), arginine vasopressin 
(AVP, vasopressin receptor V1 agonist), endothelin-1 (endothelin receptor ETA 
agonist), or AlF4 (a direct activator of G-proteins) before and after cholesterol 
depletion by M-β-CD. The cytoplasmic Ca2+ concentration of individual smooth 
muscle cells from the tail artery was also measured before/after cholesterol depletion 
(Dreja et al., 2002). In cholesterol-depleted preparations, the force response to 
calyculin A, high K
+
, cirazoline and AlF4 were unaffected. In contrast, responses to 
5-HT, AVP and endothelin were significantly reduced. Furthermore, analysis of 
sucrose density fractionation of non-treated tail artery showed an enrichment of 5-
HT2A receptors, but not α1-adrenergic receptors, with cav-1. This result could 
explain the persistence of the cirazoline-induced response after cholesterol depletion 
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(Dreja et al., 2002). The contractile response to 5-HT was dependent on extracellular 
Ca
2+
 and L-type Ca
2+ 
channels as verapamil, an L-type Ca
2+
 channel blocker, 
completely blocked 5-HT–induced contraction. As L-type Ca2+ channel activation by 
membrane depolarisation with KPSS was unaffected after cholesterol-depletion, the 
impaired 5-HT response after cholesterol depletion seems to be due to a reduced 
membrane depolarisation in response to 5-HT, leading to a compromised L-type 
Ca
2+
 channel activation (Dreja et al., 2002). 
Dreja et al. also suggested that the Ca
2+
 wave activity, originating from the SR, was 
selectively affected by cholesterol extraction, with a larger decrease for 5-HT than 
for cirazoline stimulation. This suggests that inositol trisphosphate (IP3) formation 
by 5-HT stimulation may have been impaired by cholesterol depletion. Also, Dreja et 
al. reported cholesterol depletion caused an increase in basal [Ca
2+
]i, with a possible 
consequence of increased Ca
2+
 loading to the SR. Indeed an increased response to 
caffeine (which opens RyR receptors) was observed after cholesterol depletion. 
Because Ca
2+
 release by cirazoline was also increased after cholesterol depletion 
whereas that by 5-HT was not, it may be inferred that IP3 production by the latter 
agonist had been reduced. In addition, the artery contraction to 5-HT was restored by 
exogenous cholesterol, which also restored caveolae formation. So, these results 
together conclude that the signalling pathways that regulate smooth muscle 
contraction depend on cholesterol, and serotonergic signalling depends on the 
integrity of caveolae (Dreja et al., 2002).  
The importance of the relationship between caveolae and SR on the contractility of 
rat mesenteric smooth muscle cells has been studied by Shaw et al. using pressure 
myography (Shaw et al., 2006). They used M-β-CD to disrupt caveolae, while 
calyculin-A was used to “de-associate SR and caveolae” (see below). Calyculin A is 
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a myosin phosphatase inhibitor and so produced maximum and practically 
irreversible contraction. Mesenteric arteries were stimulated with phenylephrine or 
U44619 (a thromboxane analogue) before and after M-β-CD treatment. Significantly 
reduced agonist contractility was observed for both agonists after M-β-CD treatment. 
In addition, electron microscopy of control mesenteric artery sections showed 
prominent peripheral SR in close juxtaposition to caveolae of the plasma membrane, 
as well as central SR close to mitochondria and the nucleus. However, electron 
microscopy examination of smooth muscle after the treatment with calyculin-A 
showed SR was no longer in close apposition to caveolae.  With M-β-CD treatment, 
caveolae were absent, although peripheral SR localisation close to the plasmalemma 
remained visible. Microscope examination of the artery smooth muscle that received 
cholesterol supplementation following M-β-CD showed a return of the close 
association of the peripheral SR with caveolae. Calyculin-A treatment markedly 
decreased Ca
2+
 oscillations in response to phenylephrine or U46619 (Shaw et al., 
2006). These results support the idea of the co-expression of caveolae and 
underlying peripheral SR in smooth muscle cells of mesenteric arteries regulates 
Ca
2+
 oscillations and contraction. 
The effects of caveolae disruption on vascular BKCa channels and contraction of rat 
femoral arteries are the main part of my study, and I will discuss this further in 
chapter 5 and 6.  
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Table 3. Vascular contractility associated with caveolae. + : yes; - : not shown; PE: phenylephrine. 
Vessel 
type 
Cholest
erol 
depletio
n agent 
type 
Elect
ron 
micr
osco
py 
Forc
e 
meas
ure
ment 
Physiological effects References 
Aorta, 
renal 
artery 
and 
mesenteri
c artery 
of rat 
M-β-CD 
and  
filipin 
+ 
Orga
n 
bath 
In the aorta, treatment with either filipin or M-β-CD only inhibited the NO component 
whereas in the renal artery, both NO and EDHF component were affected. In mesenteric 
arteries, filipin treatment only reduced EDHF component. 
  (Xu et al., 2007) 
 
Rat tail 
artery 
devoid of 
endotheli
um 
M-β-CD + 
Orga
n 
bath 
 
Enrichment of cav-1 occurred in the same fraction of sucrose gradient with 5-HT2H 
receptors, but not α1-adrenergic receptors. The contraction was inhibited in response to 
5-HT, arginine vasopressin (AVP) and endothelin-1 after disruption of caveolae, but 
responses to KPSS, calyculin A, cirazoline or AlF4 were not affected. 
(Dreja et al., 2002) 
Rat 
mesenteri
c arteries 
M-β-CD + 
Press
ure 
myo
grap
h 
Under normal conditions, SMCs exhibited a prominent peripheral SR that often 
encircled individual caveolae. Disruption of caveolae in SMCs caused decreased 
contractile force in response to PE or U46619.  
Electron microscopy investigation suggested that the disruption of the caveolae–SR 
associations with calyculin-A or M-β-CD treatment may explain the impaired Ca2+ 
oscillation triggered by PE or U46619. 
(Shaw et al., 2006) 
Intact 
aorta 
and 
fatty 
streak 
area of 
rabbit 
M-β-CD 
and  
filipin 
+ 
Orga
n 
bath 
Disruption of aortic endothelial caveolae caused reduced acetylcholine-induced 
relaxation. Caveolae disruption did not affect contraction with PE or relaxation 
responses to A23187 or the NO donor, sodium nitroprusside. 
L-NAME pre-treatment increased PE-induced contraction in a similar degree for both 
control and M-β-CD treated rings suggesting cholesterol depletion did not alter basal 
eNOS activity. Electron microscopy provided the evidence that the fatty streak deposit, 
observed in the animals fed with hypercholesterolemic diet, is associated with a decrease 
in caveolae ‘transductosomes’ abundance, which appears to represent a novel 
mechanism of endothelial dysfunction. 
  (Darblade et al., 
2001) 
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1.2.6 Caveolin knockout mice  
Cav-1 and cav-3 single and double knockout mice have been generated (Cohen et al., 
2004, Insel and Patel, 2007). Use of these animals as a model can aid the understanding 
of the caveolin signalling hypothesis (Insel and Patel, 2007). The importance of cav-1 in 
the formation of caveolae in vascular SMCs was studied by Drab et al. (2001). They 
demonstrated the absence of caveolae in cav-1 knockout mice, although cav-3 was still 
present in these animals. Furthermore, the most predominant phenotypes were detected 
in cardiac, vascular and pulmonary tissues and might be due to the loss of caveolae in 
multiple cells types (Murata et al., 2007). The tissue specific phenotypes exhibited by 
knockout mice are useful in examining the role of caveolae and caveolins at organ level. 
For example, cav-1 knockout mice showed blunted artery contractility, and this is 
consistent with the hypothesis that cav-1 tonically inhibits eNOS under normal 
conditions (Razani and Lisanti, 2001a). It has to be said, however, that use of knockout 
mice may have complications. Side effects of protein ablation may unexpectedly occur 
as the result of compensatory mechanisms in vivo. Thus, the outcome of cav-1 knockout 
is not necessarily expected to be exactly the same as that of M-β-CD or filipin treatment 
in vitro. Furthermore, while knockout of caveolins abolish the protein expression per se, 
drugs such as M-β-CD are “functional antagonists” of caveolins and will have no effect 
on caveolins expressed outside of caveolae.  
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1.2.7 Caveolins outside of caveolae   
Caveolin signalling has been shown to act independently of caveolae with other proteins 
in cells that do not have caveolae, such as leukocytes (Millan et al., 2006). Furthermore, 
caveolin has been shown to interact with other proteins outside of caveolae in cells such 
as cardiac myocytes (Head and Insel, 2007). Several studies have reported that caveolins 
outside of caveolae can regulate numerous signalling pathways, for example cAMP 
production (Head and Insel, 2007), cell adhesion (del Pozo et al., 2005), T cell 
activation (Ohnuma et al., 2004) and leukocyte diapedesis (movement of the cells 
through intact capillary walls into surrounding tissue (Millan et al., 2006)). Other studies 
have implicated caveolins in the trafficking of signalling molecules from and to the cell 
membrane (Head and Insel, 2007). Furthermore, although it has been shown that cav-1 
is linked with eNOS outside of caveolae, it is also reported that non-caveolar cav-1 fails 
to exert its inhibitory effect on eNOS. The physical proximity of cav-1 to eNOS within 
caveolae, therefore, is crucial in inhibiting NO release (Sowa et al., 2001). 
1.2.8 Methods to study caveolae 
Several approaches have been used to study caveolae as a subset of lipid rafts, using 
biochemical, microscopic, pharmacological and molecular biological techniques. In the 
case of a biochemical approach, lipid rafts and caveolae are extracted by subcellular 
fractionation after disruption of cells with or without detergents (Ostrom and Insel, 
2006, Patel et al., 2008a). Subsequently, lipid rafts and caveolae are separated using 
centrifugation of fractions with continuous (Optiprep) or discontinuous (sucrose) 
gradients, and can be isolated using immunoprecipitation, especially with anti-caveolin 
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antibodies. Without immunoprecipitation, one may not be able to distinguish between 
lipid rafts and caveolae due to the common properties shared by both (Ostrom and Insel, 
2006, Insel and Patel, 2007, Patel et al., 2008a). Pharmacological methods are also used 
to study caveolae, typically by treating cells with cholesterol depleting agents such as 
M-β-CD or filipin (Schnitzer et al., 1994, Lam et al., 2004, Xu et al., 2007). These 
agents are capable of removing the cholesterol from caveolae due to their ability to 
isolate lipophiles in their hydrophobic core by using cyclic oligomers of glucose 
(cyclodextrins) (Pitha et al., 1988). Several studies have reported that treatment with M-
β-CD led to the removal of cholesterol and then the disruption of caveolae structure 
(Prendergast et al., 2010). 
Microscopy studies can complement and validate the results of biochemical or 
pharmacological studies by determining the location of raft components (Ostrom and 
Insel, 2006). One of the most important aspects of microscopic techniques when 
combined with immunocytochemistry and immunohistochemistry is to show the 
expression of specific proteins in cells and tissues. Confocal microscopy, in particular, is 
a powerful tool as the co-expression of two proteins in a tissue or in an individual cell 
can be investigated (Riddle et al., 2011). In addition to confocal microscopy, electron 
microscopy was a giant leap forward in our understanding of cell structure, as it can 
magnify cells or a section of tissue up to X100,000, and can distinguish objects as small 
as 0.2 nm. Furthermore, in some cases, electron microscopy can be used for high 
resolution subcellular immunocytochemistry using immuno-gold labelled antibodies. In 
general, electron microscopy includes transmission electron microscopy (TEM), 
scanning electron microscopy (SEM) and electron microscope tomography (EMT). 
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TEM can be used to explore the internal structure of a cell. SEM can study the detailed 
architecture of the surface of a cell (Brodusch et al., 2013). EMT was used for decades 
and is used for three-dimensional imaging of the sub-cellular structures of a cell (Frey et 
al., 2006). All of these electron microscope types have been used in studies to describe 
caveolae shape, to show the localisation of a specific protein to caveolae, and to show 
caveolae disruption from the plasma membrane of several types of cells after treatment 
with a cholesterol depletion agent (Frey et al., 2006, Riddle et al., 2011). 
Gene knockout in mice is an alternative approach to study caveolae. Caveolin- knockout 
mice (cav-1, -2, -3 and cav-1/3 double KO mice) have been generated (Cohen et al., 
2004, Insel and Patel, 2007). Several diseases including cardiomyopathies and 
pulmonary arterial hypertension have been shown in cav-1 KO mice as a result of a lack 
of cav-1, as well as a lack of cav-2 and caveolae (in certain cell types) (Cohen et al., 
2004, Insel and Patel, 2007). However, it is not possible to say whether the loss of 
expression of caveolins in KO mice directly or indirectly caused these diseases, as 
discussed earlier.  
In addition to the methods described above, myography is a useful method to assess the 
effects of the removal of cholesterol using M-β-CD (Adebiyi et al., 2011) where 
contraction of arteries can be measured before and after treatment. 
1.3 Ion channels in vascular SMCs 
1.3.1 Calcium channels 
Vascular contractile force is regulated mainly by cytoplasmic free Ca
2+
 concentration of 
SMCs (Bolton and Imaizumi, 1996, Wellman and Nelson, 2003). In vascular SMCs, 
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neurotransmitters, membrane depolarisation and hormones can stimulate an increase in 
the cytoplasmic Ca
2+
 concentration due to the release of stored intracellular Ca
2+
 from 
the SR and/or an influx of extracellular Ca
2+
 due to the activation of Ca
2+
 channels in the 
cell membrane (Guibert et al., 1996). The Ca
2+
 entry pathways through Ca
2+
 channels 
into vascular SMCs can be classified into: (i) VDCCs such as L- and T-type Ca
2+
 
channels; and (ii) voltage-independent Ca
2+
 channels such as receptor-operated channels 
(ROCs), which are regulated by agonist-receptor interactions, as reviewed by (Spedding 
and Paoletti, 1992). 
1.3.1.1 Classification of voltage-dependent calcium channels   
Voltage-dependent Ca
2+
 channels represent the major Ca
2+
 entry pathway in vascular 
SMCs. VDCCs were first identified in 1953 by Fatt and Katz in crustacean muscle (Fatt 
and Katz, 1953). Later, VDCCs were also recognised in many cells types including 
vascular SMCs (Lacinova, 2005). VDCCs were initially classified based on their 
pharmacological and electrophysiological properties into (i) high voltage activated 
channels (HVACs) such as L-type Ca
2+
 channels, and (ii) low voltage activated channels 
(LVACs) such as T-type Ca
2+
 channels. The membrane potential required by HVACs 
for activation, such as L-type Ca
2+
 channels, is around -30 mV, whereas the membrane 
potential required by LVACs for activation is around -50 mV (Lacinova, 2005).  
1.3.1.1.1 L-type Ca2+ channel in vascular tissue 
In vascular SMCs, VDCCs are particularly important because influx of extracellular 
Ca
2+
 is essential for SMCs contraction (Fransen et al., 2012). L-type Ca
2+
 channel 
activity is a key regulator of vascular SMCs contractile state, and Ca
2+
 influx pathways 
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mainly depend on this channel type (Yamamura et al., 2013). The L-type VDCCs are 
the classic target of Ca
2+
 channel blockers extensively prescribed as antihypertensive 
drugs (Cribbs, 2001). Ablation of the L-type Ca
2+
 channel gene (CACN1C) in vascular 
SMCs in mice shows this channel has a dominant role in development of SMC tone 
(Moosmang et al., 2003). Knockdown of the channel using siRNA reduces blood 
pressure in a hypertensive rodent model (Rhee et al., 2009). L-type Ca
2+
 channels can be 
activated by several ways: (i) directly through depolarisation of the membrane by 
solutions such as high extracellular K
+
, which opens VDCCs, increasing Ca
2+
 entry 
(Nelson and Quayle, 1995). L-type Ca
2+ 
channels can also be activated by 
dihydropyridine agonists such as Bay K-8644 (Yamamura et al., 2013) that bind to the 
channel. (ii) indirectly by activating G-proteins and cellular signal transduction 
pathways in response to an agonist, such as noradrenaline (Nelson et al., 1988).  
Calcium entry through the L-type Ca
2+
 channel is important in maintaining the basal 
tone of smooth muscle, especially in the arteries of spontaneously hypertensive rats, as 
reviewed by (Karaki et al., 1997). It has also been demonstrated that stretching vascular 
tissues activates L-type Ca
2+
 channels and increases basal tone in basilar artery 
(Langton, 1993). In my work, I have chosen to directly activate L-type Ca
2+
 channel to 
induce rat femoral artery contraction. 
1.3.1.1.2   L-type Ca
2+
 channel blockers 
L-type calcium channels are responsible for regulating the influx of calcium into muscle 
cells, which in turn stimulates smooth muscle contraction and cardiac myocyte 
contraction (Hess et al., 1984). Calcium channels blockers bind to L-type Ca
2+ 
channels 
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located on the vascular smooth muscle and inhibit calcium influx into the cells. 
Therefore, these cause vascular smooth muscle relaxation (vasodilation). The most 
forceful and specific of the Ca
2+
 channel blockers are the dihydropyridines group, such 
as nifedipine, amlodipine and felodipine (Dube et al., 1985). On the other hand, the 
drug, Bay K8644 is a structural analogue of the dihydropyridines, which has effects 
opposite to those of nifedipine and other similar Ca
2+ 
antagonists (Schramm et al., 
1983). This compound causes vasoconstriction by competing for the nifedipine binding 
site, suggesting that it acts by increasing Ca
2+ 
influx through VDCCs (Schramm et al., 
1983).  
1.3.2 Potassium channels  
Potassium channels play a critical role in the regulation of electrical potential across the 
membrane of SMCs. The SMC membrane potential is essential in regulating contractile 
force by controlling Ca
2+
 influx, as well as indirectly regulating the release of 
intracellular Ca
2+
. Therefore, changes in SMC membrane potential will lead to a 
decrease or increase in cytosolic Ca
2+
 concentration, and therefore contraction. Factors 
that regulate the activity of K
+
 channels can have an effect on SMC contraction and 
therefore on vascular resistance, blood flow and blood pressure (Ko et al., 2008).  
As K
+
 channels regulate the membrane potential in SMCs, they control the probability 
of VDCCs being open, and hence regulate Ca
2+
 entry into the SMCs (Nelson et al., 
1995). Furthermore, it has been demonstrated that decreased K
+
 currents lead to a 
depolarised SMC membrane, which in turn gives rise to increased Ca
2+
 influx into the 
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SMC: this may play an important role in stimulating SMC contraction (Nelson and 
Quayle, 1995).  
1.3.2.1 Classification of vascular potassium channels  
In general, SMCs have four main types of K
+
 channels classified by their 
electrophysiological and pharmacological properties (Cook, 1988, Nelson and Quayle, 
1995). Voltage-activated K
+ 
channels (Kv) are encoded by the Kv gene family, BKCa 
channels by the Slo gene, inward rectifiers (KIR) by Kir2.0s, and ATP-sensitive K
+
 
channels (KATP) by Kir6.0s (Hu and Zhang, 2012). Furthermore, Ca
2+
-dependent K
+
 
channels (KCa) have been subdivided into three distinct classes based on their 
conductance. They are the large conductance BKCa channels, which are blocked by 
charybdotoxin (CTX) and IBTX (Miller, 1995), the intermediate-conductance (IK) 
channels, which are inhibited by TRAM-34 (Gaete et al., 2012), and the small-
conductance (SK) apamin-sensitive K
+ 
channels (Burnham et al., 2002). 
1.3.2.1.1 Large-conductance (BKCa) channels 
The large-conductance, Ca
2+
-activated K
+
 channels (BKCa, also called Slo or MaxiK) 
were first identified by Marty 1981 (Marty, 1981). These channels are abundant in 
vascular SMCs (Hu and Zhang, 2012) and are characterised by their large conductance 
of K
+
 (Hu and Zhang, 2012). BKCa channels play an important role in many cellular 
functions, such as action potentials, hyperpolarisation and the modulation of vascular 
tone under physiological conditions. The major role of vascular SMC BKCa channels in 
the regulation of arteriolar tone is to hyperpolarise the SMC plasma membrane, which 
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consequently would decrease the opening of L-type Ca
2+ 
channels and relax the blood 
vessel.  
BKCa channels are a tetramer composed of pore-forming α-subunits and a family of 
tissue-specific accessory β-subunits. The α-subunit is abundantly expressed in SMCs 
and encoded by a single gene (KCNMA1) with various spliced isoforms; β-subunits are 
encoded by four genes (KCNMB1-4) (Lee and Cui, 2010). The α-subunit consists of 
seven transmembrane-spanning domains (S0–S6). S4 contributes to voltage-sensing and 
S5–S6 make up the pore-forming region (figure 1.8) (Latorre and Brauchi, 2006, Lee 
and Cui, 2010). In addition, a transmembrane S0 domain leads to an extracellular N-
terminus (Lee and Cui, 2010). The large cytosolic tail domain of the α-subunit includes 
two conductor domains (RCK1 and RCK2) forming an intracellular C-terminus. These 
conductor domains are believed to be Ca
2+
-sensing because they have high affinity Ca
2+
 
binding sites on both RCK1 and RCK2 domains (Yuan et al., 2010). RCK1 and RCK2 
are therefore believed to provide the structural basis for Ca
2+
 sensitivity and form a gate 
ring to stimulate channel opening in response to increases in intracellular Ca
2+
 (Dopico 
et al., 2012).  
The β-subunits comprise of two transmembrane-spanning domains (S1 and S2). Both 
ends of the β-subunits (N- and C-terminals) are intracellular (Ledoux et al., 2006). 
These domains are believed to contribute to their sensitivity to cytosolic Ca
2+
 
concentration. SMC BKCa channels contribute to the regulation of membrane potential, 
and therefore vascular tone, and function as a negative feedback mechanism to decrease 
vasoconstriction (Brayden and Nelson, 1992). As well as being modulated by several 
vasodilators and vasoconstrictors, these channels are a potential therapeutic target for 
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several artery diseases, such as hypertension and atherosclerosis. BKCa channels are 
considered to be promising candidate because little expression of these channels is 
found in cardiomyocytes, offering vascular selectivity. Additionally, the ability of BKCa 
channels to allow efflux of K
+ 
is greater than any other K
+
 channel present in SMCs due 
to their large conductance (Ghatta et al., 2006). Furthermore, the sensitivity of BKCa 
channels to voltage-dependent opening is weaker than other voltage-dependent K
+
 
channels in SMCs (Ghatta et al., 2006). 
 
 
 
Figure ‎1.8. Diagram showing the components of the BKCa channel. BKCa channels consist of 
channel-forming (α) and accessory (β) subunits. The α-subunit is made of seven membrane-
spanning domains (S0 to S6). The K
+
 pore is located between S5 and S6. S4 contributes to 
voltage-sensing. The α-subunit contains an extracellular N-terminal and intracellular C-terminal 
domain. The cytoplasmic tail domain contains RCK1 and RCK2 as intracellular Ca
2+
 binding 
domains. The β-subunits are made of two membrane-spanning domains (S1 and S2), with both 
the N-terminal and C-terminal located in the cytoplasm.  
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1.3.2.1.1.1   BKCa channel openers 
 
The BKCa channel openers are made up of a big group of synthetic benzimidazolone 
derivatives, such as NS-004 and NS-1619, and biaryl amines, such as mefenamic and 
flufenamic acids (Hill et al., 2010). The activation mechanism of both NS-004 and 
NS1619 on BKCa channels is to target the α-subunits and (i) enhance the Ca
2+
 binding 
sites (RCK1 and RCK2) at the C-terminal of the α-subunit, and (ii) support the 
interaction between the α- and ß-subunits. The action of NS-1619 was first identified by 
Olesen et al. in 1994 in aortic SMCs (Olesen et al., 1994) where it induced 
hyperpolarisation of SMCs. In addition, BKCa channels in vascular SMCs can also be 
activated by other physiological BKCa channels openers such as isoproterenol (White et 
al., 2000). 
1.3.2.1.1.2   BKCa channels blockers   
BKCa channels blockers are made up from a large group of agents and toxins such as 
IBTX, charybdotoxin and quaternary ammonium compounds including 
tetraethylammonium ions (TEA
+
) (Langton et al., 1991) and tetrabutylammonium ions 
(TBA
+
) (Kwok et al., 1998). Some of these blockers, such as IBTX and TEA
+
, are 
relatively selective for the BKCa channel, while charybdotoxin also inhibits other K
+
 
channels such as IKCa and SKCa. IBTX and charybdotoxin act by blocking the 
movement of K
+
 by binding to a site in the external vestibule of the pore and occluding 
the extracellular side of the pore (Giangiacomo et al., 1992). All the above BKCa 
channels blockers lead to the depolarisation of SMCs and activate VDCCs, leading to 
vasoconstriction (Giangiacomo et al., 1992). Additionally, several studies showed that 
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application of vasoconstrictors such as 5-HT, phenylephrine, angiotensin II (Alioua et 
al., 2002) and endothelin-1(Minami et al., 1995) was accompanied by a suppression of 
BKCa channel activity.  
1.4 Contraction and relaxation mechanisms of intact arteries 
In the vascular SMCs of resistance arteries, vasoconstrictor stimuli initiate SMC 
contraction by causing an increase in the intracellular Ca
2+
 concentration (Aaronson and 
Ward, 2007). An increase in intracellular Ca
2+ 
concentration leads to Ca
2+
 binding to the 
cytoplasmic regulatory protein calmodulin, thus forming Ca
2+
/calmodulin complexes. 
An increase in Ca
2+
/calmodulin complexes leads to the activation of the enzyme myosin 
light-chain kinase (MLCK). The activation of MLCK leads to the phosphorylation of 
myosin light chain heads, which in turn leads to myosin-actin cross-bridge formation, 
causing the contraction of SMCs (Aaronson and Ward, 2007). A change in Ca
2+
 
concentration in SMCs is mediated by: (i) an influx of extracellular Ca
2+
 via VDCCs, 
such as L-type Ca
2+
 channels, and receptor-operator channels (ROCs); (ii) the release of 
stored Ca
2+
 from the SR due to the activation of GPCRs by vasoconstrictors such as 
norepinephrine (NE) and endothelin-1 (ET1); and (iii) decreased removal of intracellular 
Ca
2+
 via Ca
2+
-ATPase pumps (Levick, 2010). The main Ca
2+
 entry pathway in SMCs is 
through L-type Ca
2+
 channels (Moosmang et al., 2003). In contrast, increased 
concentrations of cytoplasmic Ca
2+
 lead to the activation of K
+ 
channels such as BKCa 
channels. Activation of BKCa channels causes an efflux of K
+
, therefore causing 
membrane hyperpolarisation and thus decreasing contraction due to the switching off of 
L-type Ca
2+
 channels. 
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Endothelial cells regulate local vascular tone via the diffusion of several vasodilatory 
factors from ECs into SMCs. Nitric oxide is one of these factors. Activated muscarinic-3 
receptors (M3) in the ECs cause an influx of Ca
2+
 via ROCs and release Ca
2+
 from the 
ER due to increases in IP3. Both lead to an increase in intracellular Ca
2+
 concentration. 
An increase in intracellular Ca
2+ 
concentration leads to the interaction of Ca
2+
 with 
cytosolic calmodulin, thus forming Ca
2+
/calmodulin complexes. An increase in 
intracellular Ca
2+
/calmodulin complexes leads to the dissociation of eNOS from cav-1, 
thereby increasing eNOS activity and promoting the conversion of L-arginine to L-
citrulline and the production of NO (figure 1.9) (Griffith and Stuehr, 1995).  
For resistance artery SMCs, NO diffuses from ECs into SMCs, leading to the activation 
of guanylyl cyclase (GC). The activation of GC leads to the conversion of guanosine-5'-
triphosphate (GTP) to cGMP. cGMP activates protein kinase G (PKG), which has 
multiple vasodilating effects: (i) it activates K
+
 channels, causing membrane 
hyperpolarisation that inhibits Ca
2+
 influx by switching off L-type Ca
2+
 channels; (ii) it 
stimulates the sequestration and extrusion of Ca
2+
 via Ca
2+
-ATPase; and (iii) it 
stimulates myosin phosphatase by inhibiting Rho kinase (figure 1.9). 
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Figure ‎1.9. A schematic representation of the signalling mechanisms in both SMC and EC 
which regulate the normal contraction and relaxation of intact arteries. 
 
 
 
1.5 Hypothesis  
The role of caveolae and caveolins in regulating arterial contractility is the main subject 
of my thesis. We hypothesise that BKCa channels are co-expressed to caveolae in 
vascular cells of the rat femoral artery. The specific aims of this project are to: (i) 
examine the structural properties and distribution pattern of caveolae, caveolins and 
BKCa channels in rat femoral artery using electron microscopy and confocal microscopy; 
and (ii) study the role of caveolae and BKCa channels in regulation of the contraction 
and relaxation in femoral artery rings using myography. 
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Chapter 2 General Materials and Methods 
2.1 Dissection of the femoral arteries and tissue preparation  
Male Wister rats (200-250 g) were humanely killed while unconscious, having been 
made so by exposure to a gradually raised concentration of CO2, followed by cervical 
dislocation and exsanguination by trained personnel in accordance with Schedule 1 of 
the UK Animals (Scientific Procedures) Act, 1986. The legs were cut off, and femoral 
arteries were carefully dissected from the surrounding fat and connective tissues and 
placed into the physiological salt solution (PSS) (see 2.5.5 in this chapter).  
2.2 Reagents and kits 
All general chemicals were purchased from Sigma-Aldrich Ltd (The Old Brickyard, 
New Road, Gillingham, Dorset, SP8 4XT) or Fisher Scientific (Bishop Meadow Road, 
Loughborough, LE11 5RG) or VWR International (Hunter Boulevard, Magna Park, 
Lutterworth, Leicestershire, LE17 4XN). Derails of specialised chemicals are given in 
corresponding sections. 
2.2.1 Primary antibodies 
Mouse monoclonal anti-cav-1 (cat no. 610406) and anti-cav-3 (cat no. 610420) 
antibodies were purchased from BD Biosciences (Edmund Halley Road, Oxford Science 
Park, Oxford, OX4 4DQ). Mouse monoclonal anti-actin and anti-α-actin antibodies were 
purchased from Sigma-Aldrich Ltd. Rabbit polyclonal anti-vWF antibody was 
purchased from Dako UK Ltd (Cambridge House, St Thomas Place, Ely, 
Cambridgeshire, CB7 4EX). Rabbit polyclonal anti-BKCa channel antibody was bought 
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from Alomone Labs (Jerusalem, Israel). Dilutions used for primary antibodies were as 
follows. Anti-cav-1, 1:200; anti-cav-3, 1:500; anti-BKCa, 1:500; anti-actin and anti-α-
actin, 1:300; anti-vWF, 1:300. All the primary antibodies were diluted using antibody 
diluting solution. 
2.2.2 Secondary antibodies 
Anti-mouse Alexa Fluor 488 (green)/ Alexa Fluor 594 (red) and anti-rabbit Alexa Fluor 
488 (green)/ Alexa Fluor 594 (red) were used as secondary antibodies (Life 
Technologies Ltd, 3 Fountain Drive, Inchinnan Business Park, Paisley, PA4 9RF). All 
secondary antibodies were diluted in 1:500 using antibody diluting solution. 
2.2.3 Slide preparation for histology, immunohistochemistry and 
immunocytochemistry  
The slides were washed with soap, rinsed with running tap water then distilled water, 
and then dried. For immunohistochemistry experiments, the slides were then rinsed with 
100% ethanol and dried for 100 minutes at room temperature. They were then dipped in 
the gelatine-coating solution (gelatine (0.8 g) and chromium potassium sulfate (0.08 g) 
dissolved in 400 ml of warm distilled water) for 3 minutes. Afterwards, the gelatin-
coated slides were air-dried overnight. Gelatin-coating was necessarily in order to 
prevent the tissue slices coming off from the slides during the staining procedure. 
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2.3 Ultrastructure study of femoral artery using transmission electron 
microscopy and histology techniques 
The purpose of transmission electron microscopy (TEM) was to investigate the 
topological relationship between caveolae and sarcoplasmic reticulum (SR) (caveolae-
SR) or caveolae and mitochondria (caveolae-mitochondria) in the SMCs and ECs of 
intact and methyl β-cyclodextrin (M-β-CD) treated femoral arteries. 
The purpose of histological technique was to show the microscopic structure of rat 
femoral artery and to confirm the removal of endothelial cells from the intima of the 
femoral artery. 
2.3.1 Transmission electron microscope preparation of rat femoral arteries  
Femoral arteries were treated with 5 mM M-β-CD (n=5) and matched with a control 
group of arteries (n=5). Both groups were cut into small pieces (about 0.5 mm
3
). The 
segments were immediately fixed (4% paraformaldehyde and 2.5% glutaraldehyde) in 
0.1 M sodium cacodylate (pH 7.4) overnight at room temperature. Next day, the samples 
were rinsed three times in 0.1 M sodium cacodylate and then post-fixed in 1% (w/v) 
osmium tetroxide (OsO4) in 0.1 M sodium cacodylate for 1 hour. The samples were then 
rinsed with 0.1 M cacodylate for 30 minutes each, and then incubated with 0.1 M 
cacodylate overnight. The next day, the samples were washed with distilled water and 
ethanol, for 30 minutes each, and incubated in 2% aqueous uranyl acetate for 60 minutes 
before routine embedding in resin. The samples were dehydrated through a graded series 
of alcohol (60, 70, 80, 90 and 100%), five minutes for each. Afterwards, the segments 
were immersed in 100% acetone to remove water from the tissues. The samples were 
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then embedded in resin (30% resin:70% acetone; 70% resin:30% acetone and 100% 
resin) for 1, 1 and 2 hours, respectively. The samples were left in the oven at 60
°
C to 
polymerise overnight (Kuo et al., 2001). Ten sections were cut from each group (control 
group and M-β-CD treated group) at a thickness of 70-90 nm using an ultramicrotome, 
Leica EM FC6 (Ernst-Leitz-Straße 17-37, Wetzlar, D-35578, Germany). Ultrathin 
sections were picked up on coated copper grids of 300-mesh, with 0.3% Pioloform. 
Subsequently, the grids were dried out overnight at room temperature. The grids were 
double stained with 2% aqueous uranyl acetate, four minutes each, and thereafter the 
grids were rinsed with distilled water for one minute; the grids were re-stained again 
with 0.1 M lead citrate for four minutes. Afterwards, the grids were washed with 
distilled water for a minute and left overnight at room temperature to dry. 
2.3.2 Histological preparation of rat femoral arteries 
Intact and endothelium-denuded arteries were used (n=5 in each group). The 
endothelium was removed from artery rings by gently rubbing the intimal surface with a 
human hair. Arteries were cut into small pieces and then fixed in 10% formaldehyde 
fixative. In an automatic tissue processor (Shandon Elliott duplex processor, Type SCE-
0545, Shandon LTD, Camberley), the tissues were dehydrated in 60%, 70%, 80% and 
100% ethanol for 30 minutes each. After the dehydration, the samples were cleared with 
xylene for 90 minutes and embedded in paraffin wax for three hours. During this 
process the tissue samples were placed into molds along with liquid embedding wax, 
which then hardened. The blocks were sectioned at a thickness of 5 microns using a 
Leica microtome (RM2245). The sections were mounted onto slides coated with 2% 
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gelatin. For histological examination, 20 sections from endothelium-denuded and 
endothelium-intact arteries were stained with Ehrlich Hematoxylin and Eosin (Culling, 
1974). Cytoplasm showed up as a pink colour whereas nuclei were stained a blue/purple 
colour. 
2.4 Studies using immunohistochemistry, immunocytochemistry and Western 
blotting techniques 
Immunohistochemical technique was used to identify the localisation of cav-1, cav-3 
and BKCa channels at the tissue level of the rat femoral artery. Immunocytochemical 
technique was used to examine expression pattern of these proteins in the individual 
smooth muscle cells of rat femoral arteries and cultured human coronary artery 
endothelial cells (HCAEC) (PromoCell GmbH, Handschuhsheimer Landstr.12, D-69120 
Heidelberg, Germany). vWF and α-actin were labelled as specific markers for ECs and 
SMCs, respectively. The size of proteins that were recognized by primary antibodies 
against cav-1, cav-3, BKCa channels and α-actin were examined by Western blotting. In 
some cases, double staining was performed. If two primary antibodies were from 
different species, we conducted dual indirect staining. If two primary antibodies were 
from the same species, we used the combination of indirect and direct staining 
techniques. 
2.4.1 Immunohistochemical preparation of rat femoral arteries 
Femoral arteries of rats were dissected and immediately placed in PSS (see 2.5.5 in this 
chapter). Then, the arteries were cut into approximately 4 mm lengths and embedded in 
CRYO-M-BED embedding media (Bright Instrument Limited, St Margarets Way, 
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Huntingdon, PE18 6EB) on a cork disk. The blocks were frozen in isopentane cooled in 
liquid nitrogen and were cut using a cryostat (Bright Instrument Limited) at 11 µm 
thickness. The cut section was placed in the middle of a gelatine-coated slide and, using 
a DAKO pen, a circle was drawn around the section in order to confine the liquid on the 
slice. The slice was fixed in 2% paraformaldehyde in PBS solution containing (in mM): 
KCl 2.7, KH₂PO4 1.5, NaCl 137, and Na₂HPO4 8 (pH 7.4). Aldehyde forms cross links 
between reactive end-groups of adjacent protein chains, thereby fixing the preparations. 
Fixing solution was added carefully inside the circled area and left for 5 minutes; 
afterwards the fixative was removed. A 100 mM glycine buffer (pH 7.4), which 
quenches paraformaldehyde reaction in the tissue, was added carefully and left for 10 
minutes at room temperature. The section was then permeabilized using 0.1% Triton 
X100 in PBS to make holes in the cell membrane so that antibodies, which are large 
molecules, can get in to the cells and bind to their epitopes. The permeabilizing solution 
was removed, and the slide was washed three times using PBS, 5 minutes each time, at 
room temperature. The PBS solution was then removed and an antibody diluting 
solution, containing 2% goat serum, 1% bovine serum albumin (BSA) and 0.05% Triton 
X100 in a sodium citrate buffer (SSC) containing (in mM) NaCl 150 and Na3 citrate 15 
(pH 7.2), was applied to block non-specific binding of antibodies for 30 minutes at room 
temperature in the humidifier (Ramos-Vara, 2011). 
2.4.1.1 Indirect staining 
The indirect method of immunolabelling was used when only one primary antibody was 
used, or when two primary antibodies raised in different host species were used. The 
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tissue sections were incubated with the diluted primary antibodies in a humidifier 
overnight at 4 
°
C. After overnight incubation, the primary antibodies were removed, and 
the slides were washed 3 times, for 10 minutes each time, at room temperature, using an 
antibody washing solution which contained (in mM) NaCl 150, Na3 citrate 15 and 0.05% 
Triton X100 (pH 7.2). The antibody wash solution was then removed and diluted 
secondary antibody was added and left for 90 minutes at room temperature in a 
humidifier. The humidifier was kept in the dark to avoid any bleaching of the 
fluorophore. The slides were then washed 3 times with an antibody wash solution, for 10 
minutes each time at room temperature to remove un-bound secondary antibody. 
Finally, slices were washed twice consecutively with distilled water, and then left in the 
dark to dry. A small drop of mounting media (Bright Instrument Limited) was added on 
the slide, and covered with a clean cover slip (13 mm diameter, thickness 1), and kept in 
dark overnight to dry (Ramos-Vara, 2011). 
2.4.1.2 Direct staining 
For double immunolabelling with two primary antibodies from the same host species, 
the direct staining method was used for the second primary antibody. In my work, this 
was only required when co-staining with rabbit anti-BKCa channels and rabbit anti-vWF. 
The slices were incubated with diluted rabbit anti-BKCa primary antibody, and then 
labelled with anti-rabbit secondary antibody. A Zenon IgG antibody labelling kit 
(Molecular Probes) was used to directly conjugate rabbit anti-vWF primary antibody 
with anti-rabbit secondary Fab fragments (fragment with antigen binding site) tagged 
with fluorophore. Any excess un-bound Fab fragments were neutralised by the addition 
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of goat serum before the primary-secondary antibody complex was applied to the slices. 
After washing of the primary-secondary antibody complex, the slices were post-fixed to 
compensate for lower avidity of the Fab fragment (Ramos-Vara, 2011). 
2.4.1.3 Negative control 
For the negative control, two methods were used: (i) secondary antibodies were mis-
matched against primary antibodies (eg. anti-rabbit secondary used for mouse primary). 
(ii) secondary antibodies were applied without primary antibody incubation (Ramos-
Vara, 2011).  
2.4.2 Preparation of rat femoral arteries SMCs 
Femoral arteries were dissected under a microscope and cut into small pieces (2-4 mm). 
Single cells were obtained using an enzymatic digestion procedure. Arteries were first 
incubated for 40 minutes at 35 
°
C in a low (0.1 mM) Ca
2+
 buffer containing 1.4 mg ml
-1
 
papain (Sigma), 0.9 mg ml
-1
dithioerythritol (Sigma) and 0.9 mg ml
-1
 bovine serum 
albumin. The 0.1 mM Ca
2+
 buffer contained (in mM) :137 NaCl, 0.44 NaH₂PO4.H₂O, 
0.42 Na₂HPO4, 4.17 NaHCO3, 5.6 KCl, 1 MgCl₂, 10 HEPES and 0.1 CaCl₂  (pH 7.4). 
Arteries were further digested for 20 min at 35 
°
C in the low Ca
2+
 buffer containing 1.7 
mg ml
-1
 collagenase (Type F, Sigma) and 1 mg ml
-1
 hyaluronidase (Type I-S, Sigma). 
After enzyme treatment, the artery was rinsed in the low Ca
2+ 
buffer, and single cells 
were dispersed in this solution by trituration of the digested tissue using a fire-polished 
Pasteur pipette (Skoog and Tani, 2011). 
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2.4.2.1 Fixation 
A suspension of SMCs was added onto size-1 cover slips placed in the bottom of the 
wells of a 24-well plate, and cells were allowed to settle. SMCs were fixed with 2% 
paraformaldehyde in PBS solution (pH 7.4) for 10 minutes at room temperature. 
Quenching and permeabilising were performed in the same manner as described in 
2.4.1.  
2.4.2.2 Blocking and staining  
Blocking and staining of the single cells were performed in the same way described in 
2.4.1 and 2.4.1.1 for frozen tissue sections.  
2.4.3 Immunohistochemical preparation of HCAECs 
2.4.3.1 Fixation 
HCAECs (PromoCell) were cultured on sterilised coverslips in 24 well plates with MV2 
media (PromoCell). When ready to start experiments, the entire medium was removed 
and the wells were washed with PBS (pH 7.4). In order to fix the cells, 1 ml of 2% 
paraformaldehyde in PBS solution was added to each well and left for 10 minutes. 
Afterward, the same process described for rat femoral artery smooth muscle cells 
(2.4.2.1) was followed. 
2.4.3.2 Blocking and staining  
The same process described for rat femoral artery smooth muscle cells (2.4.2.2) was 
followed. 
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2.4.4 Confocal microscope 
The most notable advantage of confocal microscopy compared to conventional 
fluorescent microscope is the elimination of out-of-focus signal. Thus, the confocal 
images are sharper and so more detailed information regarding the origin of signal can 
be obtained.  In addition, the confocal technique allows the users to collect serial optical 
sections from thick specimens thereby re-constructing the 3-D images. The disadvantage 
of confocal microscopy is it requires a powerful excitation light (usually laser) that may 
bleach fluorophore although this problem is largely overcome due to the development of 
fade-resistant probes such as Alexa Fluor. Alexa 488 is excited by 488 nm light and 
Alexa 594 is excited by 594 nm light. Light is directed by a dichroic mirror towards a 
pair of rotating mirrors. Then the excitation light excites the fluorescent sample after 
passing through the microscope objective. The same mirrors are used to descan emitted 
light due to specimen fluorescence. The light then passes through the dichroic mirror 
through a pinhole placed in the conjugate focal plane of the sample. The dichroic mirror 
is used to allow light above a certain wavelength to pass while the pinhole rejects all 
out-of-focus light arriving from the sample. Finally, the light is measured by a detector 
such as a photomultiplier tube. The reconstruction of a 2D image of the object is done 
by scanning the illumination beam across the specimen. At the same time, this image is 
built up, pixel by pixel, using a computer that is attached to the detector (figure ‎2.1). 
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2.4.5 Data analysis of immunostaining 
An immunofluorescence microscopic analysis of fluorescence intensity was semi-
quantified using Leica confocal software (LCS) Lite in an attempt to profile the relative 
strength of light along the line of interest. The intensity profile was then plotted using 
OriginPro 8.6. 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
Rotating mirrors 
Fluorescent sample 
Detector 
(PMT)    
Microscope 
Screen with pinhole   
Laser 
Dichroic mirror     
 
Figure ‎2.1. Schematic layout of the confocal microscope. Laser is scanned across the specimen 
by scanning mirrors. Pinholes serve to reject out-of-focus light. 
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2.4.6 Western blotting 
Western blot is often used along with immunohisto- and immuno-cytochemistry. The 
former assess the size of detected proteins (but not necessarily where the protein is 
expressed) and the latter identify the location of protein expression (but not necessarily 
confirming that the primary antibody is binding to the right protein). In my work, 
antibodies were used mainly for the immunohisto- and immunocyto-chemical work, but 
Western blotting technique was also used to confirm the protein expression of cav-1, 
cav-3, and α-actin in rat femoral artery lysates, as well as to confirm protein expression 
of BKCa channels in both the brain and femoral artery.  
2.4.6.1 Tissue sample preparation  
Rat femoral arteries were homogenized in a lysis buffer (3 mM EGTA, 250 mM NaCl, 3 
mM EDTA and 20 mM TrizmaHCl) in the presence of protease inhibitors (Sigma) on 
ice. Thereafter, the samples were centrifuged at 13000 rpm for 10 minutes at 4
°
C, and 
the supernatant was collected and pellet was discarded. Supernatant protein extracts 
were mixed with X2 sample buffer and heated for 10 minutes at 98 
°
C for protein 
denaturation. 
2.4.6.2 Acrylamide gel 
7 µl of rainbow molecular weight marker (GE Healthcare Life Sciences, Amersham 
Place, Little Chalfont, Buckinghamshire, HP7 9NA) and 25 µl of protein lysates were 
loaded to the wells of a 4 % stacking gel. Protein samples were separated in 10% 
resolving gel. 
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2.4.6.3 Electrophoresis 
Gel cassette containing 2 gels was placed in the gel tank, and filled to the top with SDS 
running buffer (25 mM Tris base, 192 mM glycine and 3.5 mM SDS). Remaining 
running buffer was poured into the gel tank, outside of the gel cassette.  Gel was then 
run at 120V for 60 minutes. 
2.4.6.4 Transfer 
The proteins separated on acrylamide gel were then transferred onto a nitrocellulose 
membrane in the gel tank surrounded by crushed ice. The transfer buffer consisted of 25 
mM Tris base, 192 mM glycine and 20% methanol, and protein transfer was achieved 
by providing 110 V for 1 hour.  
2.4.6.5 Blocking and detection 
The membranes were removed from the cassette and rinsed with TBST containing (in 
mM) Trizma 20, NaCl 137 and 0.1% Tween 20 (pH 7.6). The membranes were then 
stained in Ponceau S (Sigma-Aldrich) to check the separation of proteins and transfer 
efficiency before moving on to the next step. If the membranes were deemed fit for 
proceeding, Ponceau S staining was removed by washing the membranes with TBST on 
a rocking platform. Membranes were then blocked in a TBST solution containing 1 % or 
5 % non-fat milk (to block non-specific binding) for one hour at room temperature on 
the rocking platform.  
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2.4.6.5.1 Antibodies 
2.4.6.5.1.1   Primary antibodies 
The membranes were probed with mouse monoclonal anti-cav-1 (dilution, 1:200), 
mouse monoclonal anti-cav-3 (1:500), rabbit polyclonal anti-BKCa channels (1:300) and 
mouse monoclonal anti α-actin (1:300). All the primary antibodies were diluted with 
TBST with 1 % or 5 % non-fat milk, and membranes were incubated with diluted 
primary antibodies at the volume of 1 ml in the fridge overnight. 
2.4.6.5.1.2   Secondary antibodies 
Membranes were washed quickly several times with TBST to remove most of primary 
antibodies and then further washed in a TBST solution 3 times 10 min each. The 
membranes were then incubated with secondary antibodies for 90 minutes at room 
temperature. The secondary antibodies used were: anti-rabbit IgG conjugated with 
horseradish peroxidise (HRP), diluted with 1 % or 5 % non-fat milk-TBST to 1:5000, 
and anti-mouse IgG conjugated with HRP, diluted with 1% or 5 % non-fat milk-TBST 
to 1:10000. 
2.4.6.6 Western blot-stripping 
In some cases, stripping of the antibodies from the original blot was performed to allow 
re-blotting of the membrane against actin, a house-keeping protein, to check for equal 
gel loading among wells. After the first experiment, the membranes were rehydrated 
with TBST and then washed using the stripping solution consisting of 100 mM β-
mercaptoethanol, 2% SDS and 62.5 mM Tris base (pH 6.7) 2 times for 10 min each at 
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room temperature. After this, the membranes were rinsed several times with TBST, and 
blocked with a TBST with 5% non-fat milk solution. The membranes were incubated 
with mouse monoclonal anti-actin primary antibody diluted with TBST with 5 % non-fat 
milk overnight, and rest of the procedure was followed as normal Western technique. 
2.4.6.7 Visualisation 
Presence of HRP-conjugated secondary antibodies was detected using an enhanced 
chemiluminescence (ECL) technique, and light was captured using auto-radiographic 
Hyperfilm (Amersham) in a hyper-cassette. Exposure time was varied depending on the 
strength of the signal, and the Hyperfilm was developed and fixed and the image was 
scanned so that bands can be sized against pre-stained rainbow ladder. 
2.5 Femoral artery contraction and relaxation studies  
Femoral artery contraction (measured in mN) was induced using KPSS or 20 mM 
K/Bay K 8644 under the different conditions mentioned in chapters 5 and 6 using 
myography. Values were expressed as means  SEM. Vasorelaxant responses of the 
vasodilators were expressed as the fraction of the maximal contraction to either KPSS 
and/or 20 mM K/Bay K 8644. 
2.5.1 Myography 
Wire myography (Dual Wire Myograph System 510A, DMT A/S, Aarhus, Denmark) is 
an in vitro technique which allows small arteries with a diameter of 100-500 μm to be 
studied under isometric condition (Mulvany and Halpern, 1977, Mulvany and Aalkjaer, 
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1990). Arteries were dissected, cleaned, and then mounted onto a two-channel 
myograph. Each artery was then normalised to determine its maximum active tension 
development. This allows for the standardisation of the initial experimental condition. 
This is the technique I used for my study to obtain a functional read-out after 
manipulation of cholesterol/caveolae. 
The myograph contains two jaws, on which the artery was mounted (figure 2.2). One 
jaw was attached to a micrometre and the other to a piezo-electric isometric force 
transducer. Piezo-electric force transducers have a linear output over a wide range of 
force up to 50 mN and can compensate for changes in temperature. The wire myograph, 
including a sensor probe, was connected to a Myo-interface, which gives a visual read-
out of force and temperature. The Myo-interface had an analogue output that was 
converted to a digital signal by a minidigi converter and signal recorded with a PC using 
the Axoscope software (Axon Instruments, Union City, California, USA) with an 
acquisition rate of 20Hz.  
 
 
64 
 
 
Figure ‎2.2. Dual wire myograph system (410M). Adapted from the DMT website 
(www.dmt.dk). 
 
2.5.2 Mounting of artery 
Each strip of artery was mounted on two 40 μm diameter stainless steel wires, where 
one wire was attached to the force transducer and the other to the micrometre (Mulvany 
and Halpern, 1977). Wire was first secured underneath one screw on the upper surface 
of the stainless steel jaw that was connected to the micrometre. The vessel was then 
threaded onto the free end of the wire and pulled into position over the centre of the jaw, 
and the wire then secured underneath the second screw on the same stainless steel jaw. 
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After this, the second wire could be threaded through the vessel; the jaw attached to the 
micrometer and containing the artery was then carefully moved closer to the other jaw 
attached to the force transducer, so that the second wire could be secured to its 
corresponding screws. The mounting of the artery was done at room temperature, and 
once finished, the myography chamber was warmed to 37 
°
C. 
2.5.3 Equilibration 
The arteries were bathed in PSS at 37 
°
C for 30 minutes to equilibrate before being 
normalised. The aim of the equilibration period is to allow the arteries to gradually 
warm up to experimental temperature and to reset the ion gradients that may have 
become altered during dissection and the changing of the PSS. The equilibration period 
also allows for the acquisition of a stable stage of passive tension. When the chamber 
warmed up to 37 
°
C, the force transducer was zeroed while two jaws were closed 
together so that there was no tension from the artery due to stretch. 
2.5.4  Normalisation 
The objective of the normalisation procedure was to set the artery to standard primary 
conditions (i.e. resting tension). Normalisation allows arterial force to be accurately 
measured by determining the internal circumference of the artery, through stretching the 
artery sequentially and measuring the micrometre and the passive force readings (figure 
2.3). At each point of stretching, the wall tension and internal circumference of the 
vessel is tested to determine the maximum force. The wall tension is an exponential 
function of the artery’s internal circumference. Arteries with an internal circumference 
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of 0.9 IC100 are estimated to be 0.9 times the circumference they would maintain if 
relaxed and exposed to 100 mm Hg transmural pressure.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.5.5 Chemicals and solutions 
The composition of the main bathing solutions for contraction experiments were as 
follows (in mM): physiological saline solution (PSS) containing NaCl 137, 
NaH₂PO4H₂O 0.44, Na₂HPO4 0.42, NaHCO3 4.17, KCl 5.6, MgCl₂ 1, HEPES 10, 
glucose 10 and CaCl₂ 2 (pH 7.4); depolarizing high K+ physiological saline (KPSS) 
comprising PSS with an equimolar substitution of NaCl by KCl (total 80 mM KCl) (pH 
Force 
(mN) 
2 
1 
4 
3 
Figure ‎2.3. Normalisation of mounted arteries. Stepwise increases of jaw distance (and 
stretching of arteries) were performed (1, 2, 3, and 4) until the wall tension reaches 13.2 kPa 
(point 4, IC100). Once this is achieved, jaws were brought a little closer to provide 90 % of this 
value (hence the sudden decrease in the tension in the graph). 
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7.4). 20 mM K/ Bay K 8644, a solution that will contract the artery by the opening of L-
type Ca
2+
 channels but does not depolarise as much as KPSS, was also used. This 
solution contained 200 nM ±Bay K8644 dissolved in 20 mM K
+
 salt solution (KCl 20, 
NaCl 117, NaH₂PO4H₂O 0.44, Na₂HPO4 0.42, NaHCO3 4.17, KCl 5.6, MgCl₂ 1, 
HEPES 10, glucose 10 and CaCl₂ 2 (pH 7.4)). M-β-CD (10 mM) was dissolved directly 
in PSS. Ch-MCD (5 mM) was dissolved directly in PSS by heating at 80 
°
C for 10 
minutes using a water bath. 2 mM tetraethylammonium (TEA
+
) chloride was dissolved 
directly in PSS (TEA/PSS) or 20 K/ Bay K (20 K/ Bay K/ TEA). L-N
G
-Nitroarginine 
methyl ester (L-NAME) (250 µM) was dissolved directly in PSS solution or 20 K/ Bay 
K solution (20 K/ Bay K/ L-NAME). Stock solution of acetylcholine (ACh) (10 mM) 
was made in distilled water and used at X1000 dilution (final concentration of ACh was 
10 µM). NS1619 [1,3-Dihydro-l-[2-hydroxy-5-(trifluoromethyl) phenyl]-5-
(trifluoromethyl)-2i/benzimidazol-2-one] was made up as a 10 mM stock solutions in 
dimethyl sulphoxide (DMSO). Stock solution of sodium nitroprusside (SNP; 10 mM) 
was made with distilled water. Stock solution of forskolin (FSK; 10 mM) was made 
using DMSO. Stock solution of isoproterenol (ISO; 10 mM) was made with distilled 
water. Stock solution of phenylephrine (PE; 10 µM) was made with distilled water. 
Stock solution of Iberiotoxin (IBTX; 100 µM) was made in distilled water. Finally, the 
stock solution of filipin (4 µg/ml) was prepared by dissolving in PSS at 37 
°
C for 10 
minutes by using a water bath.  
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Chapter 3 Ultrastructural Study of Rat Femoral Arteries 
3.1 Aim of the chapter 
This study was designed to investigate:  
 The ultrastructural changes to the cell membrane in the SMCs and ECs of rat 
femoral arteries after treatment with methyl β-cyclodextrin (M-β-CD), observed 
using transmission electron microscope (TEM). 
 The topological relationship between caveolae and sarcoplasmic reticulum (SR) 
(caveolae-SR) or caveolae and mitochondria (caveolae-mitochondria) in the 
SMCs of intact femoral arteries.  
The key finding in this chapter 
 The results showed that treatment with M-β-CD removed caveolae from SMCs 
and ECs of rat femoral arteries. 
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3.2 Introduction 
Several studies have provided strong evidence that the SR acts as a major Ca
2+
 store in 
SMCs (Somlyo et al., 1979, Taggart, 2001). Moreover, numerous other cellular 
organelles such as mitochondria have been shown to also regulate the Ca
2+
 
concentration in SMCs (Patel and Insel, 2009). Recent structural studies of SMCs have 
reported close proximity of SR to the plasma membrane (15–30 nm), particularly around 
caveolae (Strehler and Treiman, 2004, Sweeney et al., 2006). Moreover, the relationship 
between SR/mitochondria-caveolae in vascular SMCs seems to show some interesting 
nanocontacts (Gherghiceanu and Popescu, 2007). The nanocontacts of caveolae-SR has 
led some researchers to consider highly localised events in this micro-domain; for 
example, BKCa channels are localised in the caveolae micro-domain (Babiychuk et al., 
2004, Brainard et al., 2005). BKCa channels are activated by local SR Ca
2+
 release (Ca
2+
 
sparks), and their activation can cause hyperpolarisation and hence changes in the 
excitability of SMCs. Thus, any disruption of the close links between caveolae-SR may 
be expected to have an uncoupling effect. On the other hand, a nanocontact has also 
been shown between mitochondria and caveolae in SMCs (Patel and Insel, 2009). In 
ECs, the localisation of endothelial NO synthase (eNOS) in the caveolae microdomain is 
of paramount importance for the effective relaxation of blood vessels (Ghosh et al., 
1998, Feron et al., 1996). Nitric oxide (NO) is formed by eNOS and diffuses into SMCs, 
leading to smooth muscle relaxation. Moreover, caveolae can exist in many different 
forms, such as rosettes, grape-like clusters and elongated tubules (figure 3.1) (Parton et 
al., 1997, Razani et al., 2002, Yamada, 1955). Interestingly, these different forms of 
caveolae are mostly present in specific tissues. For instance, vesicles/tubules are highly 
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abundant in endothelial cells, rosette shapes in adipocytes and grape-like clusters in 
skeletal muscle cells (Lisanti et al., 1994b, Parton et al., 1997, Simionescu et al., 1975). 
Myoendothelial gap junctions (MEGJ) are generally described as forming gap junctions 
between vascular ECs and vascular SMCs. The endothelial cell membrane forms an 
eminence through small narrow gaps, 1-1.5 µm in width, in the internal elastic lamina 
(IEL) to form MEGJs with the SMCs (Wasano and Yamamoto, 1983). Moreover, 
several studies have proved a physiological role of MEGJ in mesenteric arteries and 
arterioles where electrical and chemical signals are transmitted from ECs to SMCs 
(Sandow et al., 2003, Sandow and Hill, 2000, Shimokawa et al., 1996). The elastic 
tissue of a rat’s femoral artery is composed of two distinct layers, the IEL and the 
external elastic lamina (EEL), and the medial wall or tunica media between the two 
elastic laminae is filled with layers of SMCs and isolated fragmented elastic fibres 
(Wasano and Yamamoto, 1983). However, the IEL appears as a plate-like structure, 
discontinuous in thickness, about 2 µm in width and with several small gaps of about 1-
1.5 µm, which serve to allow MEGJ to form. On the other hand, the EEL appears as a 
slightly undulated sheet-like structure, about 1 µm in thickness, and has small gaps in it 
of about 3 µm in width, which allow for collagen fibres to pass into the tunica media. 
Moreover, scanning electron microscopy (SEM) shows the surface of both the IEL and 
EEL, with several small rounded fenestrations which vary in size from 1 to 5 µm 
(Wasano and Yamamoto, 1983). 
The important physiological role of MEGJs has been studied in different vascular beds 
(Beny, 1997, Hill et al., 2001, Yamamoto et al., 1999). In guinea-pig mesenteric 
arterioles, hyperpolarization generated in ECs can be transmitted to the smooth muscle 
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through MEGJs (Yamamoto et al., 1999). Membrane hyperpolarization can cause 
smooth muscle relaxation through a decrease in VDCCs open probability. 
Cholesterol is an essential component for the assembly of caveolae (Patel and Insel, 
2009, Patel et al., 2008b). Cholesterol can be depleted from cell membranes by 
cholesterol-depleting agents, such as nystatin, saponin, M-β-CD and filipin (Rothberg et 
al., 1990, Gimpl et al., 1997). M-β-CD is currently the most-used tool for disrupting 
lipid rafts and caveolae (Barnes et al., 2004). Previous studies have illustrated that the 
efficiency of M-β-CD is dependent on incubation time, tissue type and temperature 
(Linder et al., 2005). Caveolae disassembly represents a useful tool to aid in 
understanding caveolae-dependent physiological processes. Treatment of the tissues 
with M-β-CD (5-15 mM) for 1 hour at 37 °C alters the cholesterol content of the cell 
membrane and thereby disrupts caveolae (Pike and Miller, 1998; Kaiser et al., 2002). 
Cholesterol-depleting agents have been effectively used as a pharmacological tool to 
demonstrate a role of caveolae in vascular reactivity (Dreja et al., 2002, Je et al., 2004, 
Bergdahl et al., 2003). 
This chapter will focus on the topological relationship between caveolae-SR and 
caveolae-mitochondria in the SMCs of intact femoral arteries, and on the ultrastructural 
changes to the cell membrane in the SMCs and ECs of these arteries after M-β-CD 
treatment, using conventional light and transmission electron microscopy (LM and 
TEM). 
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Figure ‎3.1. A schematic diagram representing the various forms of caveolae in the cell 
membrane and/or cytoplasm. Caveolae can be found in the forms of tubules, grape-like 
clusters, rosettes or vesicular. Modified from Razani et al. (2002). 
 
3.3 Results 
Intact (control) and 5 mM M-β-CD treated femoral arteries (n=5 in each group) were 
used for the TEM study. For the electron microscopic examination, about 7-8 sections 
from each animal of both control and treated groups were examined using an H-600 
TEM (Hitachi, Pleasanton, California, USA) at an acceleration voltage of 60-120 kV. 
Then, section of the femoral artery was randomly selected from each group, and 
captured using an SIS Megaview III camera. These images were taken at different 
magnifications; X16000, 20000, 26000, 40000 and 60000.   
3.3.1 TEM examination of the intact rat femoral artery 
Serial cross-sections (70 nm) of the femoral artery were used to show general structure 
of intact artery walls. The elastic tissue mainly consists of two distinct laminae, the IEL 
(figure 3.2 A) and EEL (figure 3.3 B). Furthermore, the elastic laminae are separated 
with multiple layers of SMCs, which are punctuated by bundles of collagen fibres 
(figures 3.4 and 3.5). The IEL appears as a thick and slightly undulated tube, and 
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includes a few small gaps (figure 3.2 B), which vary in size. The gaps are uniformly 
distributed throughout the IEL. In contrast, the EEL appears as a slightly thin, 
discontinuous, tube-like structure, which includes several small gaps (figure 3.3 B), 
which also vary in size. SMCs and ECs were connected with the IEL through contact 
points, which are located between the cell membranes of both SMC and ECs and the 
IEL (figures 3.2, 3.6 and 3.7). Furthermore, most of the smooth muscle cells are 
arranged in parallel to the elastic tissue (figure 3.3). 
In the SMCs, TEM analysis revealed that most caveolae appear as omega-shaped 
invaginations in the plasma membrane, opening to the extracellular space (figure 3.8). 
The ultrastructure of a SMC consists of a simple network of tubules, encircling caveolae 
(figure 3.9). Nanocontacts were observed between caveolae-SR and caveolae-
mitochondria on close examination of sections of intact rat femoral artery (figures 3.8 
and 3.9). Tubules of SR were concentrated at the periphery of the cell close to the cell 
membrane (figure 3.9 B), whereas mitochondria were easily distinguished near to 
caveolae (figure 3.8 B). Furthermore, mitochondria were concentrated at the center of 
the cell, close to the nucleus (figure 3.8).   
TEM examination of ECs in intact rat femoral arteries showed that some caveolae 
present in the ECs (figure 3.6) were different in morphology compared with the 
caveolae present in SMCs. Some caveolae in the cell membrane of the ECs are tubules 
and some take the regular omega shape. The study also found caveosomes 
(vesicular/fully-invaginated caveolae) (figure 3.6 B). 
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3.3.2 TEM examination of rat femoral artery treated with M-β-CD 
TEM analysis of femoral arteries was investigated after the disassembly of caveolae 
from SMCs and ECs. Micrographs of SMCs (figure 3.10) and ECs (figure 3.7) showed 
a rarity or absence of caveolae in the M-β-CD-treated artery. These TEM micrographs 
also show large collagen fibres between the SMCs (figures 3.4 and 3.5), which seem to 
be inserted into the basement membranes of the SMCs. Nexin (Ne) junctions were also 
observed between the SMCs of treated vessels (figure 3.10 B). 
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Figure ‎3.2. Transmission electron micrograph of a cross-section of rat femoral artery 
showing internal elastic lamina. A. A gap in the IEL, X11500. Scale bar= 5µm. B. Detail from 
square in figure 3.2 A shows a higher magnification image of the gap (G) in the IEL.  Note 
collagen fibre bundles passing through the gap. 
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Figure ‎3.3. Transmission electron micrograph of rat femoral artery showing external 
elastic lamina (EEL). A. Discontinuous EEL, with small gaps of different width, showing 
collagen fibres (C) between SMCs, X11500. Scale bar= 10µm. B. Detail from marked area in 
figure 3.3 A shows higher magnification of the gaps (G) in the EEL.  
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Figure ‎3.4. Transmission electron micrographs showing cell-matrix linkages in the tunica 
media of rat femoral artery. A. A complex weave of collagen (C) inserted into a SMC 
membrane, X27500. Scale bar= 2µm. This artery had been treated with M-β-CD. B. Detail from 
marked area in figure 3.4 A shows parallel collagen (C) fibres inserted into the membranes of 
the SMCs.   
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Figure ‎3.5. Transmission electron micrographs of cell-matrix linkages in the tunica media 
of rat artery. A. A complex weave of collagen (C) inserted into an SMC membrane, X27500. 
Scale bar= 2µm. This artery had been treated with M--CD. B. Detail from marked area in 
figure 3.5 A shows parallel collagen fibres (C) inserted into the membrane of SMCs. 
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Figure ‎3.6. Transmission electron micrograph of rat femoral artery ECs showing caveolae. 
A. Caveolae cover most of EC membrane, long arrows show contact of SMCs with IEL, short 
arrows show contact of ECs with IEL and the double stars show gap junction plaques between 
two ECs, X60000. Scale bar= 1µm. B. Detail from marked area in figure 3.6 A shows caveolae 
(Cav) and caveosomes (V). 
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Figure ‎3.7. Transmission electron micrograph of a cross-section of rat femoral artery 
treated with 5 mM M-β-CD. A. Cell membranes of SMCs and ECs were free of caveolae, long 
arrows show contact of ECs with IEL and short arrows show contact of SMCs, X60000. Scale 
bar= 1µm. B. Detail from marked area in figure 3.7 A shows extension of IEL to sides of SMCs 
(EIEL). 
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Figure ‎3.8. Transmission electron micrograph of rat femoral artery SMC showing 
caveolae and mitochondria. A. Omega-shaped caveolae (Cav) cover most of the SMCs 
membrane, X60000. Scale bar= 1µm. B. Detail from marked area in figure 3.8 A shows 
mitochondrion (M) close to caveolae.   
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Figure ‎3.9. Transmission electron micrograph of rat femoral artery SMC showing 
relationship between caveolae and SR. A. Caveolae (Cav) cover most of the cell membrane of 
the SMCs, X60000. Scale bar= 1µm. B. Detail from marked area in figure 3.9 A. Caveolae are 
within a few nanometers of the sarcoplasmic reticulum (SR). 
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Figure ‎3.10. Transmission electron micrograph of a cross-section of rat femoral artery 
treated with M-β-CD. A. SMCs were free of caveolae. Cholesterol extraction with M-β-CD 
completely abolished caveolae structures from the cell membrane, X27500. Scale bar= 2µm. B. 
Detail from marked area in figure 3.10 A. The cell membrane of SMCs is devoid of caveolae. 
Note also nexus junctions (Ne) (intercellular connections between two SMCs filled with 
myofilaments). 
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3.3.3 Histology of rat femoral arteries 
In this technique, four intact rat femoral arteries and four endothelium-denuded arteries 
were used. Ten sections from each group were examined by conventional light 
microscope. A random section was selected from both the intact and the endothelium-
denuded group, and images captured with an Olympus digital microscope. 
3.3.3.1 Histological results of endothelium-intact rat femoral artery 
The intact arterial wall consists of three layers, tunica intima, tunica media and tunica 
adventitia (figure 3.11 B). The tunica intima is composed of a layer of endothelial cells, 
which have a squamous structure and form a fenestrated face (figure 3.11B). The tunica 
media is made up of layers of SMCs (figure 3.11 B). SMCs have the ability to stretch 
up to 1.5 times their length, and then return to their normal length on relaxation. The 
tunica media is located between the tunica intima on the inside and the tunica adventitia 
on the outside. The tunica adventitia in arteries is composed mainly of connective tissue 
(collagen and elastin) (figure 3.11 B). The lumen diameter of a rat femoral artery was 
about 200 µm (figure 3.11 A). 
3.3.3.2 Histological results of endothelium-denuded rat femoral artery 
The ECs of the femoral artery were mechanically removed by gently rubbing the intimal 
surface with a human hair (figure 3.11 C). Histology (figure 3.11 D) showed the 
removal of most of the endothelial layer. 
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Figure ‎3.11. Histological analysis of rat femoral artery. A. Photomicrograph of a histological 
cross-section of an intact artery, X400, internal diameter, 190 µm. B. Photomicrograph of 
magnified cross-section of artery, X600, showing three structural layers: TI, TM and collagen 
fibre in TA. Picture also shows the layers of SMCs inside the TM in the triangle. C. Photograph 
showing the removal of the endothelial sheath (ECS) from the femoral artery (FA) using a 
human hair (HH). D. Photomicrograph of cross-section of artery showing the lumen of the artery 
devoid of its sheath of ECs (***), X600. 
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3.4 Discussion 
Studies presented here have focused on the ultrastructure of vascular SMCs in order to 
examine the strategic relationship between caveolae-SR and caveolae-mitochondria 
contacts. This micro-architecture of SMCs plays an important role in regulation of Ca
2+
 
concentration (Shaw et al., 2006). 
Using TEM, the morphology of the cell membrane and the relationships between 
caveolae-SR (figure 3.10) and caveolae-mitochondria in SMCs (figure 3.10) and ECs 
(figure 3.6) was examined. TEM revealed that caveolae were often, but not always, in 
close proximity to peripheral SR or to mitochondria in rat femoral arteries. These results 
agree with Popescu et al. (2006) who state that caveolae were localised within a few 
nanometers from the SR and/or from mitochondria in vascular SMCs. Moreover, these 
results agree with several studies (Taggart, 2001, Dreja et al., 2002, Shaw et al., 2006, 
Tong et al., 2009) reporting that nanocontacts exist between caveolae-mitochondria and 
caveolae-SR in the SMCs of different muscular arteries. These studies also report the 
arrangement of caveolae and underlying peripheral SR in vascular SMCs which regulate 
Ca
2+
 and contractile activation. Shaw et al. (2006) observed abundant mitochondria in 
the middle of SMCs, near to the nucleus. These results also agree with our findings 
(figure 3.8). The current study also shows that some mitochondria in arterial SMCs can 
be located close to caveolae (figure 3.10). This agreed with the findings of Patel and 
Insel (2009) who observed nanocotacts between mitochondria and caveolae in 
pulmonary artery SMCs. 
Saliez et al. (2008) demonstrated the presence of caveolae in the ECs of rat mesenteric 
arteries. TEM examination of intact rat femoral arteries in the current study also showed 
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numerous caveolae present in the ECs (figure 3.6). These findings were consistent with 
Xu et al. (2007) who also stated that the integrity of caveolae in ECs is very important in 
the NO signaling cascade.  
The TEM examination of rat femoral arteries showed gaps of different sizes through the 
IEL (figure 3.2) but without an obvious presence of MEGJs from ECs to SMCs. These 
results agree with reports by Sandow et al. (2002) and Hill et al. (1999) who also 
confirmed that gaps are present in the IEL of rat femoral arteries without MEGJs from 
ECs to SMCs. In contrast, they observed the existence of MEGJs in rat mesenteric 
arteries. Our findings with respect to the IEL contrast with that of Wasano and 
Yamamoto (1983). They report that the existence of MEGJs that penetrate the IEL of rat 
femoral arteries, and they found small rounded fenestrations along the IEL and EEL. 
These fenestrations in the IEL serve to allow diffusion of chemicals or nutrient 
substances from the vascular lumen into the vascular media. In contrast, the function of 
fenestrations in the EEL is to pass intercellular collagen fibre bundles between the 
tunica media and tunica adventitia (Wasano and Yamamoto, 1983). Considering the 
SEM findings of Wasano and Yamamoto (1983) with respect to fenestrations in the IEL, 
we suggest that the fenestrations may be pathways for the diffusion of endothelial-
derived substances from ECs to SMCs. If this speculation is correct, we also hypothesise 
that it will explain the effect of the influence of ECs on the relaxation of smooth muscles 
and the diffusion of NO through connected points between both ECs/SMCs and IEL. 
Furthermore, connected points between the cell membranes of both SMCs and/or ECs 
and IEL play an important role in the diffusion of EC relaxation factors, such as NO, to 
SMCs through the fenestrations located in the IEL. Our results also demonstrated gaps 
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in the EEL (figure 3.3). Similar gaps in the EEL have been demonstrated by Wasano 
and Yamamoto (1983) in rat femoral artery SMCs. The function of these gaps may also 
be to pass macro-molecules, nutrients and other chemical factors directly between SMCs 
and the tunica adventitia. The present TEM results demonstrate that the SMCs and 
elastic fibres make a continuous network throughout the tunica media to the tunica 
adventitia. These results again support Wasano and Yamamoto (1983) who reported that 
the collagen fibres and SMCs can function as a unit to distribute the intraluminar 
pressure uniformly around the whole circumference of the vascular walls. 
To explore the role of caveolae in femoral artery contractions (see chapters 5 and 6), we 
used M-β-CD to deplete cholesterol and so the caveolae. TEM analysis showed that 
caveolae in both SMCs (figure 3.10) and ECs (figure 3.7) were disassembled from the 
plasma membrane after the treatment of the vessels with M-β-CD.  
In this study, the endothelium was removed from some femoral artery rings (see also 
chapters 5 and 6) by gently rubbing the intimal surface with a human hair. The 
morphological integrity of endothelial cells was additionally confirmed by preparing 
histological preparations of rat femoral artery with standard haematoxylin and eosin 
staining (figure 3.11 B). Mechanical removal of endothelial cells from the lumen was 
confirmed by histological techniques (figure 3.11 D). Similar results have been 
demonstrated in rat femoral artery by Radenkovic et al. (2012) who showed that  
endothelial cells could be mechanically removed from the intimal surface of artery rings 
by gently rubbing with a stainless-steel wire. These results were acquired by histology. 
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3.5 Conclusion 
In summary, the details of the ultrastructure of rat femoral arteries was examined using 
intact artery material, artery that was treated with M-β-CD, and artery that was denuded 
of ECs with a human hair. The results showed that treatment with M-β-CD removed 
caveolae and that rubbing the lumen with human hair removed ECs. 
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Chapter 4 Immunofluorescence and Western blotting Studies of 
Rat Femoral Artery and Human Coronary Artery Endothelial Cells 
4.1 Aim of the study 
To investigate the expression of BKCa channels, cav-1 and cav-3 in rat femoral artery 
SMCs and ECs and human coronary artery endothelial cells (HCAECs) using three 
methods: immunohistochemistry, immunocytochemistry and Western blot. 
The key findings in this chapter 
 Co-expression the BKCa channels with cav-1 and cav-3 in the SMC layer at 
tissue level and in individual SMCs in native rat femoral arteries. 
 Co-expression of the BKCa channels with cav-1 in ECs of rat femoral arteries. 
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4.2 Introduction 
To date, expression of three isoforms of caveolin proteins have been found in vascular 
tissues: cav-1, cav-2, and cav-3 (Drab et al., 2001, Kamishima et al., 2007). As 
described earlier, the binding of caveolins and partner proteins are thought to occur at 
CSD of caveolins (Couet et al., 1997, Oka et al., 1997) and caveolin-binding motifs on 
partner proteins (Dupree et al., 1993, Dietzen et al., 1995) (figure 4.1).  Partner proteins 
for caveolins include ion channels (Nichols and Lippincott-Schwartz, 2001), and 
mammalian BKCa channels have two potential cav-1 binding motifs: 
(
537
YTEYLSSAF
545
) and (
1007
YNMLCFGIY
1015
) (Alioua et al., 2008).   
BKCa channels are expressed in most vascular cells and play a critical role in the 
regulation of blood flow (Brenner et al., 2000, Sausbier et al., 2005). Furthermore, BKCa 
channels in vascular SMCs are regulated by several vasoconstrictors and vasodilators 
(Alioua et al., 2008). In addition, studies have shown that BKCa channels are co-
expressed with cav-1 and regulate Ca
2+ 
homeostasis in endothelial cells (Wang et al., 
2005, Riddle et al., 2011). It seems reasonable, therefore, to postulate that the interaction 
of BKCa channels with caveolin 1 and caveolin 3 may play an important role in femoral 
artery contraction/relaxation. 
In this chapter, I aimed to characterise the expression pattern of BKCa channels, cav-1 
and cav-3 using immunohistochemistry, immunocytochemistry and Western blot 
technique.  
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Figure ‎4.1. Cav-1 scaffolding domain (C-1SD) interacts with the partner proteins (eNOS, 
Src family kinase and PKC-α)‎through‎consensus‎caveolin-binding motif (CBM). Modified 
from Okamoto et al. (1998). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
93 
 
4.3 Results 
4.3.1 Immunohistochemistry results of rat femoral arteries 
4.3.1.1 Expression of‎α-actin and vWF in the SMCs and ECs of rat femoral 
arteries 
Results from the previous chapter using the traditional histology technique showed that 
transverse sections of whole femoral arteries are a useful preparation to study SMC 
layers and EC layers. The results described here further extend such approach and aim 
to identify the expression pattern of proteins of interest in specific regions. Thus, the 
artery slice was first stained with antibodies against α-actin and vWF, signature proteins 
of SMCs and ECs, respectively.  Mouse anti-α-actin and rabbit anti-vWF were then 
visualised using AF-594 (red) and AF-488 (green). Areas stained in red (anti-α-actin) 
localised to the SMCs layers (figure 4.2 A) while those in green (anti-vWF) were the 
ECs layer (figure 4.2 B). Overlay image (figure 4.2 C) showed little overlap (which 
would have appeared as yellow) between α-actin and vWF stained areas.  
For semi-quantitative analysis, a line was drawn across the artery wall (figure 4.2 C) in 
order to assess the signal strength of fluorescence across the SMC and EC layers using 
Leica Lite confocal software (figure 4.3). Green fluorescence shows the expression of 
vWF at a high level in the EC layer compared to the SMC layer. Red fluorescence 
shows the expression of α-actin at high levels in the SMC layers compare to the ECs 
layer. 
To confirm the positive immunostaining result, two negative controls were undertaken. 
For the first control, secondary antibody was mis-matched against wrong primary 
antibody (eg. anti-rabbit secondary used against mouse primary). A visual examination 
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of the mis-match experiments showed a low signal suggesting there is a little cross-
reactivity among two animal species (eg. anti-rabbit secondary does not bind to a mouse 
primary) (figure 4.2 D). For the second control, secondary antibodies were applied 
without primary antibody incubation. A visual examination of the section stained only 
with secondary antibodies showed a low signal showing that there is little direct binding 
of the secondary antibody to tissue slices (figure 4.2 E). A bright field of the rat femoral 
artery is also shown in figure 4.2 F. The cell specific antibodies were used along with 
antibodies against cav-1, cav-3 and BKCa channels in order to access the cell types 
where these proteins are expressed. 
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Figure ‎4.2. Representative confocal images of frozen sections (11 µm) of rat femoral 
arteries‎stained‎with‎mouse‎anti‎α-actin (x300) and rabbit anti-vWF (x300) and visualised 
with AF-594 (x500) and AF-488 (x500), respectively. A. Expression of α-actin (red) at high 
levels in the SMCs. B. Expression of vWF (green) in ECs at high levels. C. An overlay of A and 
B showed little overlap of red and green fluorescence. D. A negative control section of rat 
femoral artery stained with secondary antibody against mis-matched primary antibody. E. A 
negative control section of rat femoral artery stained with secondary antibodies only. F. A bright 
field section of rat femoral artery. A, B, C and F: scale bar represents= 50 µm, D and E: scale bar 
represents= 75 µm.  
 
Figure ‎4.3. Fluorescence intensity profile for the vWF‎and‎α-actin signals along the white 
line shown in figure 4.2 C. Green fluorescence indicates expression of vWF at high levels in 
ECs, and red fluorescence indicates expression of α-actin at high levels in SMCs. 
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4.3.1.2 Expression of cav-1 in ECs from rat femoral arteries 
The expression of cav-1 in ECs was examined using mouse anti-cav-1 primary antibody 
indirectly labeled with AF-488 (green) and rabbit anti-vWF indirectly labeled with AF-
594 (red). As before, the red signal mainly appeared in the EC layer (figure 4.4 A). A 
visual examination of anti-cav-1 staining indicates that the green signal appears in both 
SMCs and ECs layers (figure 4.4 B). Indeed the overlay image (figure 4.4 C) showed 
the cav-1 overlapped with vWF, which appeared yellow. Fluorescence intensity profile 
taken along the white line in figure 4.4 C is shown in figure 4.5. The semi-quantitative 
analysis clearly shows that cav-1 is expressed at high levels in both SMC and EC layers.  
To confirm the positive immunostaining results, two negative controls, mis-match of 
primary and secondary antibody and primary antibody omission, were undertaken.  Both 
results showed low signals (figure 4.4 D and E). A bright field of the rat femoral artery 
is shown in figure 4.4 F. Our results therefore confirm that cav-1 is present in the ECs 
and SMCs of rat femoral artery tissue. 
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Figure ‎4.4. Representative confocal images of frozen sections (11 µm) of the rat femoral 
artery stained with rabbit anti-vWF (x300) and mouse anti-cav-1 (x200) and visualised 
with AF-594 (x500) and AF-488 (x500) respectively. A. Expression of vWF (red) at high 
levels in the ECs. B. Expression of cav-1 (green) in both SMCs and ECs at high levels. C. An 
overlay of A and B showing overlap of vWF and cav-1 (yellow) in the ECs. D. A negative 
control stained with secondary antibody against wrong primary antibody. E. A negative 
control stained with secondary antibodies only. F. A bright field section of rat femoral artery.  
Scale bar represents= 75 µm.    
Figure ‎4.5. Fluorescence intensity profile of cav-1 and vWF along the white line shown in 
figure 4.4 C. Green fluorescence indicates expression of cav-1 at high levels in both SMCs and 
ECs. 
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4.3.1.3 Expression of cav-3 in ECs of rat femoral artery 
Expression of cav-3 in ECs was examined using rabbit anti-vWF and mouse anti-cav-3, 
labeled with AF-594 (red) and AF-488 (green) respectively. A visual examination of the 
sections indicated that red signal (figure 4.6 A) and green signal (figure 4.6 B) occur 
separately. Indeed, an overlay image (figure 4.6 C) showed no overlap between vWF 
and cav-3. Fluorescence intensity profile in the SMCs and ECs along the white line in 
figure 4.6 C is shown in figure 4.7. The green fluorescence shows the expression of 
cav-3 at high levels in the SMC layers, and cav-3 is absent from the EC layer. 
To confirm the positive immunostaining result, two negative controls, mis-match of 
primary and secondary antibody and primary antibody omission, were undertaken.  In 
both cases, there was a low signal (figure 4.6 D and E). A bright field of rat femoral 
artery is shown in figure 4.6 F. Our results therefore confirm that cav-3 is present in the 
SMCs but not in the ECs of rat femoral artery tissue. 
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Figure ‎4.6. Representative confocal images of frozen sections (11µm) of rat femoral 
arteries stained with rabbit anti-vWF (x300) and mouse anti-cav-3 (x500) and visualised 
with AF-594 (x500) and AF-488 (x500) respectively. A. Expression of vWF (red) at high 
levels in the ECs. B. Expression of cav-3 at high levels only in the SMCs. C. An overlay of A 
and B showing no overlap of red and green fluorescence in either ECs or SMCs. D. A negative 
control section of rat femoral artery stained with secondary antibody mis-matched with wrong 
primary antibody. E. A negative control section of rat femoral artery stained with secondary 
antibodies only. F. A bright field section of rat femoral artery. A, B, C and F: scale bar 
represents= 50 µm; D and E: scale bar represents= 75 µm. 
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Figure ‎4.7. Fluorescence intensity profile of cav-3 and vWF along the white line shown 
in figure 4.6 C. Green fluorescence shows expression of cav-3 at high levels in the SMCs 
only. 
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4.3.1.4 Expression of BKCa channels in the ECs of rat femoral arteries 
Expression of BKCa channels in ECs was examined using rabbit anti-vWF and rabbit 
anti-BKCa channels (against the peptide sequence 1184-1200: [C] 
STANRPNRPKSRESRDK). The former was directly conjugated with Fab AF-594 (red) 
as described in chapter 2 (2.4.1.1), and the latter was indirectly stained with AF-488 
(green). A visual examination of the sections stained with rabbit anti-vWF indicates that 
the red signal appears in the EC layer (figure 4.8 A). A visual examination of the 
sections stained with anti-BKCa channels indicated that the green signal appears in both 
the SMC and EC layers (figure 4.8 B), with overlay image showing overlap in EC 
section (yellow, figure 4.8 C). The fluorescence intensity profile of the white line 
shown in figure 4.8 C is shown in figure 4.9. Green fluorescence shows the expression 
of BKCa channels at high levels in both SMC and EC layers. 
As before, two negative controls were undertaken by mis-matching primary and 
secondary antibody (figure 4.8 D) and by omitting the primary antibodies (figure 4.8 E).  
There was little signal detected in either case. A bright field of rat femoral artery is 
shown in figure 4.8 F. Our results therefore showed BKCa channels are expressed not 
only in SMCs but also in the ECs of rat femoral arteries.  
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Figure ‎4.8. Representative confocal images of frozen sections (11 µm) of the rat femoral 
artery stained with rabbit anti-vWF (x300) and rabbit anti-BKCa channels (x500) and 
visualised with AF-594 (x500) and AF-488 (x500) respectively. A. Expression of vWF (red) 
in the ECs. B. Expression of BKCa channels (green) in both SMCs and ECs at high levels. C. 
An overlay of A and B showing co-expression of vWF and BKCa channels (yellow spots) in 
the ECs. D. A negative control stained with secondary antibody mis-matched with a wrong 
primary antibody. E. A negative control stained with secondary antibodies only. F. A bright 
field section of rat femoral artery. A, B, C and F: scale bar represents= 25µm; D: scale bar 
represents= 75µm; E: scale bar represents= 50 µm. 
 
Figure ‎4.9. Fluorescence intensity profile for BKCa channels and vWF along the white 
line shown in figure 4.8 C. Green shows expression of BKCa channels occurring at high 
levels in both SMCs and ECs. 
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4.3.1.5 Expression of BKCa channels in the SMCs of rat femoral arteries 
The expression of BKCa channels in SMCs was examined by co-staining of rabbit anti-
BKCa channels and mouse anti-α-actin, labeled with AF-488 (green) and AF-594 (red) 
respectively. A visual examination of the sections stained for BKCa channels indicated 
that the green signals occurred in both SMC layer and EC layer (bright green spots 
above the scale) (figure 4.10 A). Red signal due to the staining with anti-α-actin came 
from SMC layers (figure 4.10 B). An overlay image (figure 4.10 C) showed clear 
overlap of the BKCa channels and α-actin (which appeared as yellow). This visual 
impression was further supported by the fluoresence intensity profile (figure 4.11), 
taken from the white line shown in figure 4.10 C. Thus, this experiment clearly showed 
that the BKCa channels are expressed in the SMC layers.  
Two negative controls and bright filed image are also shown (figure 4.10 D, E and F). 
Our results therefore confirm that the BKCa channels is present in the SMCs of rat 
femoral arteries. 
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Figure ‎4.10. Representative confocal images of frozen sections (11 µm) of the rat femoral 
artery stained with rabbit anti-BKCa channels (x500) and mouse anti-α-actin (x300) and 
visualized with AF-488 (x500) and AF-594 (x500) respectively. A. Expression of BKCa 
channels (green).  Note bright green spots above the scale. B. Expression of α-actin (red). C. An 
overlay of A and B showing the co-expression of BKCa channels and α-actin (yellow) in the 
SMCs. D. A negative control stained with secondary antibody against mis-matched primary 
antibody. E. A negative control stained with secondary antibodies only. F. A bright field section 
of rat femoral artery. A, B, C, E and F: scale bar represents= 50µm, and D: scale bar represents= 
75µm. 
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Figure ‎4.11. Fluorescence intensity profile of BKCa channels‎and‎α-actin along the white 
line shown in figure 4.10 C. Green fluorescence indicates the expression of BKCa channels 
and red fluorescence, that of α-actin. 
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4.3.1.6 Co-expression of BKCa channels with cav-1 in rat femoral artery 
The next experiment was designed to investigate the co-expression of BKCa channels 
with cav-1. Frozen sections (11 µm) of femoral artery stained with mouse anti-cav-1 
(AF-488, green) and rabbit anti-BKCa channels (AF-594, red) are shown in figure 4.12 
A and figure 4.12 B. A visual examination of an overlay image (figure 4.12 C) showed 
the cav-1 co-expressed with BKCa channels (yellow), and this seems to occur in both 
SMCs and ECs. Fluorescence intensity profile taken along the white line in figure 4.12 
C is shown in figure 4.13. The expression pattern of cav-1 seems similar to that of BKCa 
channels. 
As before, two negative controls, mis-match of primary and secondary antibody and 
omission of primary antibodies, showed low signal (figure 4.12 D and E). A bright 
field of rat femoral artery section is shown in figure 4.12 F. Our results therefore 
suggest that BKCa channels and cav-1 are co-expressed, and it seems that this occurs in 
both SMCs and ECs. 
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Figure ‎4.13. Fluorescent intensity profile for cav-1 and BKCa channels taken along the 
white line shown in figure 4.12 C. Green fluorescence shows expression of cav-1 while red 
fluorescence shows expression of BKCa channels. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure ‎4.12. Representative confocal images of frozen sections (11µm) of rat femoral 
artery stained with mouse anti-cav-1 (x200) and rabbit anti-BKCa channels (x500) and 
visualised with AF-488 (x500) and AF-594 (x500) respectively. A. Expression of cav-1 
(green). B. Expression of BKCa channels (red). C. An overlay of the confocal images (A and B) 
shows co-expression of the cav-1 and BKCa  channels (yellow). D. A negative control stained 
with secondary antibody against wrong primary antibody. E. A negative control stained with 
secondary antibodies only. F. A bright field section of rat femoral artery. A, B, C and F: scale 
bar represents= 25 µm; D and E: scale bar represents= 75µm. 
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4.3.1.7 Co-expression of BKCa channels with cav-3 in rat femoral arteries 
To investigate the co-expression of BKCa channels with cav-3, rabbit anti-BKCa channel 
and mouse anti-cav-3 antibodies were labelled with AF-488 (green) and AF-594 (red) 
and respectively. A visual examination of the sections stained with anti-BKCa channels 
indicated that green signal appears both in the SMC and in the EC layers (figure 4.14 A). 
A visual examination of the sections stained with anti-cav-3 indicated that the red signal 
appears in SMC layers (figure 4.14 B). A visual examination of an overlay image 
(figure 4.14 C) showed the co-expression of BKCa channels with cav-3 in the SMC 
layers, which appears as yellow, but BKCa channels are also expressed in areas not 
stained with red. Fluorescence intensity profile, taken along the white line shown in 
figure 4.14 C, is shown in figure 4.15. It was somewhat unexpected that there was 
some signal measured for cav-3 (length up to 25 µm for red) although visually this area 
was largely devoid of red staining (figure 4.14 B). Nonetheless, the stronger signal for 
cav-3 (red) was found in the SMCs. 
Two negative controls, mis-match of primary and secondary antibody and omission of 
primary antibodies, showed low signal (figure 4.14 D and E). A bright field of rat 
femoral artery is shown in figure 4.14 F. 
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 Figure ‎4.15. Fluorescence intensity profile for BKCa channels and cav-3 along the white 
line shown in figure 4.14 C. Green fluorescence shows expression of BKCa channels and red 
shows expression of cav-3. 
 
 
Figure ‎4.14. Representative confocal images of frozen sections (11 µm) of rat femoral 
arteries stained with rabbit anti-BKCa channels (x500) and mouse anti-cav-3 (x500) and 
visualised with AF-488 (x500) and AF-594 (x500) respectively. A. Expression of BKCa 
channels (green) in both SMCs and ECs. B. Expression of cav-3 (red) seen in the SMCs. C. 
An overlay of the confocal images showing co-expression of the BKCa channels and cav-3 
(yellow). D. A negative control stained with secondary antibody mis-matched against a wrong 
primary antibody. E. A negative control stained with secondary antibodies only. F. A bright 
field section of rat femoral artery. A, B, C and F: scale bar represents= 50 µm; D and E: scale 
bar represents= 75µm. 
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4.3.2 Immunocytochemistry results of rat femoral arteries 
4.3.2.1 Co-expression of BKCa channels with cav-1 in individual SMCs of rat 
femoral arteries 
In this section, immunocytochemistry was used to investigate the co-expression of BKCa 
channels with cav-1 and cav-3 at the individual SMC level. Single SMCs were 
dissociated and then stained with rabbit anti-BKCa channels and mouse anti-cav-1 and 
labelled with AF-594 (red) and AF-488 (green) respectively. A visual examination of a 
cell stained with anti-BKCa channel antibody indicated that the red signal appears 
throughout the cell membrane and in the cytoplasm of the SMC (figure 4.16 A). A 
visual examination of cells stained with anti-cav-1 indicated that the green signal 
appears throughout the cytoplasm and the cell membrane of the SMC (figure 4.16 B). A 
visual examination of an overlay image (figure 4.16 C) showed the BKCa channels co-
expressed with cav-1, appearing yellow. Fluorescence intensity profile, taken along the 
white line shown in figure 4.16 C, is shown in figure 4.17. Both red and green signals 
show peaks at the edges of the cell, suggesting high levels of expression of both BKCa 
and cav-1 in the cell membrane area of the SMC.  
Two negative controls, mis-match of primary and secondary antibody and omission of 
primary antibodies, showed low signal (figure 4.16 D and E). A bright field of a SMC 
is shown in figure 4.16 F. 
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Figure ‎4.16. Representative confocal images of a single rat femoral artery SMC stained 
with anti-BKCa channels (x500) and anti-cav-1 (x200) and labelled with AF-594 (x500) 
and AF-488 (x500) respectively. A. Expression of BKCa channels (red). B. Expression of 
cav-1 (green). C. An overlay of the confocal images (A and B) showing co-expression of the 
BKCa channels with cav-1 (yellow spots). D. A negative control of SMC stained with 
secondary antibody against wrong primary antibody. E. A negative control of individual 
SMC stained with secondary antibodies only. F. A bright field section of an individual SMC. 
A, B, C, D and F: scale bar represents= 25 µm; E: scale bar represents= 50 µm.  
 
Figure ‎4.17. Fluorescence intensity profile of cav-1 and BKCa channels taken along the 
white line shown in figure 4.16 C. Peaks in green and red fluorescence occur at the edge of the 
SMC.  
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4.3.2.2 Co-expression of BKCa channels with cav-3 in individual SMCs of rat 
femoral arteries 
Individual SMCs were stained with rabbit anti-BKCa channel and mouse anti-cav-3 and 
labelled with AF-594 (red) and AF-488 (green), respectively. A visual examination of a 
cell stained with anti-BKCa channel antibody indicated that the red signal appears in the 
cell membrane and in the cytoplasm of the SMC (figure 4.18 A). A visual examination 
of a cell stained with anti-cav-3 antibody indicated that the green signal appears in the 
cytoplasm and cell membrane of the SMC (figure 4.18 B). An overlay image (figure 
4.18 C) showed the BKCa channels co-expressed with cav-3, showing yellow. The 
fluorescent intensity profile, taken along the white line shown in figure 4.18 C, is 
shown in figure 4.19. Clear peaks in both red and green fluorescence indicate high 
expression level of both BKCa channels and cav-3 in the cell membrane although some 
signal is also seen from the interior of the cell. 
Two negative controls, mis-match of primary and secondary antibody and omission of 
primary antibodies, showed a low signal (figure 4.18 D and E). A bright field of a 
single SMC is shown in figure 4.18 F. 
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Figure ‎4.18. Representative confocal images of isolated rat femoral artery SMCs stained 
with anti-BKCa channels (x500) and anti-cav-3 (x500) and labelled with AF-594 (x500) and 
AF-488 (x500) respectively. A. The expression of BKCa channels (red). B. The expression of 
cav-3 (green). C. An overlay of the previous confocal images (A and B) showing co-expression 
of the BKCa channels with cav-3 (yellow). D. A negative control stained with secondary 
antibody mis-matched against wrong primary antibody. E. A negative control stained with 
secondary antibodies only. F. A bright field of an individual SMC. A, B, C, D and F: scale bar 
represents= 25 µm; E: scale bar represents= 50 µm. 
Figure ‎4.19. Fluorescent intensity profile of BKCa channels and cav-3 along the white line 
shown in figure 4.18 C. Red fluorescence shows the expression of BKCa channels and green 
fluorescence shows the expression of cav-3. Both signals peak at the cell membrane area. 
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4.3.3 Immunocytochemistry results of  HCAECs 
Single cell dissociation of artery smooth muscle cells is a widely used procedure 
(Kamishima et al., 2007). However, isolation of single ECs from arteries without 
contaminating other cell types is difficult. Therefore, in order to examine possible co-
expression of BKCa channels with cav-1 and/or cav-3 in individual ECs, I used cultured 
human coronary artery endothelial cells (HCAECs) as an EC model. 
4.3.3.1 Expression of vWF in HCAECs 
Even though HCAECs are marketed as ECs, it was necessary to characterise these cells 
first to confirm that they are indeed ECs. HCAECs were positively stained with anti-
vWF (figure 4.20 A). The fluorescent intensity profile, taken along the white line in 
figure 4.20 A, is shown in figure 4.21. These results suggest that cultured HCAECs still 
express a signature protein (vWF) of ECs. 
Two negative controls, mis-match of primary and secondary antibody and omission of 
primary antibody, showed a low signal (figure 4.20 B and C). 
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Figure ‎4.20. Representative confocal images of HCAECs stained with anti-vWF antibody 
(x300) and visualized with AF-488 (x500). A. Expression of anti-vWF (green) in HCAECs. 
B. A negative control of HCAECs stained with secondary antibody against wrong primary 
antibody. C. A negative control of HCAECs stained with secondary antibodies only. A and C: 
scale bar represents= 75 µm; B: scale bar represents= 50 µm. 
 
 
Figure ‎4.21. Fluorescent intensity profile of vWF taken along the white line shown in 
figure 4.20 A.  
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4.3.3.2 Co-expression of BKCa channels with cav-1 in HCAECs 
The co-expression of BKCa channels with cav-1 in HCAECs was next examined.  
HCAECs were stained with rabbit anti-BKCa channels and mouse anti-cav-1 and 
labelled with AF-594 (red) and AF-488 (green) respectively. A visual examination of 
the HCAECs stained with anti-BKCa channels indicates that staining appears in the 
central portion of the cell (figure 4.22 A). A visual examination of the HCAECs stained 
with anti-cav-1 showed punctuating signals in the cell membrane area (figure 4.22 B). 
A visual examination of an overlay image (figure 4.22 C) showed no evidence for co-
expression of the BKCa channels with cav-1 staining, i.e. little yellow signal. Fluorescent 
intensity profile taken along the white line shown in figure 4.22 C is shown in figure 
4.23. Red shows the expression of BKCa channels in the central portion of HCAECs. 
Green fluorescence shows the expression of cav-1 at the cell membrane area.  
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Figure ‎4.22. Representative confocal images of HCAECs stained with anti-BKCa channels 
(x500) and anti-cav-1 (x200) and visualised with AF-594 (x500) and AF-488 (x500) 
respectively. A. Expression of BKCa channels (red). B. Expression of cav-1 (green). C. An 
overlay of the confocal images (A and B) showing no evidence for co-expression of BKCa 
channels with cav-1 (yellow spots are absent). A, B and C, scale bar represents= 50µm. 
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Figure ‎4.23. Fluorescence intensity profile of BKCa channels and cav-1 taken along the 
white line shown in figure 4.22 C. Red fluorescence showed expression of BKCa channels at 
low levels in the central portion of the HCAECs. Green fluorescence showed expression of 
cav-1 at high levels in the cell membrane area of HCAECs with little overlap with red signal. 
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4.3.3.3 Co-expression of BKCa channels with cav-3  in HCAECs 
Next, possible co-expression of BKCa channels with cav-3 was examined in HCAECs. 
Cells were stained with rabbit anti-BKCa channels and mouse anti-cav-3 and labelled 
with AF-594 (red) and AF-488 (green) respectively. A visual examination of HCAECs 
stained with anti-BKCa channels indicated that the red signal appears in the central 
portion of the cell (figure 4.24 A). A visual examination of HCAECs stained with anti-
cav-3 indicated that there was very little green signal (figure 4.24 B) resulting in no 
overlap in the overlay image (figure 4.24 C). The result that cav-3 is not expressed in 
HCAECs is further supported by the fluorescent intensity profile (figure 4.25), taken 
along the white line shown in figure 4.24 C. This result is compatible with the previous 
immunohistochemistry results showing no expression of cav-3 in the ECs of rat femoral 
arteries.  
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Figure ‎4.24. Representative confocal images of HCAECs stained with anti-BKCa channels 
(x500) and anti-cav-3 (x500) and visualised with AF-594 (x500) and AF-488 (x500) 
respectively. A. Expression of BKCa channels (red). B. Expression of cav-3 (green). C. An 
overlay of the confocal images (A and B) showing no overlap between cav-3 and BKCa channels. 
A, B and C: scale bar represents= 50 µm. 
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Figure ‎4.25. Fluorescent intensity profile of BKCa channels and cav-3 along the white line 
shown in figure 4.24 C. Little green fluorescence indicates that there is little expression of cav-
3. 
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4.3.4 Results of the Western blot 
Several primary antibodies were used for immunochemical experiments, but the 
detection of signals does not necessarily confirm the presence of target proteins.  
Primary antibodies are designed to exploit a unique sequence of a target protein, but 
such sequence may be shared with other proteins. Thus, Western blotting was performed 
using lysates of rat femoral arteries to access the size of proteins detected by antibodies 
against cav-1, cav-3, BKCa channels and α-actin. If a single band with predicted size can 
be detected, then the Western blot results can validate the usefulness of primary 
antibodies. Experiments with the mouse monoclonal anti-cav-1 antibodies showed a 
single band at 24 kDa (figure 4.26, lane A). Experiments with anti-cav-3 antibody 
showed a single band at 18 kDa (figure 4.26, lane C). Rabbit polyclonal anti-BKCa 
channel antibody was also used in Western blotting, and results showed a single band at 
97 kDa (figure 4.26, lane E). The essentially same sized band was detected using anti-
BKCa channel primary antibody on rat brain lysates (figure 4.26, lane F).  
Re-blotting with anti-α-actin antibody after stripping the nitrocellulose membrane first 
blotted against anti-cav-1 showed a single band of α-actin at 42 kDa (figure 4.26, lane 
B). Re-blotting with anti-α-actin antibody after the membrane was blotted for anti-cav-3 
showed a single band of α-actin at 42 kDa (figure 4.26, lane D). These results validate 
the primary antibodies used in the immunohistochemistry and immunocytochemistry.   
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Figure ‎4.26: Western blot results using  cav-1, cav-3,‎α-actin and BKCa primary antibodies 
on rat femoral artery and brain lysates. Lanes A, B, C, D and E: rat femoral artery protein 
lysates; Lane F: rat brain protein lysate. Lane A shows a single band of cav-1 at 24 kDa. Lane 
B shows two bands, α-actin at 42 kDa and a light band of cav-1 at 24 kDa remaining after the 
stripping of the nitrocellulose membrane. Lane C shows a single band of cav-3 at 18 kDa. Lane 
D shows two bands, α-actin at 42 kDa and a band of cav-3 at 18 kDa remaining after stripping 
of the nitrocellulose membrane. Lanes E and F show a single band of BKCa channels at 96 kDa 
for each lane. The dark “band” in Lanes A and F at the top is an artifact, and corresponds to the 
top of the gel. 
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4.4 Discussion  
The mammalian caveolin family comprises of cav-1, cav-2 and cav-3, expressed in 
different arterial beds (Kamishima et al., 2007, Riddle et al., 2011). Caveolins are 
caveolae signature proteins that associate with and regulate a variety of signalling 
proteins, including ion channels (Alioua et al., 2008, Riddle et al., 2011). Several recent 
studies have focused on the co-expression of BKCa channels with cav-1/cav-3 in 
different vascular beds (Alioua et al., 2008, Riddle et al., 2011). However, the 
relationship of cav-1/cav-3 with the function of BKCa channels has not been previously 
examined either in rat femoral arteries or HCAECs. 
In this chapter, we hypothesised that the BKCa channels and cav-1 and/or cav-3 may 
interact with each other in rat femoral arteries and HCAECs. Three complementary 
methods were used to test this hypothesis: immunohistochemistry, 
immunocytochemistry and Western blot. The major findings of the present study are as 
follows: (i) co-expression of BKCa channels with cav-1 in both SMCs and ECs and co-
expression of BKCa channels with cav-3 in the SMCs of rat femoral artery frozen slices; 
(ii) co-expression of BKCa channels with cav-1 and cav-3 in isolated SMCs; (iii) no 
evidence for co-expression of the BKCa channels with cav-1 or cav-3 in the cultured 
HCAECs; (iv) Western blot results confirming the protein expression of BKCa channels, 
cav-1, cav-3 in protein lysates of rat femoral arteries and brain. 
These results may suggest a role for caveolins in regulating signalling pathways through 
BKCa channels in vascular ECs and SMCs of rat femoral arteries.  
The co-expression of BKCa channel with caveolins may occur at the C terminus of the 
channel showing consensus caveolin binding motif (
1007
YNMLCFGIY
1015
). Our results 
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agree with Riddle et al. (2011), who reported the co-expression of BKCa channels with 
cav-1 in both the SMCs and ECs of native gracilis resistance arterioles of rats from 
immunohistochemistry experiments. Furthermore, Alioua et al. (2008), reported the 
expression of both cav-1 and BKCa channels in native freshly-dissociated aortic 
myocytes using immunohistochemistry. Furthermore, our findings also agreed with 
Brainard et al. (2005) who reported the co-expression of BKCa channels with cav-1 in 
human myometrial SMCs (cultured cells) using immunocytochemistry. 
Several studies have reported that the expression of cav-3 is muscle-specific (Engelman 
et al., 1998b). Furthermore, Kamishima et al. (2007) suggested that cav-3 is important in 
the Ca
2+
 removal of resistance artery SMCs. However, the role of cav-3 in regulating ion 
channels in SMCs is still controversial. Here in this chapter, immunolabelling 
experiments revealed the co-expression of BKCa channels with cav-3 at tissue level in 
SMCs from rat femoral arteries using immunohistochemistry (figure 4.14 C), as well as 
the co-expression of BKCa channels with cav-3 at the level of individual SMCs using 
immunocytochemistry (figure 4.18 C). Semi-quantitative analysis of 
immunohistochemistry (figure 4.15) and immunocytochemistry (figure 4.19) for cav-3 
and BKCa channels revealed an overlap of the signals demonstrating the co-expression 
of BKCa channels with cav-3 in the SMC layer of femoral tissues and in the individual 
SMC. As with cav-1, this co-expression suggests that the cav-3 scaffolding domain 
(DGVWRVSYTTFTVSKYWCYR, amino acid residues 55–74) may interact with 
caveolin binding motifs in the C terminus of the BKCa channels of rat femoral artery 
SMCs. 
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To further examine whether the BKCa channels are co-expressed with cav-1 and cav-3 in 
human vascular ECs, immunohistochemistry experiments were performed on HCAECs. 
Immunofluorescence imaging demonstrated no evidence for co-expression of the BKCa 
channels with cav-1 in HCAECs (figure 4.21 C). Semi-quantitative analysis of results 
of this immunostaining (figure 4.23) revealed a low level of expression of BKCa 
channels with cav-1 proteins compared with the expression levels of BKCa channels and 
cav-1 in native rat femoral artery ECs. This may be due to a loss of protein expression in 
the cultured cells compared with native tissues. Immunofluorescence imaging indicated 
no overlap occurs between cav-3 and BKCa channels in HCAECs (figure 4.24 C) due to 
the fact that cav-3 is not expressed in HCAECs. Semi-quantitative analysis of this 
immunostaining (figure 4.25) revealed the expression of BKCa channels at a low level 
and no expression of cav-3 proteins in  HCAECs. The findings of the current study 
agree with those of Jow et al. (1999), who reported the absence of BKCa channels from 
human aortic endothelial cells (HAEC) (cultured cells), by using patch clamp, RT-PCR, 
calcium imaging (Jow et al., 1999). In contrast, our results disagree with those of Wang 
et al. (2005), who reported the co-expression of  BKCa channels and cav-1 in membrane 
of bovine aortic endothelial cells (cultured cells) by using confocal immunofluorescence 
microscopy. Generally, presence and expression of plasmalemmal BKCa channels in 
vascular endothelial cells is controversial as reviewed by Sandow and Grayson (2009). 
Analysis of the Western blot results (figure 4.26) of the whole rat femoral artery lysates 
showed the correct bands for cav-1 (24 kDa), cav-3 (18 kDa), α-actin (42 kDa), and 
BKCa channels (96 kDa). Our results agreed with Feher et al. (2010) who demonstrated 
the expression of cav-1, BKCa channels and α-actin in the coronary arteries of lean and 
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obese rats using Western immunoblotting (Feher et al., 2010). Furthermore, Alioua et al. 
(2008) reported the expression of cav-1 and BKCa channels in the lysates of rat aorta and 
in the lysates of human embryonic kidney 293 cells (cell line) using Western blot. 
Additionally, our findings agreed with Sampson et al. (2004) who showed the 
expression of cav-1 and cav-3 in the lysate of rat arterial tissues using Western blot.  
4.5 Conclusion 
In conclusion, we confirm the co-expression the BKCa channels with cav-1 and cav-3 in 
the SMC layer at tissue level and in individual SMCs in native rat femoral arteries, as 
well as the co-expression of the BKCa channels with cav-1 in ECs of rat femoral arteries. 
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Chapter 5 The Effect of Caveolae Disruption by M-β-CD on the 
Contraction of Femoral Artery Rings 
5.1 Aim of the chapter:  
The aim of this chapter was to study the effects of caveolae disruption on rat femoral 
artery contraction before and after endothelium removal.  
 The key findings in this chapter 
 Caveolar disruption by a cholesterol depleting agent caused a significant increase 
in the contraction response of intact rat femoral arteries to 20 K/ Bay K. 
 Caveolar disruption also abolished the release of basal NO production/release 
from the ECs. 
 BKCa channels may have a limited effect on smooth muscle contraction in these 
arteries in the absence of basal NO release.  
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5.2 Introduction 
SMCs and ECs of muscular distributing arteries such as the femoral artery show cell 
membranes covered with caveolae (Okamoto et al., 1998, Cohen et al., 2004), also see 
chapter 3). Caveolar domains contains various molecules such as BKCa channels, nitric 
oxide synthase (eNOS), and GPCRs (Drexler et al., 1993, Oh and Schnitzer, 2001, 
Hardin and Vallejo, 2009).  
Several studies provided the evidence that caveolae and caveolins play important role in 
the regulation of vascular tone and signal transduction pathways necessary for normal 
blood vessel function (Drexler et al., 1993, Flavahan and Vanhoutte, 1995, Parton, 
2001). The role of caveolae and the caveolins in organising signalling pathways means 
that they influence myogenic tone directly by affecting smooth muscle contractility and 
indirectly by modifying the release of vasodilator factors, including NO, from the 
endothelium (Xu et al., 2008, Hardin and Vallejo, 2006). Caveolae are particularly 
prevalent in ECs where they regulate NO production by interacting with eNOS at the 
scaffolding domain located between amino acids 82 and 101 of cav-1 (Bucci et al., 
2000, Minshall et al., 2003, Cohen et al., 2004, Gratton et al., 2004).  
Cholesterol-extracting agents such as M-β-CD and filipin have been widely used to 
evaluate the role of lipid rafts/caveolae (Darblade et al., 2001, Dreja et al., 2002, Kaiser 
et al., 2002, Gschwend et al., 2003, Linder et al., 2005, Wijetunge and Hughes, 2005, 
Xu et al., 2007, Xu et al., 2008, Sandow and Grayson, 2009, Radenkovic et al., 2012). 
Treatment with M-β-CD is thought to selectively extract cholesterol from the plasma 
membrane (Kilsdonk et al., 1995, Yancey et al., 1996), leading to disruption of caveolae 
(Babiychuk et al., 2004, Smith et al., 2005, Jie et al., 2007).  
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The disruption of caveolae by M-β-CD has been reported to cause an impairment of 
endothelium-dependent relaxation (Cohen et al., 2004) and increased contraction of 
blood vessels (Xu et al., 2008). The decrease of membrane capacitance seen with M-β-
CD treatment is consistent with the removal of caveolae from the membranes of SMCs 
(Shaw et al., 2006) and ECs (Yamamoto et al., 2011). Effects of caveolae disruption on 
ECs may include signalling alterations at the level of the receptors and/or Ca
2+
 
mobilising molecules/channels, or via its effect on the interaction of cav-1 with eNOS 
affecting NO production (Darblade et al., 2001, Linder et al., 2005, Xu et al., 2007). On 
the other hand, cholesterol-saturated methylcyclodextrin (Ch-MCD) has been reported 
to have the ability to replenish cholesterol in the membranes of vascular cells that had 
been depleted by M-β-CD. Thus treatment with M-β-CD leads to loss of basilar artery 
contractility to endothelin-1, and subsequent treatment with Ch-MCD leads to recovery 
of the contraction (Bergdahl et al., 2003).  
BKCa channels play a critical role in the function of arteries including the control of 
blood flow and pressure (Brenner et al., 2000, Sausbier et al., 2005). Immunostaining 
and electrophysiological studies have shown that BKCa channels are co-expressed with 
cav-1 in endothelial cells (Wang et al., 2005, Kamishima et al., 2007, Riddle et al., 
2011). Furthermore, mammalian BKCa channels have two potential binding motifs for 
cav-1 (Alioua et al., 2008, Lu et al., 2010). Activation of BKCa channels leads to 
membrane hyperpolarisation, inhibition of L-type Ca
2+
 channels and vascular relaxation 
(Lacinova, 2005). BKCa channels are activated by depolarisation and/or increases in 
locally produced Ca
2+
 transients (sparks) from RyRs in the SR membrane (Marty, 1981). 
The distance between the caveolae and superficial SR is about 20 nm in SMCs 
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(Gherghiceanu and Popescu, 2007). The proximity between SR and BKCa channels 
within caveolae seems crucial in the coupling of local SR Ca
2+
 release with the opening 
of BKCa channels. Furthermore, if the Ca
2+
 sparks are triggered by occasional opening of 
L-type Ca
2+
 channels, and if L-type Ca
2+
 channels are also located within caveolae, then 
the disruption of caveolae may also decrease spark frequency/amplitude due to the 
increased distance between L-type Ca
2+
 channels and RyRs (Lohn et al., 2000).  
In the previous chapter, I have established that rat femoral artery expresses BKCa 
channels in both ECs and SMCs. I also established that femoral artery ECs express cav-
1, and SMCs express cav-1 and cav-3. Here, I used myography to study the effect of 
cholesterol depletion from the membrane on the contraction of rat femoral arteries, and 
identify the molecules that are affected by caveolae disruption. 
  
128 
 
5.3 Results 
5.3.1 Contraction of femoral arteries in response to KPSS and 20 K/ Bay K 
5.3.1.1 Experimental protocol 
After 50 min normalisation, vessels were first contracted with KPSS. Once a plateau 
was reached and maintained, the arteries were washed with PSS until force returned to 
baseline. This procedure was repeated three times until reproducible contractions were 
elicited (figure 5.1). Repeated applications of KPSS generally caused a gradual increase 
of force. Arteries were then contracted with a “standard” contractile solution (20 K/ Bay 
K). At the plateau of the 20 K/ Bay K contraction, ACh (final concentration, 10 μM) 
was added. ACh-induced relaxation indicates the functional integrity of the endothelium 
(figure 5.1 A). Note that 10 µM ACh that causes almost total relaxation in other arteries 
such as mesenteric artery but normally induces only a partial and transient relaxation in 
rat femoral arteries. KPSS (80 mM KCl) causes substantial depolarisation which 
activates VDCCs. Partial depolarisation caused by 20 mM KCl alone would not be 
sufficient to induce useful contraction, but addition of Bay K 8644 further facilitates the 
opening of VDCC. The initial contraction/relaxation using KPSS, 20 K/ Bay K and ACh 
was important for testing the viability of the arteries to ensure that the isolating and 
mounting techniques had no adverse effect on responses. If an artery failed to contract to 
either KPSS or to 20 K/ Bay K, or did not relax in response to ACh, it was excluded 
from the study.  
As a control, the effect of repeated contractions with 20 K/ Bay K was also tested. After 
completing the preliminary contractions as shown in figure 5.1 A, arteries were 
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contracted with 20 K/ Bay K three times (figure 5.1 B). The contraction induced by 20 
K/ Bay K was not significantly altered by repeated applications of 20 K/ Bay K (figure 
5.2). 
5.3.1.2  Data analysis 
All data are presented as a mean ± standard error of mean. The contraction force is 
expressed in mN. n is number of observations. Statistical significances were determined 
using the either paired Student’s t-test (for two data sets) or ANOVA (for multiple 
comparison) (Graphpad, Instat). A value of P<0.05 was considered to be statistically 
significant. 
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Figure ‎5.1. Protocol for testing viability of femoral artery for contraction experiments. A. 
Control contraction with KPSS, followed by 20 K/ Bay K contraction and testing of the intact 
endothelium using ACh. B. Test repeat applications of 20 K/ Bay K on contraction force. 
 
 
 
 
131 
 
 
Figure ‎5.2. Effect of repeated contraction with 20 K/ Bay K on rat femoral artery.  Mean 
data showing the effects of repeat contraction on the response to 20 K/ Bay K. No statistical 
significance was seen. n=6.  
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5.3.2 The effects of caveolar disruption by M-β-CD on rat femoral artery 
contraction  
5.3.2.1 Experimental protocol 
After completing the preliminary contractions as shown in figure 5.1 A, arteries were 
incubated with 5 mM M-β-CD for 1 hour. Afterwards, the vessels were washed with 
PSS three times to clean cholesterol debris from the lumen. The vessels were then left 
for 10 min to recover before the next step. The vessels were then contracted with 20 K/ 
Bay K. Afterward, 20 K/ Bay K was washed out with PSS. The arteries were left for 10 
min to recover. Vessels were stimulated with KPSS at the end to examine the effect of 
M-β-CD treatment on KPSS induced contraction.   
5.3.2.2 Analysis  
Incubation of femoral arteries with 5 mM M-β-CD for 1 hour augmented contraction in 
response to 20 K/ Bay K but not to KPSS (figure 5.3 A). Force increased in response to 
20 K/ Bay K from 11.84 ± 1.30 mN to 18.25 ± 2.00 mN (n= 14, **P< 0.01). In contrast, 
the contraction induced by KPSS was not significantly altered by M-β-CD (33.10 ± 1.43 
mN to 33.36 ± 2.02 mN, n= 14, ns) (figure 5.3 B).  
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Figure ‎5.3. Effect of caveolar disruption with M-β-CD on rat femoral artery contractions.  
A. Original traces show that treatment with 5 mM M-β-CD augments contraction in response to 
20 K/ Bay K but not to KPSS. B. Mean data showing the effects of cholesterol depletion on the 
response to 20 K/ Bay K and KPSS. Statistically significant difference was detected using 
Student’s t-test: n=14, **P< 0.01 and ns=non-significant difference, respectively. 
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5.3.3 The effects of caveolar disruption by filipin on rat femoral artery 
contraction 
5.3.3.1 Experimental protocol 
Next, caveolae was disrupted using another cholesterol depleting agent, filipin. After 
completing the same preliminary contraction shown in figure 5.1 A, arteries were 
incubated with filipin (4 µg/ml, 1 hour). Afterwards, the vessels were washed with PSS 
three times, left for 10 min to recover, and contracted with 20 K/ Bay K. Arteries were 
then left for 10 min to recover and stimulated with KPSS.  
5.3.3.2 Analysis   
The results obtained with filipin were very similar to those with M-β-CD. Filipin 
treatment augmented contraction to 20 K/ Bay K but not to KPSS (figure 5.4 A). 
Incubation with filipin increased the force produced in response to 20 K/ Bay K from 
5.36 ± 1.30 mN to 9.36 ± 2.21 mN (n= 12, *P< 0.05). In contrast, the contraction 
induced by KPSS was not significantly altered by filipin treatment (18.60 ± 2.90 mN to 
18.73 ± 3.12 mN, n= 12,  ns) (figure 5.4 B).  
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Figure ‎5.4. Effect of caveolar disruption with filipin. A. Filipin treatment augments 
contraction in response to 20 K/ Bay K but not to KPSS. B. Mean data showing the effects of 
filipin treatment on the response to 20 K/ Bay K and KPSS. Statistical significance was detected 
using Student’s t-test: n=12, * P< 0.05. 
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5.3.4 The effects of Ch-MCD after caveolar disruption by M-β-CD  
5.3.4.1 Experimental protocol 
Next, Ch-MCD was used to reverse the effects of cholesterol depletion by M-β-CD.  
After completing the experimental protocol shown in figure 5.1 A, the vessels were 
incubated with Ch-MCD (5 mM) for 1 hour to replenish cholesterol. The vessels were 
then washed with PSS three times, left for 10 min to recover, and contracted with 20 K/ 
Bay K. Arteries were then washed with PSS, left for 10 min and stimulated with KPSS.  
5.3.4.2 Analysis  
Ch-MCD reversed the effect of M-β-CD on 20 K/ Bay K contractions (figure 5.5 A). 
Incubation of arteries in M-β-CD for 1 hour increased force generated in response to 20 
K/ Bay K from 3.50± 0.62 mN to 5.73± 1.35 mN, n=16), but not to KPSS. Subsequent 
incubation of arteries with Ch-MCD reversed the effect of M-β-CD (2.74 ± 0.59 mN 
after Ch-MCD, n=12). 
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Figure ‎5.5. Reversibility of the M-β-CD effect on contractions by Ch-MCD. A. M-β-CD 
treatment augments contraction to 20 K/ Bay K and Ch-MCD reverses this effect. B. Mean data 
showing the effect of M-β-CD and Ch-MCD on 20 K/ Bay K and KPSS contractions. M-β-CD 
treatment enhanced 20 K/ Bay K contraction. After re-admission of cholesterol, contraction 
returned to levels seen before application of M-β-CD. Contractions induced with KPSS were not 
affected by M-β-CD or Ch-MCD. n=12. 
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5.3.5 The effects of Ch-MCD on the 20 K/ Bay K contractions  
5.3.5.1 Experimental protocol 
Next, whether Ch-MCD exerts direct effects on contraction with 20 K/ Bay K (i.e. in the 
absence of prior treatment by M--CD) was tested. After completing the protocol shown 
in figure 5.1 A, the vessels were incubated with Ch-MCD (5 mM) for 1 hour. 
Afterwards, the vessels were washed with PSS three times, left for 10 minutes to 
recover, and contracted with 20 K/ Bay K.   
5.3.5.2 Analysis  
Incubation of arteries with Ch-MCD had no effect on its own on 20 K/ Bay K-induced 
force (figure 5.6 A).  Mean data are shown in figure 5.6 B (3.15 ± 0.45 mN to 2.98 ± 
0.59 mN, n= 6, ns).  
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Figure ‎5.6. Effect of Ch-MCD on contractions with 20 K/ Bay K. A. Incubation with Ch-
MCD did not alter the contraction response to 20 K/ Bay K. B. Mean data showing the effect of 
Ch-MCD. Statistical significance was examined using Student’s t-test: n=6, ns. 
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5.3.6 The effects of endothelial removal on the response to M-β-CD 
5.3.6.1 Experimental protocol 
Next, whether the endothelium removal would have effects on the change seen with 
caveolar disruption was tested. After establishing the viability or arteries, the 
endothelium was mechanically removed. The vessels were then washed with PSS three 
times and left to recover. Vessels were contracted again with 20 K/ Bay K, then at the 
plateau of 20 K/ Bay K contraction, ACh (10 μM) was added to confirm the removal of 
the endothelium. Afterwards, the vessels were washed and left for about 10 min to 
recover. In order to deplete cholesterol, the vessels were incubated with M-β-CD (5 
mM) for 1 hour. Subsequently, the vessels were washed with PSS three times, left for 10 
min, and contracted with 20 K/ Bay K.  
5.3.6.2 Analysis 
After endothelial removal, M-β-CD no longer augmented contraction to 20 K/Bay K 
(figure 5.7 A). Analysis showed that M-β-CD treatment did not significantly alter force 
generated in response to 20 K/ Bay K in the absence of endothelium (6.61 ± 0.91 mN to 
7.40 ± 1.07 mN, n= 14, ns) (figure 5.7 B). This indicates that effect of M-β-CD on 20 
K/ Bay K contraction using rat femoral artery is mediated by endothelial cells.   
141 
 
 
 
 
 
 
 
Figure ‎5.7. Effect of M--CD on endothelium-denuded femoral artery. A. After endothelial 
denudation, incubation with M-β-CD did not augment the contraction response to 20 K/ Bay K. 
ECs were mechanically removed prior to contracting the artery with 20 K/ Bay K, as shown by 
the absence of relaxation to ACh. B. Mean data showing no significant difference in the 
contractions of endothelium-denuded arteries stimulated with 20 K/ Bay K following M-β-CD 
treatment. Statistical significance was examined using Student’s t-test: n=14, ns. 
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5.3.7 The effects of L-NAME and M-β-CD are not additive 
5.3.7.1 Experimental protocol 
In the previous section, the effect of M-β-CD was shown to be largely endothelium-
dependent. As eNOS is known to be localised in caveolae, and caveolar loss reduces the 
effectiveness of endothelium-dependent vasodilators (Xu et al., 2008), my results could 
be explained by the effect of M-β-CD on NO production. Thus, I first investigated the 
effects of basal NO release on contractions. After completion of the preliminary 
contraction to 20 K/ Bay K, the vessels were incubated in L-NAME (250 µM), an eNOS 
inhibitor, for 10 min. Afterwards, the vessels were contracted again using 20 K/ Bay K 
in the presence of L-NAME.  At the plateau of 20 K/ Bay K/ L-NAME contraction, ACh 
(10 μM) was added to test the effect of L-NAME on endothelium-dependent 
vasodilation. The vessels were then washed and left about for 10 min to recover. In 
order to disrupt caveolae the vessels were incubated with M-β-CD (5 mM) for 1 hour. 
The vessels were then washed with PSS three times and contracted with 20 K/ Bay K. 
At the plateau of 20 K/ Bay K contraction, ACh was added. Afterwards, the vessels 
were washed and left for about 10 min to recover. The vessels were then pre-incubated 
in L-NAME (250 µM) for 10 min and contracted with 20 K/ Bay K/ L-NAME. 
5.3.7.2 Analysis 
Application of L-NAME augmented contraction to 20 K/ Bay K. Note that, in the 
presence of L-NAME, application of ACh caused contraction, rather than relaxation.  
This result is consistent with L-NAME inhibiting basal NO release from the 
endothelium in this artery. When arteries were subsequently incubated in M-β-CD, 
143 
 
contraction to 20 K/ Bay K was enhanced (figure 5.8 A). Note after M-β-CD treatment, 
ACh application no longer causes relaxation (figure 5.8 A).  L-NAME no longer had an 
additional contractile effect after M-β-CD treatment. This could be explained if both M-
-CD and L-NAME act on the same pathway, most likely inhibiting basal NO release 
from the endothelium.  Analysis of the results showed that incubation of arteries with L-
NAME caused a significant increase in the force generated in response to 20 K/ Bay K, 
from 6.82 ± 1.61 mN to 14.90 ± 2.76 mN (n= 6, **P< 0.01). However, when arteries 
were treated with M-β-CD, L-NAME no longer caused significant additional contraction 
(17.70 ± 2.73 mN to 16.00 ± 3.19 mN (n= 6, ns) (figure 5.8 B). Overall, these results 
support the previous observation that the action of M-β-CD is endothelium-dependent, 
and that M-β-CD and L-NAME both increase force by eNOS inhibition. 
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Figure ‎5.8. Effect of inhibition of NO synthase by L-NAME on femoral artery 
contractions. A. Incubation with 250 µM L-NAME augmented contraction response to 20 K/ 
Bay K. When arteries were incubated with M-β-CD, contraction with 20 K/ Bay K was 
enhanced. However, L-NAME no longer had an additional contractile effect after M-β-CD 
treatment. B. Mean data showing 250 µM L-NAME significantly increases the contraction 
response to 20 K/ Bay K. L-NAME did not enhance the contraction after M-β-CD treatment. 
Statistical significance was examined using Student’s t-test: n=6, **P< 0.01.  
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5.3.8 Effect of L-NAME on rat femoral artery rings pre-contracted with 
phenylephrine  
Although useful in its simplicity, contraction induced with 20 K/ Bay K may not 
necessarily reflect the events during more physiological contractions.  Here, the effect of 
L-NAME was further examined using arteries contacted with an α-adrenergic agonist, 
phenylephrine  (PE).     
5.3.8.1 Experimental protocol  
After the vessels were constricted with 20 K/ Bay K, and ACh was added to confirm the 
presence of the endothelium, they were contracted with cumulative doses of PE (0.1 
µM, 0.3 µM, 1 µM, 3 µM, 10 µM and 30 µM) (figure 5.9 A). Artery rings were then 
pre-incubated with L-NAME (250 µM) for 10 minutes and then contracted again with 
cumulative doses of PE (0.1-30 µM) in the presence of L-NAME (figure 5.9 A). 
5.3.8.2 Analysis 
The response to cumulative doses of PE was measured at the peak of each contraction 
component. Values are expressed as means ± SEM. PE concentration-response curves 
were constructed before and after treatment with L-NAME. 
Concentration-response curves shifted to the left after incubation with L-NAME (figure 
5.9 B), i.e. a given concentration of PE was more effective after L-NAME treatment. 
These results indicate that PE causes contraction in rat femoral artery and that 
incubation with L-NAME augments PE-induced contraction, possibly by inhibiting 
basal endothelial NO release.  
146 
 
 
0.1 0.3 1 3 10 30
F
o
rc
e 
(m
N
)
0
10
20
30
40
50
60
PE (M)
B
 
Figure ‎5.9. Effect of L-NAME on PE-induced femoral artery contraction. A. Traces show 
phenylephrine contractions (0.1 - 30 μM) before and after incubation with L-NAME (250 µM) 
B. Phenylephrine concentration-response curves before (●) and after (○) incubation with L-
NAME. Data are expressed as mean   SEM (n=6). 
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5.3.9 The disruption of caveolae by M-β-CD is associated with the impairment of 
BKCa channel function in rat femoral arteries 
The function of the BKCa channel is reported to be influenced by caveolar location and 
interaction with caveolins. In this experiment, I tested whether the observed change in 
contraction by disrupting caveolae is mediated by the BKCa channel. As BKCa channels 
were found in both endothelial and smooth muscle cells in rat femoral artery (see 
chapter 4), I designed two experiments to examine: (i) the effect of BKCa channel 
inhibition by tetraethylammonium ions (TEA
+
) on the contraction of femoral arteries in 
response to 20 K/ Bay K before and after treatment with M-β-CD; (ii) the effect of BKCa 
channel inhibition by TEA
+
 on the contraction of endothelium-denuded femoral arteries 
in response to 20 K/ Bay K before and after treatment with 5 mM M-β-CD. 
5.3.9.1 Experimental protocol A 
Endothelium-intact artery rings were contracted with 20 K/ Bay K. They were then pre-
incubated in TEA
+
 (2 mM), a relatively selective BKCa channel inhibitor at this 
concentration (Langton et al., 1991), for 10 min. Vessels were next contracted with 20 
K/ Bay K in the presence of 2 mM TEA
+
. In order to disrupt caveolae, vessels were 
incubated with M-β-CD (5 mM) for 1 hour. Subsequently, the vessels were pre-
incubated in TEA
+
 (2 mM) for 10 minutes and contracted with 20 K/ Bay K/ TEA.   
5.3.9.2 Experimental protocol B 
The endothelium was mechanically removed from the lumen of the artery and a similar 
protocol to that applied in Experimental protocol A was then used. Vessels were 
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contracted with 20 K/ Bay K and ACh (10 μM) was added to confirm the absence of the 
endothelium. Vessels were pre-incubated in TEA
+
 (2 mM) for 10 min and contracted 
with 20 K/ Bay K/ TEA. Vessels were then incubated with M-β-CD (5 mM) for 1 hour, 
pre-incubated in TEA
+
 (2 mM) and contracted with 20 K/ Bay K/ TEA. 
5.3.9.3 Analysis 
Incubating artery rings with 2 mM TEA
+
 caused an increase in the resting force of the 
artery, and also the contraction force in response to 20 K/ Bay K (figure 5.10). This 
result suggests TEA
+
-sensitive K
+
 channels are contributing to the membrane potential 
at both resting state and when arteries are contacted with 20 K/ Bay K. The two data 
traces illustrated in figure 5.10 show different patterns of response. In the upper trace, 
spikes are superimposed on top of the increase in resting force, indicating TEA
+
 is 
inducing spontaneous oscillations in this vessel. As before, incubating arteries with 5 
mM M-β-CD for 1 hour augmented contraction in response to 20 K/ Bay K (figure 
5.10). After treatment with M-β-CD, TEA+ no longer caused significant additional 
contraction in response to 20K/ Bay K (figure 5.10). Analysis showed that treatment of 
intact femoral arteries with M-β-CD caused a significant increase in the force generated 
in response to 20 K/ Bay K, from 7.07 ± 2.05 mN to 15.29 ± 2.84 mN (n=8, **P< 0.01) 
(figure 5.11). Increases in the resting tension caused by 2 mM TEA
+
 alone before and 
after M-β-CD treatment was 1.15 ± 0.68 mN and 2.15 ± 0.81 mN, respectively (ns, 
figure 5.11). 2 mM TEA
+
 application significantly increased the contraction with 20 K/ 
Bay K from 7.07 ± 2.05 mN to 18.53 ± 3.25 mN (n=8, *P< 0.05). After the vessels had 
been incubated with M-β-CD, incubation with TEA+ (2 mM) caused a non-significant 
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increase in the force generated in response to 20 K/ Bay K, from 18.53 ± 3.25 mN to 
19.54 ± 2.22 mN (n=8, ns) (figure 5.11).  The observation that TEA
+
 increased force 
before, but not after, M--CD treatment suggests caveolar disruption decreases the 
contribution of a TEA
+
-sensitive K
+
 channel to the membrane potential. 
In  endothelium-denuded femoral arteries, application of 2 mM TEA
+
 caused a small but 
non-significant increase in 20 K/ Bay K contraction (from 6.06 ± 1.44 mN to 8.01 ± 
1.58 mN (n= 8, ns)) (figure 5.12 B).  M-β-CD application had no significant effect on 
20 K/ Bay K contraction (6.06 ± 1.44 mN to 6.19 ± 1.32 mN (n= 8, ns)).  After arteries 
were incubated with M-β-CD, TEA+ caused a small, non-significant, additional 
contraction in response to 20 K/ Bay K /M-β-CD from 6.19 ± 1.32 mN to 7.23 ± 1.61 
mN (n= 8, ns).  
Overall, these results indicate that inhibition of the potassium channels, possibly BKCa 
channels, by TEA
+
 effectively increases the contraction of rat femoral artery in the 
presence of endothelial cells. Caveolae disruption by M-β-CD and/or endothelium 
removal caused TEA
+
 to become much less effective at augmenting contraction to 20 K/ 
Bay K. M-β-CD treatment and removal of endothelium both seem to inhibit basal 
endothelial NO release. NO is a known activator of BKCa channels in SMCs, so reduced 
basal NO release may lead to less active BKCa channels, so SMC depolarization, and 
contraction.    
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Figure ‎5.10. Effect of TEA
+
 on femoral artery contractions to 20K/ Bay K. Traces show 
that incubation of arteries with 2 mM TEA
+
 by itself causes contraction, and also augments the 
contraction response to 20 K/ Bay K. In the upper trace (A), TEA
+
 triggered spontaneous 
oscillations in force. When arteries were subsequently incubated in M-β-CD, this caused an 
enhanced contraction in response to 20 K/ Bay K, but this effect of M-β-CD was absent when 
the arteries were treated with TEA
+
. Increases in the basal tension due to TEA
+
 application alone 
were similar before or after M-β-CD treatment. 
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Figure ‎5.11. Mean data for effect of TEA+ on femoral artery contractions to 20 K/ Bay K 
before and after M-β-CD treatment. Data show a significant increase in the contraction in 
response to 20 K/ Bay K after incubation of the artery with 2 mM TEA
+
 before, but not after, 
treatment with M-β-CD. Statistical significance was examined using ANOVA: n=8, * P<0.05 
and ** P< 0.01. 
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Figure ‎5.12. Effect of TEA+ on contractions to 20 K/ Bay K in an endothelium-denuded 
artery. A. Application of 2 mM TEA
+
 or M-β-CD had little effect on 20 K/ Bay K contraction.  
B. Mean data showing a non-significant increase in the contraction response to 20 K/ Bay K by 
TEA
+
 or M-β-CD. Statistical significance was examined using ANOVA n=8.  
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5.3.10 Effect of Iberiotoxin (IBTX) before and after disruption of caveolae by M-β-
D 
In this experiment, I tested the effect of a more specific inhibitor of BKCa channels, 
IBTX, in order to examine whether the observations gained using TEA
+
 are re-
produced.  
5.3.10.1 Experimental protocol  
After completion of the preliminary protocol (figure 5.1 A), vessels were pre-incubated 
in IBTX (100 nM) for 10 minutes. Vessels were then contracted with 20 K/ Bay K in the 
presence of 100 nM IBTX. The endothelium was then mechanically removed, the 
vessels washed, left for about 10 minutes to recover, and re-contracted with 20 K/ Bay 
K.  ACh (10 μM) was added to confirm the absence of the endothelium. Vessels were 
then pre-incubated in IBTX (100 nM) for 10 minutes and contracted with 20 K/ Bay K/ 
IBTX.  Caveolae were then disrupted by incubation with M-β-CD (5 mM) for 1 hour. 
Afterwards, the vessels were pre-incubated in IBTX (100 nM) for 10 minutes and 
contracted to 20 K/ Bay K/ IBTX.  
5.3.10.2 Analysis 
Incubating arteries with 100 nM IBTX for 10 minutes augments contraction to 20 K/ 
Bay K (figure 5.13 A). After the endothelium removal, incubation of arteries with 100 
nM IBTX no longer enhanced 20 K/ Bay K contractions (figure 5.13 A). After arteries 
were incubated with M-β-CD, IBTX caused no additional contraction in response to 20 
K/ Bay K (figure 5.13 A). Application of 100 nM IBTX to endothelium-intact rings 
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increased contraction with 20 K/ Bay K, from 6.01± 0.09 mN to 11.99 ± 2.66 mN.  
However, the P value was not quite significant (P=0.0657), presumably due to a small 
sample size. After removal of ECs, application of IBTX to the arteries caused a small 
increase in force, from 5.87 ± 0.60 mN to 7.06 ± 1.10 mN. Incubating the vessels with 
M-β-CD caused a small increase in the force generated in response to 20 K/ Bay K/ 
IBTX, from 7.06 ± 1.10 mN to 7.57 ± 1.28 mN (n=4) (figure 5.13 B). 
These results indicate that inhibition of BKCa channels by IBTX increased contraction to 
20 K/ Bay K in femoral artery in the presence of the endothelium. Endothelium removal 
resulted in abolition of this IBTX effect, as well as that of M-β-CD. These results with 
IBTX, a very specific BKCa channel inhibitor, are comparable to those obtained with 
TEA
+
, validating the effects seen with TEA
+
, suggesting that they are likely to be 
mediated by BKCa channels.   
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Figure ‎5.13. Effect of IBTX on femoral artery contractions to 20 K/ Bay K. A. Experimental 
trace shows incubation of artery with 100 nM IBTX augments contraction in response to 20 K/ 
Bay K. After endothelial removal, IBTX was no longer effective at increasing force. B. Mean 
data showing an increase in the contraction response to 20 K/ Bay K after incubation of the 
artery with IBTX when EC is present. n=4. 
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5.3.11 Inhibition of basal release of NO by L-NAME is associated with reduced 
contraction in response to BKCa channel inhibition with IBTX 
5.3.11.1 Experimental protocol  
This experiment was designed to examine whether the effects of L-NAME and IBTX on 
contraction were additive, an indication that two mechanisms act through different 
pathways. Vessels were contracted with 20 K/ Bay K and, at the plateau of the 
contraction, IBTX (100 nM) was added to the chamber. Arteries were then washed and 
pre-incubated with L-NAME (250 µM) for 10 minutes. Vessels were then contracted 
using 20 K/ Bay K/ L-NAME, and at the plateau of the contraction, IBTX (100 nM) was 
added. 
5.3.11.2 Analysis  
Adding IBTX (100 nM) during 20 K/ Bay K induced further contraction (figure 5.14 
A). When arteries were treated with L-NAME, the effect of IBTX was smaller (figure 
5.14 A). Analysis of results showed that incubation of arteries with L-NAME by itself 
caused an increased contraction with 20 K/ Bay K (figure 5.14 B). IBTX (100 nM) 
caused additional contraction over and above that caused by 20 K/ Bay K of 18.30 ± 
0.90 mN and 7.02 ± 2.95 mN in the absence and presence of L-NAME, respectively (n= 
4, **P< 0.01) (figure 5.14 B). These results indicate that the inhibition of BKCa 
channels by IBTX induces contraction of rat femoral arteries, as shown in the previous 
section. After incubating arteries in L-NAME, IBTX has less effect on 20 K/ Bay K 
contractions. Once again, this data is consistent with basal NO release from the 
endothelium causing activation of BKCa channels in vascular SMCs. Inhibiting NO 
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synthesis with L-NAME or BKCa channels with IBTX (or TEA
+
) therefore has a similar 
overall effect on force.  
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Figure ‎5.14. Effect of IBTX and L-NAME on contractions with 20 K/ Bay K. A. Addition of 
100 nM IBTX induced further contraction to 20 K/ Bay K. When arteries were pre-incubated 
with 250 µM L-NAME, IBTX was less effective in increasing force. B. Mean data showing a 
significant increase in contraction response to 20 K/ Bay K by IBTX before, but not after, 
incubation with L-NAME. Statistical significance was established using Student’s t-test: n=4, 
**P< 0.01. 
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5.3.12  TEA+ inhibits relaxation of rat femoral artery to sodium nitroprusside 
The results so far indicate that the contraction caused by 20 K/ Bay K is partly 
dependent on basal release of NO, which subsequently activates BKCa channels in 
smooth muscle cells.  In other arteries, NO and NO donors have been shown to activate 
smooth muscle BKCa channels to cause vasodilation (Mistry and Garland, 1998). In 
order to test whether a similar mechanism exists in rat femoral artery, experiments were 
performed to examine the effect of the BKCa channel inhibitor TEA
+
 on relaxations to 
the NO donor sodium nitroprusside (SNP).  
5.3.12.1 Experimental protocol A 
To assess the effect of TEA
+
 on vasorelaxation, arteries were constricted with 20 K/ Bay 
K and cumulative doses of SNP added (0.1 µM, 0.3 µM, 1 µM, 3 µM, 10 µM, 30 µM 
and 100 µM) (figure 5.15 A). The protocol was then repeated in the presence of 2 mM 
TEA
+
 (figure 5.15 A).  
5.3.12.2 Experimental protocol B 
The same protocol as above was repeated on arteries without endothelial cells (figure 5. 
15). 
5.3.12.3 Experimental protocol C 
The same protocol as above was repeated on arteries contracted with KPSS (without 
ECs) (figure 5.16). 
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5.3.12.4 Data analysis  
SNP (0.1-100 μM) caused concentration-dependent relaxation in endothelium-intact rat 
femoral arteries contracted with 20 K/ Bay K, before and after incubation with 2 mM 
TEA
+
 (figure 5.15 A). Concentration-response curves show the vasorelaxation response 
to SNP was inhibited after incubation with 2 mM TEA
+
, however, the data were only 
significantly different at 30 µM SNP (n=8, *P<0.05) (figure 5.15 B). 
In the endothelium-denuded rings, SNP caused concentration-dependent relaxation 
(figure 5.16 A). In the presence of TEA
+
, SNP was less effective. Concentration-
response curves show the vasorelaxation response to SNP was significantly inhibited in 
the presence of TEA
+
 at concentration of SNP of 1 µM and above (1 μM SNP, P<0.01; 3 
- 100 μM SNP, P<0.001, n=8) (figure 5.17). Vasorelaxation in response to SNP was 
also attenuated in arteries contracted with KPSS (1 μM SNP, P<0.01; 3 - 100 µM SNP, 
P<0.001, n=8) (figures 5.16 B and 5.17). The latter result is also consistent with K
+
 
channel activation being involved in SNP relaxations, with BKCa channel being the most 
likely candidate.  
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Figure ‎5.15. Effect of TEA+ on SNP-induced relaxation of endothelium-intact rat femoral 
artery. A. Experimental trace showing vasorelaxation in an artery contracted by 20K/ Bay K.  
SNP (0.1 to 100 μM) before and after the treatment with TEA+ (2 mM). B. Comparison of 
fractional relaxation induced by SNP in femoral artery before (○) and after (●) the treatment 
with 2 mM TEA
+
.   
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Figure ‎5.16. Effect of TEA+ on SNP-induced relaxation of endothelium-denuded femoral 
artery. A. Traces showing vasorelaxation in an artery pre-contracted by 20K/ Bay K.  SNP (0.1 
- 100 μM) produced relaxation before and after treatment with 2 mM TEA+; B Trace showing 
vasorelaxation produced by SNP (0.1 - 100 μM) in an artery contracted with KPSS. 
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Figure ‎5.17. Effect of TEA+ on SNP concentration-response curves in endothelium-
denuded femoral artery. Vasorelaxation induced by SNP in arteries contracted with 20 K/ Bay 
K, before (●) and after (○) the treatment with 2 mM TEA+ and in arteries contracted with KPSS 
(▼).  
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5.4 Discussion 
Contraction of vascular SMCs is initiated by an increase in the intracellular Ca
2+
 
concentration ([Ca
2+
]i). [Ca
2+
]i can rise from two sources, the extracellular space 
(Ca
2+
 influx) and intracellular stores (Ca
2+
 release) (Yamamura et al., 2013). 
Excitatory hormones and neurotransmitters often trigger a combination of Ca
2+ 
influx and Ca
2+ 
release (McFadzean and Gibson, 2002). Ca
2+
 influx occurs through 
Ca
2+ 
permeable channels, either voltage dependent (L-type Ca
2+ 
channels 
(McFadzean and Gibson, 2002), or voltage independent. The latter includes the 
receptor-activated calcium channels (ROCCs, activated by agonists acting on 
GPCRs) and store-operated calcium channels (SOCCs, activated by depletion of the 
Ca
2+ 
stores) (McDaniel et al., 2001).  
Activation of L-type Ca
2+
 channels was used as the primary source of contraction 
here as they play a major role in rat femoral artery (Fransen et al., 2012). I 
investigated the effects of cholesterol-binding agents and inhibitors of BKCa channels 
in the presence and absence of ECs on a simple contraction induced by 20 K/ Bay K.  
My results collectively suggest that basal NO release from ECs is a key determinant 
of the size of 20 K/ Bay K contraction, and that BKCa channels play a critical role in 
this NO-dependent femoral artery contractility. NO is a well established vasodilator 
(Cohen et al., 1999, Fransen et al., 2012), but the mechanisms by which NO exert its 
effects are not completely understood (Cohen et al., 1999).  
In this study, two principal methods were used for eliciting contraction, KPSS and 
20 K/ Bay K (Dreja et al., 2002, Xu et al., 2007, Yamamura et al., 2013). KPSS, a 
high K
+
 solution (80 mM), was used to depolarize the SMC membrane (Fransen et 
al., 2012). Isometric contraction can be increased until maximal force is generated by 
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elevating K
+
 to 50 mM K
+
 (Fransen et al., 2012). 20 K/ Bay K causes a partial 
depolarization (20 mM KCl) and activation of L-type Ca
2+
 channels (Bay K 8644) 
(Yamamoto et al., 1984).  Both KPSS and 20 K/ Bay K cause the artery to contract 
by triggering an influx of Ca
2+
 into the SMC via VDCCs (Yamamura et al., 2013). 
However, there is a critical difference in contraction induced by KPSS and 20 K/ 
Bay K.  If the arteries are contracted with the former, the opening of K
+
 channels 
cannot cause hyperpolarisation and thus will not lead to artery relaxation. If the 
arteries are contracted with the latter, opening of K
+
 channels can still cause 
hyperpolarisation and so it will lead to artery relaxation. Together, these two similar 
but distinctive approaches will aid in untangling the possible role played by K
+
 
channels in the changes caused by application of M-β-CD and filipin (Darblade et 
al., 2001, Xu et al., 2007). More specifically, TEA
+
 and IBTX were used as 
inhibitors of BKCa channels (Szado et al., 2001) to identify the K
+
 channel involved. 
In addition, ACh (to activate eNOS) and L-NAME (to inhibit eNOS) were used to 
assess the role of NO.  
The results in this chapter demonstrate that caveolae disruption using either M-β-CD 
or filipin causes significant increases in the isometric force of femoral arteries in 
response to 20 K/ Bay K but not to KPSS (figures 5.2 A and 5.4 A). The fact that 
contractions were unaffected in response to KPSS also suggests that L-type Ca
2+
 
channels might be located outside of the caveolae. A similar result was reported by 
Dreja et al. (2002). Also, it has been demonstrated that the function of L-type Ca
2+
 
channels is independent of caveolae (Lohn et al., 2000). Furthermore, the presence of 
intact endothelium seems crucial in the change seen with cholesterol depletion. The 
role of caveolae in ECs has been described previously by several studies (Darblade 
et al., 2001, Isshiki et al., 2002, Linder et al., 2005, Xu et al., 2007).  
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The effect of M-β-CD was reversed with application of Ch-MCD (figure 5.5 A). A 
similar result was reported in the endothelin-1 contraction using basilar arteries of 
rats (Bergdahl et al., 2003). Thus, although M-β-CD may have other effects, the 
functional read-out used here (isometric force) can reflect its supposed effect, 
cholesterol depletion.  
Based on a previous study which indicated that NO has a predominant role in 
mediating relaxation in large arteries (Saliez et al., 2008), I compared the 20 K/ Bay 
K contractions using endothelium-denuded femoral artery before and after treatment 
with M-β-CD. The results clearly show that M-β-CD no longer augmented 
contraction to 20 K/ Bay K in the absence of endothelium (figure 5.7 A), suggesting 
that effect of M-β-CD is endothelium-dependent.  
The endothelium regulates smooth muscle tone by producing and releasing relaxing 
and contracting factors (Moncada et al., 1991, Cohen and Vanhoutte, 1995). 
Amongst these factors, NO is considered to hold a key position as the major 
vasodilator (Kikkawa et al., 1999). In some isolated arteries, but not in all, inhibition 
of the basal NO release by L-NAME significantly increased maximum contraction to 
various vasoconstrictors (Tabernero et al., 1996). In order to further investigate 
whether the increased 20 K/ Bay K contraction occurred as a result of “removal” of 
the tonic inhibitory effect due to basal NO release, I compared contractions in 
arteries pre-incubated in L-NAME, an eNOS inhibitor (figure 5.8 A). Incubation of 
arteries with L-NAME caused enhanced contractions to 20 K/ Bay K. When the 
arteries were subsequently incubated in M-β-CD, this caused increased contraction 
to 20 K/ Bay K. However, L-NAME no longer enhanced contractions after M-β-CD 
treatment. In addition, relaxation with ACh was impaired after treatment with M-β-
CD or incubation with L-NAME. Thus, it seems that both M-β-CD and L-NAME act 
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on the same pathway. These results suggest that the basal NO release and diffusion 
into SMCs cause a tonic endothelium-dependent relaxation, and that inhibition of 
this process thus increases the contraction, at least in the femoral arteries I 
investigated. The findings of the current study are consistent with those of Kikkawa 
et al. (1999) who found that constriction of canine basilar artery rings was increased 
after incubation with L-NMMA pre-contracted with 40 mM KCl. They suggested 
that L-NMMA selectively inhibited basal NO release. DiCarlo et al. (1995) found 
that the maximal vasoconstrictor responses to phenylephrine is enhanced in the 
presence of L-NAME in iliac artery of rat. They suggested that L-NAME has a 
negative effective on α1-adrenoceptor-mediated contraction due to inhibition of the 
basal release of NO. Our results showing enhanced contraction to PE in the presence 
of L-NAME (figure 5.9) are also consistent with this result. 
Findings in this chapter can be compared with several previous studies looking at 
NO release in response to endothelium-dependent vasodilators such as ACh.  
Darblade et al. (2001) found that treating rabbit aorta rings with either M-β-CD or 
filipin impaired endothelium-induced relaxation by ACh. In guinea pig aorta, 
treatment with either M-β-CD or filipin impaired endothelium-dependent relaxation  
(Kaiser et al., 2002). The findings are also consistent with those of Chen et al. 
(2012), who confirmed the cav-1-mediated inhibition of activated eNOS in cultures 
of human ECs using fluorescence resonance energy transfer and co-
immunoprecipitation analyses. Also, the present findings seem consistent with Blair 
et al. (Blair et al., 1999), who found that disrupting caveolae with oxidised low-
density lipoprotein (a cholesterol-binding agent), causes eNOS to leave the caveolae 
and inhibits ACh-induced activation of the enzyme in pulmonary artery endothelial 
cells.  
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Relatively few works have examined the relationship between BKCa channels and 
caveolae. I initially hypothesised that changes in caveolae structure might affect 
BKCa channels in smooth muscle. However, M-β-CD treatment no longer caused 
increase in 20 K/ Bay K contraction in the absence of endothelium (figure 5.7 A). 
This indicates that the contractile function of vascular SMCs was only slightly, if at 
all, altered by treatment with M-β-CD in the absence of the endothelium.  
Nonetheless, the molecules that reside within SMCs are the final point of action 
where the contractility of an artery is determined. Thus, the possible role played by 
BKCa channels was examined by using specific inhibitors of this channel.  
Contraction of intact arteries in response to 20 K/ Bay K/ TEA was first compared 
before/after the treatment with M-β-CD (figure 5.10). This showed a significant 
increase in the contraction force in intact arteries after treatment with TEA
+
, 
presumably as a result of blocking of potassium channels in SMCs (figure 5.11). 
After treatment with M-β-CD, TEA+ no longer had a large contractile effect (figure 
5.11). The effect of TEA
+
 on 20 K/ Bay K contractions was also compared in 
endothelium-denuded artery rings, before and after M-β-CD treatment (figure 5.11 
A). This result showed a non-significant contraction by TEA
+
 in response to 20 K/ 
Bay K, both before and after treatment with M-β-CD (figure 5.12 B). Thus the effect 
of TEA
+
, along with that previously shown for M-β-CD, is endothelium-dependent.   
To summarise, these results indicated that application of TEA
+
 is effective at 
increasing the contraction of rat femoral artery only in presence of the endothelial 
cells. Caveolae disruption by M-β-CD and/or endothelium removal both reduced the 
effectiveness of TEA
+
 to increase contraction. The simplest explanation is that 
endothelial cells release a substance, NO, that activates BKCa channels in smooth 
muscle cells to cause vasorelaxation. M-β-CD treatment and/or endothelium removal 
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abolish NO release. TEA
+
 has a similar effect to M-β-CD because it blocks BKCa 
channels, leading to loss of the effective influence of K
+
 channels on membrane 
potential and L-type Ca
2+
 channels.  
Because TEA
+
 is sometimes regarded as a relatively non-selective K
+
 channel 
inhibitor, the experiments were repeated with the selective KCa channel inhibitor 
IBTX, and similar results were obtained (figures 5.12 and 5.14). As with TEA
+
, the 
effect of IBTX was examined before and after removal of endothelial cells, and 
before and after disruption of caveolae by M-β-CD (figure 5.13). Inhibition of BKCa 
channels by IBTX effectively increased the contraction of rat femoral artery in the 
presence of the endothelium. After caveolae were disrupted by M-β-CD or after the 
endothelium was removed, this caused IBTX to be less effective in increasing 
contraction force in response to 20 K/ Bay K (figure 5.13). These results mirrored 
those obtained with TEA
+
.   
Further experiments were designed to find out whether the effects both of L-NAME 
and IBTX on vascular contractility of rat femoral arteries were additive (figures 
5.14). Inhibition of BKCa channels by IBTX enhanced vascular contraction to 20 K/ 
Bay K, as shown previously. Inhibition of eNOS by L-NAME enhanced vascular 
contraction to 20 K/ Bay K, as shown previously. However, IBTX caused a much 
smaller contraction in the presence of L-NAME than in its absence, suggesting both 
share the same pathway. Inhibiting release of basal NO by L-NAME may cause 
decreased sGC/cGMP/PKG activity in SMCs, so BKCa channels may be in a less 
activated state, causing depolarisation, activation of L-type Ca
2+
 channels and 
contraction. 
As a final test of this hypothesis, the role of BKCa channels in vasorelaxation to SNP, 
a nitric oxide donor, was investigated. SNP was used in this experiment to induce 
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vascular relaxation in endothelium-intact and in the endothelium-denuded artery 
rings before/after blocking potassium channels with TEA
+
. SNP has similar effects 
to NO on smooth muscle cells (Bonaventura et al., 2007). Endothelium-derived NO 
or that produced by the metabolism of SNP can promote smooth muscle relaxation 
through stimulation of guanylyl cyclase activity to increase the synthesis of 
guanosine 3',5'-cyclic monophosphate (cGMP). Increased cGMP regulates vascular 
tone via multiple mechanisms, including reducing cytosolic [Ca
2+
]i (Bonaventura et 
al., 2007) and activation of vascular BKCa channels (Archer et al., 1994). TEA
+
 was 
used in this experiment as an inhibitor of BKCa channels in vascular SMCs (Langton 
et al., 1991).  Vasorelaxation to SNP in the endothelium-denuded rings was inhibited 
following by TEA
+
 (figures 5.16 and 5.17). These results suggest that blocking 
potassium channels in SMCs by TEA
+
 led to decreased vasorelaxation.  Incubation 
of blood vessels with TEA
+
 can abolish endogenous nitric oxide-induced 
endothelium-mediated hyperpolarization in vascular smooth muscle, and 
consequently causes vascular spasm (Bialecki and Stinson-Fisher, 1995, Dorigo et 
al., 1999). 
The effect of SNP in relaxing the artery was at least partially endothelium 
dependent; (figures 5.15 A and 5.17). The results suggest that endothelium-derived 
relaxing factors  modulates SNP-induced relaxation. Our results also supported those 
of a study by Bonaventura et al. (Bonaventura et al., 2008), who found that the 
relaxation induced by SNP in vascular smooth muscle cells is potentiated by 
endothelial production of NO. Also they reported that incubation of rat aorta with L-
NAME reduces the increase in Ca
2+ 
concentration in endothelial cells induced by 
SNP. These results were acquired by organ bath and confocal microscopy.  
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Our results also showed that the SNP-induced vasorelaxation was limited in 
endothelium-denuded femoral rings pre-contracted by KPSS. This result suggested 
that vascular smooth muscle hyperpolarization by SNP might be mediated by 
potassium channel activation. A similar result was reported by Callera et al. (2004), 
who reported that the relaxation induced by SNP in carotid artery, whether 
endothelium-intact or endothelium-removed, was attenuated in arteries contracted 
with KPSS.  
5.5 Conclusion 
Our results suggest that caveolar disruption by a cholesterol depleting agent caused a 
significant increase in the contraction response of intact rat femoral arteries to 20 K/ 
Bay K, resulting from: (i) the abolishment of the release of the basal NO from the 
ECs (ii) a consequent reduction of the effective influence of BKCa channels on L-
type Ca
2+ 
channels in the SMCs, so increasing the contraction force. BKCa channels 
may have a limited effect on smooth muscle contraction in these arteries in the 
absence of basal NO release.  
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Chapter 6 The Effect of Caveolae Disruption by M-β-CD in 
Femoral Arteries on the Response to Vasodilators 
6.1 Aim of the chapter 
The goal of the present chapter was to examine the effect of caveolae disruption by 
M-β-CD on intact and endothelium-denuded femoral arteries in response to several 
types of vasodilator agents which are thought to act via opening of BKCa channels to 
induce SMC relaxation.  
The key findings in this chapter 
 Caveolae are important for the vasorelaxation of femoral artery in response to 
the BKCa channel opener NS-1619.  
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6.2 Introduction  
Membrane hyperpolarization of vascular SMCs has been shown to be an important 
mechanism for producing vasodilatation (Holland et al., 1996). Activation of BKCa 
channels can cause hyperpolarization and then vasorelaxation. BKCa channels are 
considered one of the most important types of potassium channels in vascular 
tissues, and their dual modulation by membrane potential and/or calcium sparks 
allows then to regulate tone in arterial smooth muscle (Brayden and Nelson, 1992). 
Further, BKCa channels can mediate vascular SMCs relaxation through the direct 
activation by several types of vasodilators, such as NS-1619 (Feher et al., 2010), or 
indirect activation through GPCR receptors, such as β-adrenergic receptors, which 
act via second messenger systems (Sadoshima et al., 1988, White et al., 2000).  
Stimulation of β-adrenergic receptors by several vasodilator agents, such as 
isoproterenol (ISO), leads to activation of AC, resulting in an increase in intracellular 
cAMP concentration [cAMP]i. Additionally, adenylyl Cyclase (AC) can be directly 
activated by forskolin (FSK). Increase in [cAMP]i activates cAMP-dependent 
protein kinase  (also known as protein kinase A, PKA), allowing it to phosphorylate 
BKCa channels. Phosphorylation by PKA results in BKCa channel activation, with the 
consequent hyperpolarization, closure of VDCCs, reduced global [Ca
2+
]i and 
vasodilation (Sadoshima et al., 1988, White et al., 2000). On the other hand, 
increased intracellular cGMP through stimulation of soluble guanylate cyclase (sGC) 
by NO, leads to increases in intracellular cGMP concentration [cGMP]i. sGC can 
also be activated by nitric oxide donors, such as SNP (Khan et al., 1998, Robertson 
et al., 1993). Increased [cGMP]i activates cGMP-dependent protein kinase (also 
known as protein kinase G, PKG). This can also phosphorylate and activate BKCa 
channels, inducing vascular SMC relaxation (Khan et al., 1998, Robertson et al., 
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1993). In this regard, it has also been demonstrated that cAMP-stimulating agents 
can increase the activity of BKCa channels through cross-activation of PKG in 
vascular SMCs (White et al., 2000).  
As well as activating BKCa channels through protein phosphorylation, activation of 
PKA and PKG by cAMP and cGMP-stimulating agents can lead to an increase in the 
activity of BKCa channels via increasing the frequency of local Ca
2+ 
sparks through 
RyR channels in the SR (Porter et al., 1998). Additionally, PKA and PKG also 
increase activity of the SR Ca
2+
-ATPase (SERCA), which leads to transfer of Ca
2+
 
from the cytosol of the cell to the lumen of the SR. This occurs through 
phosphorylation of phospholamban, which then dissociates from SERCA, allowing it 
to pump Ca
2+
 into the SR more quickly (Porter et al., 1998).  
In this chapter, I will use myography to assess the effect of caveolae disruption by 
M-β-CD on the femoral artery vasorelaxation in response to vasodilators known to 
activate BKCa channels. 
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6.3 Results 
The effect of caveolae disruption on the response of femoral artery to three types of 
vasodilators was studied with myography.  
6.3.1 The effects of caveolar disruption by M-β-CD on intact and endothelium-
denuded femoral artery vasorelaxant response to NS-1619 
This experimental series tested the hypothesis that the femoral artery vasorelaxation 
response to the BKCa channel opener NS-1619 would be attenuated post-caveolar 
disruption.  
6.3.1.1 Experimental protocol A 
The first protocol was designed to assess the effect of endothelial removal on the 
vasorelaxant response to NS-1619. Arteries were pre-constricted with 20 K/ Bay K, 
and, at the plateau of the maximum contraction to 20 K/ Bay K, ACh (10 μM) was 
added to the myography chamber to check the functional integrity of the 
endothelium. Vessels were re-contracted with 20 K/ Bay K, and, at the plateau to 20 
K/ Bay K contraction, cumulative doses of NS-1619 (0.1 µM, 0.3 µM, 1 µM, 3 µM, 
10 µM and 30 µM, and 100 µM) were added to the chamber to induce concentration-
dependent vasorelaxation in endothelium-intact rings (figure 6.1 A). Afterword, the 
endothelium was mechanically removed from vessels (see 2-3-2 in chapter 2). Then, 
vessels were re-contracted with 20 K/ Bay K and ACh (10 μM) added to check 
absence of the endothelium. Vessels were re-contracted with 20 K/ Bay K, and at the 
plateau to 20 K/ Bay K contraction, cumulative doses of NS-1619 were added to 
induce concentration-dependent vasorelaxation (figure 6.1 A). Vehicle controls 
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showed that at the highest dose of NS-1619 (DMSO = 1%) the arteries relaxed and 
therefore these data have been omitted from the concentration-response curves.   
6.3.1.2 Experimental protocol B 
This protocol was designed to assess the effect of caveolar disruption by M-β-CD on 
the vasorelaxant response to NS-1619 in endothelium-intact artery rings. 
Endothelium-intact arteries were contracted with 20 K/ Bay K, and, at the plateau of 
the contraction, cumulative doses of NS-1619 (0.1 µM-100 µM) were added to 
induce concentration-dependent vasorelaxation (figure 6.2 A). Vessels were then 
incubated with M-β-CD (5 mM) for 1 hour to disrupt caveolae. Vessels were re-
contracted with 20 K/ Bay K and cumulative doses of NS-1619 added to induce 
concentration-dependent vasorelaxation (figure 6.2 B).   
6.3.1.3 Experimental protocol C 
To assess the effect of caveolar disruption by M-β-CD on the response to NS-1619 
after endothlium removal, endothelium-denuded arteries were contracted with 20 K/ 
Bay K, and cumulative doses of NS-1619 (0.1-100 µM) were added to induce 
concentration-dependent vasorelaxation (figure 6.3 A). Vessels were then incubated 
with M-β-CD (5 mM) for 1 hour, re-contracted with 20 K/ Bay K and cumulative 
doses of NS-1619 added to induce vasorelaxation (figure 6.3 A). 
6.3.1.4 Experimental protocol D 
To investigate the membrane permeability mechanisms involved in NS-1619 
vasorelaxation KPSS was used to contract vessels. At the plateau of KPSS 
contraction cumulative doses of NS-1619 were added to the myograph chamber to 
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induce concentration-dependent vasorelaxation in endothelium-intact rings (figure 
6.4 A). 
6.3.1.5 Data analysis 
The force response (in mN) to cumulative doses of vasodilator was measured in rat 
femoral artery rings pre-constricted with KPSS and/or 20 K/ Bay K. Responses are 
expressed as the fractional relaxation, that is the fraction of the maximum 
contraction to either KPSS and/or 20 K/ Bay K obtained at a given concentration of 
vasodilator. Experiments were performed at 7 concentrations (0.1-100 µM). All 
values are expressed as mean  SE. Student’s t-test for paired samples was used to 
compare values.  
6.3.1.5.1 Results  
NS-1619 (0.1-100 μM) caused concentration-dependent relaxation in endothelium-
intact (control) arteries contracted with 20 K/ Bay K (figure 6.1 A). Relaxation was 
transient at lower concentrations of NS-1619 and sustained at higher concentrations. 
In the endothelium-denuded rings, no transient dilation was seen at lower doses of 
NS-1619 (0.1–3 μM), while higher doses (10-100 μM) still caused relaxation. 
Concentration-response curves show that the vasorelaxation response to NS-1619 
was significantly inhibited after removal of the endothelium (figure 6.1 B) at 0.1, 
0.3, 1 and 30 µM NS-1619. 
In endothelium-intact rings treated with M-β-CD (figure 6.2 A), doses of NS-1619 
from 0.1 to 30 M now caused a sustained increase in the force. The concentration-
effect curves show that the vasorelaxation response to NS-1619 in the endothelium-
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intact artery was significantly inhibited following exposure to M-β-CD at 1, 3, 10 
and 30 µM NS-1619 (figure 6.2 B).  
In endothelium-denuded rings treated with M-β-CD there were less obvious changes 
in the response to NS-1619 (figure 6.3 A). Concentration-effect curves show the 
vasorelaxation response to NS-1619 was only significantly attenuated at 1 M  NS-
1619 following the treatment with M-β-CD (figure 6.3 B). 
To investigate the role of K
+
 channels in the NS-1619 relaxation, arteries were 
induced to contract with KPSS (figure 6.4 A). In endothelium-intact rings contracted 
with KPSS, the vasorelaxation response to NS-1619 was slight, with maximum 
fractional relaxation responses reaching only 0.60±0.08 (figure 6.4 B). This result 
indicated that NS-1619 is only partially effective in relaxing KPSS contractions. 
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Figure ‎6.1. Effect of NS-1619 (0.1 - 100‎μM) in femoral artery pre-contracted with 
20K/ Bay K before and after endothelial removal. A. Recordings show response of 
control (endothelium-intact) rings and endothelium-denuded artery rings to cumulative 
doses of NS-1619. B. Concentration-response curve for NS-1619 in endothelium-intact 
rings (●) and endothelium-denuded rings (○). Data are expressed as fractional relaxation. 
Significance  was established using Student’s t-test *; P<0.05, **; P<0.01, n=6. 
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Figure ‎6.2. Effect of M-β-CD on NS-1619 relaxation of femoral artery. A. Recordings 
show effect of NS-1619 (0.1 - 100 M) on control (endothelium-intact) rings before and 
after the treatment with M-β-CD. B. Concentration-response curve for NS-1619 in 
endothelium-intact artery before (●) and after (○) M-β-CD treatment. Data for before M--
CD treatment are reproduced from figure 1B for comparison. Data are expressed as 
fractional relaxation. Significance was established using Student’s t-test *; P<0.05, **; 
P<0.01, n= 6. 
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Figure ‎6.3. Effect of M-β-CD on NS-1619 induced relaxation of endothelium-denuded 
femoral artery. A. Recordings show effect of NS-1619 (0.1 - 100 M) on endothelium-
denuded rings before and after the treatment with M-β-CD. B. Cumulative concentration-
response curve for NS-1619 in endothelium-denuded rings before (●) and after (○) 
treatment with M-β-CD. Data for before M-β-CD treatment and are reproduced from figure 
6.1 B for comparison. Data are expressed as fractional relaxation. Significance was 
established using Student’s t-test; *; P<0.05, n= 6. 
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Figure ‎6.4. NS-1619 relaxation of KPSS contractions in rat femoral artery. A. 
Experimental trace shows vasorelaxation in an artery pre-contracted with KPSS. NS-1619 
(0.1 to 30 μM) produced a slight relaxation B. Mean data expressed as fractional 
relaxations, n= 4. 
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6.3.2 The effects of caveolar disruption by M-β-CD on intact and endothelium-
denuded femoral artery vasorelaxant response to isoproterenol 
Isoproterenol (ISO) binds β-adrenergic receptors to cause vasodilation. Binding 
results in activation of adenylate cyclase, generation of cAMP, and activation of 
PKA, which may cause vasodilation by activating BKCa channels (see Introduction 
to this chapter). This experiment was designed to test the hypothesis that the femoral 
artery vasorelaxation response to ISO would be attenuated post-caveolar disruption.  
6.3.2.1 Experimental protocol  
The arteries were pre-constricted with 20 K/ Bay K, and, at the plateau of the 20 K/ 
Bay K contraction, cumulative doses of ISO (0.1 µM, 0.3 µM, 1 µM, 3 µM, 10 µM, 
30 µM, and 100 µM) were added to induce concentration-dependent vasorelaxation 
in endothelium-intact rings and in endothelium-denuded rings before and after 
treatment with M-β-CD (5 mM) for 1 hour to disrupt caveolae (figures 6.5 and 6.6). 
To provide evidence for the membrane permeability mechanism and for comparison, 
the artery rings were contracted with KPSS, and, at the plateau of the contraction, 
cumulative doses of ISO were added to induce concentration-dependent 
vasorelaxation in endothelium-denuded rings (figure 6.7 A). 
6.3.2.2 Analysis 
In endothelium-intact arteries pre-contracted with 20 K/ Bay K, ISO (0.1-100 µM) 
caused partial relaxation at low concentrations (0.1 -10 µM) (figure 6.5 A and 6.5 
C). At higher concentrations of ISO (30-100 µM) contraction was seen. After 
removal of the endothelium, ISO still relaxed the artery rings (figure 6.5 B). 
However, ISO relaxations were reduced by endothelial removal at ISO 
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concentrations between 3-100 µM (figure 6.5 C). In endothelium-denuded arteries, 
caveolar disruption with M-β-CD had little effect on the overall pattern of the 
response to ISO (figure 6.6). Vasorelaxation in response to ISO was absent in 
endothelium-denuded arteries contracted with KPSS (figure 6.7). The latter result 
suggests K
+
 channel activation may be involved in ISO relaxations. 
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Figure ‎6.5. Effect of isoproterenol on rat femoral artery before and after endothelium 
removal.  Experimental traces shows the effect of ISO (0.1 - 100 μM) in an artery 
contracted with 20K/ Bay K in A. Control (endothelium-intact) rings ,and B. Endothelium-
denuded arteries. C. Concentration-response curve for ISO before (●) and after (○) 
endothelial removal. Data are expressed as fractional relaxation. Significant was 
established using Student’s t-test *; P<0.05, **; P<0.01; ***; P<0.001, n= 6.  
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Figure ‎6.6. Effect of M-β-CD on isoproterenol relaxations in endothelium-denuded rat 
femoral artery. A. Experimental traces show the effect of ISO (0.1 - 100 μM) on arteries 
after treatment with M-β-CD. B. Concentration-response curve for ISO in endothelium-
denuded rings before (●) and after (○) treatment with M-β-CD. Data are expressed as 
fractional relaxations. Significance was established using Student’s t-test *; P<0.05, n= 6. 
 
 
 187 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ISO (M)
0.01 0.1 1 10 100
F
ra
c
ti
o
n
a
l 
R
e
la
x
a
ti
o
n
0.0
0.2
0.4
0.6
0.8
1.0
1.2
B
Figure ‎6.7. Absence of isoproterenol relaxation of KPSS contractions in rat femoral 
artery. A. Experimental trace shows effect of ISO (0.1-100 μM) in an artery pre-
contracted with KPSS.  B. Mean data expressed as fractional relaxations, n= 6. 
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6.3.3 The effects of caveolar disruption by M-β-CD on femoral artery 
vasorelaxant response to forskolin 
In the previous section I have studied the ability of ISO, an AC/cAMP/PKA coupled 
vasodilator, to induce vasorelaxation in femoral arteries, and studied the effects of 
caveolar disruption by M-β-CD on this relaxation. However, the action of ISO 
appeared complex, with relaxations at low concentrations and contractions at higher 
concentrations (figure 6.5). Furthermore, the relaxing action of ISO depended partly 
on the endothelium. In order to simplify the experiments, FSK was used to directly 
activate AC to induce vasorelaxation, thus by-passing receptor(s)-ISO interaction. 
ECs were mechanically removed. The experiment was designed to test the 
hypothesis that caveolar disruption by M-β-CD would attenuate vasorelaxation in 
femoral artery in response to FSK.  
6.3.3.1 Experimental protocol  
The endothelium was mechanically removed from vessels (see 2-3-2 chapter 2). 
Vessels were contracted with 20 K/ Bay K, and, at the plateau of the contraction, 
cumulative doses of FSK (0.1 µM, 0.3 µM, 1 µM, 3 µM, 10 µM, 30 µM, and 100 
µM) were added to the chamber to induce concentration-dependent vasorelaxation 
(figure 6.8 A). Vessels were then incubated with M-β-CD (5 mM) for 1 hour, re-
contracted with 20 K/ Bay K, and cumulative doses of FSK were added to induce 
concentration-dependent vasorelaxation (figure 6.8 B). 
6.3.3.2 Analysis 
In 20 K/Bay K contracted arteries, FSK (0.1-100 μM) produced full relaxation 
(figure 6.8 A). However, FSK caused similar concentration dependent relaxation of 
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arteries whether before or after the treatment with M-β-CD (figure 6.8 B). Although 
BKCa channels are known to be activated by PKA, further experiments are required 
to determine the role of BKCa channels in FSK-induced vasodilation in this artery, 
and effects of caveolar disruption on this process. 
 
 
 
 
 
 
 
 
 190 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FSK (M)
0.1 1 10 100
F
ra
ct
io
na
l 
R
el
ax
at
io
n
0.0
0.2
0.4
0.6
0.8
1.0
B
Figure ‎6.8. Effect of FSK (0.1 - 100‎μM)‎in‎rat‎femoral‎artery‎pre-contracted with 20 
K/ Bay K. A. Recordings show endothelium-denuded rings before and after the treatment 
with M-β-CD. B. Concentration-response curve for FSK before (●) and after (○) treatment 
with M-β-CD. Data are expressed as fractional relaxation. Results were not statistically 
significantly different at any concentration of FSK, n= 8.   
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6.4 Discussion 
The overall goal of this in vitro study was to assess the involvement of caveolae in 
inducing vasorelaxation of femoral arteries in response to NS-1619, ISO, and FSK, 
all of which are known to activate BKCa channels. For this purpose, myography was 
used to assess the vasorelaxation response before and after caveolae disruption by 
M--CD. Moreover, these vasodilators were tested for their efficacy before and after 
removing the endothelial layer, to determine whether the vasorelaxation was 
dependent on endothelial factors. NS-1619 was chosen based on its published ability 
to directly activate the BKCa channels and then cause vasorelaxation (Holland et al., 
1996). ISO was chosen as this activates β-adrenergic receptors, increases vascular 
cAMP levels and then activates BKCa channels (White et al., 2000, Tanaka et al., 
2003). FSK was chosen to induce the vasorelaxation as it directly activates AC.  
Initially, I tested the effect of the known BKCa channel activator NS-1619 to induce 
vasorelaxation in endothelium-intact artery rings. NS-1619 (0.1-100 μM) led to full 
relaxation of arteries pre-contracted with 20 K/ Bay K (figure 6.1 A), while it was 
only partially effective in relaxing KPSS contraction, up to a maximal relaxation of 
0.60±0.08 (figure 6.4). These results suggest that the femoral artery is significantly 
sensitive to K
+
 channel activation to induce vasorelaxation under control conditions. 
In relation to the 20 K/ Bay K contraction, Bay K-8644 is dependent on its ability to 
promote Ca
2+
 influx via L-type VDDCs, thus inducing contraction. VDCCs can be 
closed via the membrane hyperpolarisation that follows activation of BKCa channels 
(see chapter 5). In contrast, when arteries were contracted with KPSS, the potassium 
gradient across the plasma membrane is reduced and the membrane is completely 
depolarized. In this situation, activation of potassium
 
channels will have limited 
effective on membrane potential, consequently limited effect on vascular tone and 
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therefore, potassium channel opening will not be effective to induce vasodilation 
(Meisheri et al., 1990). The findings of the current study are partially consistent with 
those of (Holland et al., 1996), who reported that the NS-1619 induced 
concentration-dependent relaxation of rat basilar artery rings contracted with both 5-
HT and histamine. However, they also reported that NS1619 produced 
concentration-dependent relaxation artery contracted with a salt solution containing 
80 mM K
+
. This latter result disagrees with our finding that NS1619 produce only 
partial relaxation of rat femoral artery contracted with KPSS.  
Removal of the endothelium from femoral artery abolished the transient 
vasorelaxation in response to NS-1619 at low concentrations (0.1 to 10 µM) whilst 
leaving the relaxation at higher concentrations (100 µM) unchanged (figure 6.1). In 
this experiment, endothelium removal might have inhibited the femoral artery 
relaxation at low concentrations of NS-1619 by abolishing release of NO or other 
endothelium-dependent vasodilator. The findings of the current study are consistent 
with those of (Feher et al., 2010), who reported endothelium-dependent 
vasorelaxation in rat aorta in response to NS-1619. In contrast (Feng et al., 2008) 
showed that NS-1619 induced relaxations of human coronary arterioles were not 
altered with endothelium removal, suggesting BKCa channel function is endothelium-
independent. Similarly (Geary et al., 1998) reported that NS-1619 induced 
vasorelaxation in intact and endothelium-denuded rat tail artery rings.  
Further studies investigated the effect of caveolae disruption on NS-1619 relaxation.  
In endothelium-intact rings treated with M-β-CD, vasorelaxation was markedly 
inhibited compared to the control in response to doses of NS-1619 from 0.1 to 30, 
but the artery fully relaxed with the highest dose (100 μM) (figure 6.2). The effects 
of M-β-CD at low doses of NS-1619 may be due to loss of a vasoactive compound 
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produced by the endothelium such as NO, and/or loss of MEGJs, although further 
experiments, such as pre-incubation of the artery with a NOS inhibitor such as L-
NAME, are required to test this hypothesis. In endothelium-denuded rings treated 
with M-β-CD (figure 6.3) the vasorelaxation was partially inhibited compared to 
that seen before treatment with M-β-CD, but the relaxation was only significantly 
different at 1 μM NS-1619.  
Overall, the results support the idea that low concentrations of NS-1691 cause an 
endothelium-dependent vasorelaxation of rat femoral artery and that this relaxation is 
dependent on the presence of caveolae. The results may point to a role for 
endothelial BKCa channels in vasorelaxation to NS-1619. This would be consistent 
with the immunohistochemistry and immunocytochemistry results in chapter 4 
showing the presence of BKCa channels in endothelial cells. However, discovering 
the precise role of emdothelial BKCa channels requires additional experiments, such 
as pre-incubation of arteries with BKCa channel inhibitors such as TEA
+
 and IBTX 
before NS-1619 application. 
In contrast to NS-1619, ISO relaxes arteries via activation of second messenger 
systems. In a step to find out if vasorelaxation response to ISO would be attenuated 
post-caveolar disruption the vasorelaxation in response to ISO was tested before and 
after removal of the endothelium, and after caveolae disruption in endothelium-
denuded rings. Our results show that ISO in endothelium-intact arteries caused 
relaxation at low concentrations (0.1-10 µM) while at higher concentrations (30-100 
µM) contraction was seen (figure 6.5 A).  Higher concentrations (30-100 µM), may 
lead to activation of other vasoconstrictor receptors, such as -adrenoreceptors or 
even 5-HT receptors. Antagonists of these receptors could be used to investigate this 
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possibility. After removal of the endothelium, ISO relaxations were reduced at ISO 
concentrations between 3-100 µM (figure 6.5 B).  
In endothelium-denuded arteries, caveolar disruption with M-β-CD had little effect 
on the overall pattern of the response to ISO (figure 6.6). Vasorelaxation in response 
to ISO was abolished in endothelium-denuded rings pre-contracted with KPSS 
(figure 6.7). This suggests K
+
 channel activation may be involved in ISO 
relaxations. The findings of the current study are partially consistent with those of 
(Yoshida et al., 1999), who reported marked inhibition of vasorelaxation in 
pulmonary arterioles of dogs in response to ISO after removal of the endothelial 
layer.   
In an attempt to by-pass the complexities of receptor(s)-ISO interaction, AC was 
directly activated by forskolin to induce vasorelaxation (Vanhoutte, 1989). FSK fully 
relaxed arteries before and after M-β-CD treatment and no significant difference was 
seen following treatment with M-β-CD (figure 6.8). This result suggested that 
vasorelaxation in the femoral artery in response to FSK is endothelium-independent 
and caveolae disruption has little effect on the relaxation. The findings of the current 
study are consistent with those of (Yoshida et al., 1999), who reported that the FSK 
induced vasorelaxation in endothelium-intact and endothelium-denuded pulmonary 
artery of dog, and that these relaxations were endothelium-independent.  
6.5 Conclusion 
Although several studies have shown BKCa channel-mediated vasorelaxation in 
blood vessels (Meisheri et al., 1990, Holland et al., 1996, Geary et al., 1998), the 
effect of caveolae disruption in response to different vasodilators has not been 
reported, at least in the femoral artery. This study demonstrated for the first time that 
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the integrity of caveolae are important for the vasorelaxation of femoral artery in 
response to the BKCa channel opener NS-1619. The relative role of endothelial and 
smooth muscle cell BKCa channels in this relaxation requires further study.  
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Chapter 7  
Chapter 8 Final Discussion 
8.1 Overview of thesis results 
This study was prepared to assess the functional role of caveolae in regulating the 
contractility of rat femoral artery, with particular emphasis on how the signature 
proteins of caveolae, the caveolins, may control the activity of Ca
2+
 and voltage-
activated large conductance potassium channels  and thus vascular contractility.  
Femoral artery was chosen in this study due to the importance of this blood vessel in 
delivering blood and oxygen to the muscles and superficial tissues of the legs, 
especially during exercise (Mulvany and Aalkjaer, 1990). Many studies have been 
carried out to investigate the role of caveolae on vascular tissues, using several 
different techniques (Razani and Lisanti, 2001b, Ostrom and Insel, 2006). However, 
this is the first study to look specifically at the effects of caveolae in regulating 
contractility in femoral arteries.  
In this thesis I have addressed my aims. Initially, I wanted to establish the presence 
of caveolae using transmission election microscopy, and then to look at the effect of 
cholesterol removal by cholesterol depleting agents on caveolae in both ECs and 
SMCs of femoral artery. TEM has been used extensively to study caveolae in 
vascular tissues (Minshall et al., 2003, Shaw et al., 2006). The results showed that 
caveolae were present in both ECs and SMCs, and when cholesterol was depleted the 
caveolae disappeared. Several contractility studies were designed to examine the 
effect of caveolae on BKCa channel function in the presence and absence of 
endothelial layers in chapters 5 and 6. However, to establish a method to identify the 
presence of endothelium in the artery, histology was performed before and after the 
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removal of endothelium. It was shown histologically that the endothelium layer can 
be removed by gentle rubbing the interior lumen of the artery. After confirming the 
presence of caveolae by TEM, other techniques have been used to investigate the 
presence and the co-expression of BKCa channels to the caveolar domain in the cell 
membrane of SMCs and ECs. These included the methods of 
immunohistochemistry, immunocytochemistry, and Western blot. BKCa channels 
were found to be co-expressed with cav-1 and cav-3 in the SMC layer both at the 
tissue level and in individual SMCs, and co-expression of BKCa channels with cav-1 
was seen at the tissue level in ECs in rat femoral artery. One explanation for these 
results is that caveolin scaffolding domains serve as anchor sites for BKCa channels 
within caveolae in vascular cells. These findings support the results in the preceding 
chapter, which showed caveolae in the cell membrane of SMCs and ECs of rat 
femoral artery tissue using TEM, and provide novel background information for 
understanding the physiological function of BKCa channels in the regulation of 
vascular contractility.   
In the next section of my thesis, in order to determine the physiological role of 
caveolae in femoral arterial contractility, myography techniques were used. The 
effects of the removal of cholesterol from the SMC and EC cell membrane using M-
β-CD, which would disrupt caveolae, were studied. Prior to my thesis, some studies 
had investigated the effect of caveolae disruption by M-β-CD in regulation of arterial 
contraction and relaxation (Darblade et al., 2001, Xu et al., 2007). Cholesterol 
depletion by M-β-CD causes inhibition of release of NO from ECs (Darblade et al., 
2001). Cholesterol depletion can also cause increased contraction in response to 
stimulation with agonists such as PE (Tabernero et al., 1996). Furthermore, some of 
these studies showed that when NO release is inhibited by blocking eNOS activity, 
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this has a similar effect to M-β-CD, also causing increased contraction in response to 
contractile agonists (Jiang et al., 2005). On the other hand, studies in single SMCs 
using patch clamp show a direct effect of cholesterol depletion by M-β-CD on 
inward Ca
2+
 currents, causing an increased influx of Ca
2+
 via VDDCs and a 
decreased efflux of K
+
 through BKCa channels (Prendergast et al., 2010). These 
results therefore suggest caveolar depletion can have effects on both ECs and SMCs 
(Bialecki and Stinson-Fisher, 1995).     
Caveolar disruption by the cholesterol depleting agents M-β-CD and filipin caused a 
significant increase in the contraction force in response to 20 K/ Bay K in 
endothelium-intact rat femoral arteries (chapter 5). This could result from: (i) 
Reduced release of a vasodilator, or enhanced release of a vasoconstrictor, from ECs. 
(ii) loss of communication between ECs and SMCs (MEGJs). (iii) A direct effect of 
caveolar disruption on SMCs, such as abolishment of the effective influence of BKCa 
channels on L-type Ca
2+
 VDDC. As there was no significant change in force 
development to 20 K/ Bay K when I compared endothelium-denuded arteries before 
and after treatment with M-β-CD, this suggests that the main contractile effects of 
caveolar disruption were due to changes in the synthesis or release of an endothelial 
factor. 
Further experiments were designed to assess the role of NO in the changes in 
contractility seen after caveolar disruption by M-β-CD. I compared the contraction 
of endothelium-intact femoral arteries in response to 20 K/ Bay K in the presence of 
the NO synthase inhibitor L-NAME, before and after treatment with M-β-CD. These 
results showed that the incubation with L-NAME caused the arteries to contract 
more to 20 K/ Bay K. When the arteries were subsequently incubated in M-β-CD, 
this, as had previously been shown, also enhanced 20 K/ Bay K contraction. 
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However, L-NAME no longer had a contractile effect after M-β-CD treatment (i.e. 
the two effects were not additive). In addition, there was impaired relaxation to ACh, 
whether after treatment with M-β-CD or incubation with L-NAME, as previously 
shown by many groups (Darblade et al., 2001, Xu et al., 2007). Overall, these results 
suggested that the influx of Ca
2+
 via L-type channels in response to 20 K/ Bay K 
causes the contraction of SMCs. The abolishment of a vasodilator effect of NO due 
to caveolae disruption by M-β-CD and/or blocking eNOS by L-NAME increased the 
contraction in response to 20 K/ Bay K. Therefore inhibition of synthesis and/or 
release and/or diffusion of NO by caveolar disruption caused aberrations in 
endothelium-dependent relaxation, thus increasing the contraction. The increase of 
force by eNOS inhibition also shows basal release of endogenous NO in this artery 
segment. 
To directly investigate the role of BKCa channels in the increased arterial contraction 
in response to caveolar disruption I compared the contractions of endothelium-intact 
arteries in response to 20 K/ Bay K before/after the treatment with M-β-CD in the 
presence of TEA
+
 and IBTX, selective blockers for BKCa channels. Incubation of 
artery rings with TEA
+
 or IBTX caused an augmentation in the contraction to 20 K/ 
Bay K. After treatment with M-β-CD, TEA+ or IBTX no longer had a significant 
contractile effect. I interpret these results as follows: in the absence of M-β-CD basal 
NO release from the endothelium leads to activation of BKCa channels in smooth 
muscle cells. After M-β-CD treatment, NO release is inhibited and therefore there is 
less influence of SMC BKCa channels on femoral artery contraction. TEA
+
 and IBTX 
have the same apparent effect as M-β-CD as they cause inhibition of BKCa channels, 
in this case by directly binding and inhibiting channel activity.   
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The possibility of an effect of SMC caveolar disruption on BKCa channels should not 
be overlooked. Our results demonstrated a (small) increase in the contractile force in 
response to 20 K/ Bay K in endothelium-denuded arteries after treatment with M-β-
CD. This result might indicate that the contractile function of vascular SMCs was 
partly altered by treatment with M-β-CD. BKCa channels might be re-distributed 
away from the plasma membrane adjacent to the sarcoplasmic reticulum after the 
treatment with M-β-CD, due to disruption of the caveolar-SR microdomain. The 
increase in contraction might therefore be partly due to the absence of the effective 
influence of Ca
2+
 'sparks' on BKCa channels, hence causing depolarisation, activation 
of VDCCs and increasing the contraction force. However, my results showing that 
endothelium removal largely abolishes the effect of M-β-CD suggest that this 
mechanism may not be dominant in rat femoral arteries.   
The above results led to further examination of the influence of NO on BKCa 
channels in modulating vasorelaxation in femoral artery using SNP, an NO donor.  
SNP has been shown to induce smooth muscle cell hyperpolarization and thus 
vasorelaxation via activation of BKCa channels in some vascular tissues (Bialecki 
and Stinson-Fisher, 1995). To test this in the rat femoral artery, I compared the 
relaxation of arteries to SNP before and after inhibition of BKCa channels by TEA
+
 
treatment. TEA
+
 caused significant inhibition of relaxation. 
Taken together, the results of chapter 5 provide evidence for the importance of 
endothelium-derived relaxing factors, specifically NO, in activating BKCa channels 
in SMCs, so inducing hyperpolarization and vasorelaxation of rat femoral arteries.  
However, it is unclear whether changes in the regulatory function of caveolae on 
BKCa channels have an influence on vasodilation under other conditions. So, I set out 
the last results chapter in my thesis to examine the role of caveolar disruption by M-
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β-CD in modulating the response to several vasodilators agents which have been 
previously shown to activate BKCa channels. 
Prior to my thesis, some studies have demonstrated the role of BKCa channel 
activation in mediating vasorelaxation in different blood vessels in response to NS-
1619, FSK and ISO (Meisheri et al., 1990, Holland et al., 1996, Geary et al., 1998).  
Initially, I investigated the effect of caveolar disruption by M-β-CD on 
vasorelaxation of femoral artery in response to NS-1619,  M-β-CD significantly 
inhibited vasorelaxation, indicating it may have affected the ability of BKCa channels 
to induce the hyperpolarization. When I compared relaxations before and after 
treatment with M-β-CD, the transient vasodilation seen at low concentrations of NS-
1619 was reduced. This suggests that endothelium-derived relaxing factors may be 
important for NS-1619 vasorelaxation in this artery.  
ISO was also used as a vasodilator. ISO has been shown extensively to induce 
vasorelaxation via activation of β-adrenergic receptors (Yoshida et al., 1999). The  
increased intracellular cAMP concentration ([cAMP]i) and subsequent activation of 
PKA opens BKCa channels, inducing hyperpolarization, which leads to 
vasorelaxation (Ahn et al., 1995). To determine effect of caveolae disruption on 
vasorelaxation I compared responses before and after the treatment with M-β-CD. 
Although relaxations to ISO were partially reduced by M--CD treatment, the 
complex response of these arteries seen in response to ISO application, with 
relaxation at low concentrations and contraction at higher concentrations, made 
further interpretation difficult. In order to simply the experimental protocol, FSK 
was used to directly activate AC. However, there was no effect of caveolar 
disruption on FSK-induced vasorelaxation.   
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8.2 Physiological significance and clinical translation  
It is well-known that the femoral artery has an important role in blood supply to 
lower part of the human body, especially during physical activity and exercise 
performance, which is characterized by significant cardiovascular alteration such as 
increase blood flow through femoral artery to distal organs. 
Caveolae have been shown to be involved in the regulation of many signaling 
cascades, ion channels and receptors in ECs and SMCs. Furthermore, it has been 
shown that caveolae depletion from cell membrane of these cells leads to inhibition 
of the release of NO, which is important clinically and physiologically to induce 
vascular relaxation. Potentially, therefore, caveolar disruption can alter the function 
of the endothelial cells and may lead to vascular dysfunction. I found that removal of 
caveolae from the endothelium by M--CD leads to an increase in the contraction of 
vascular smooth muscle in response to 20 K/ Bay K. I also found that after removal 
of the endothelium there was no effect of M--CD on the contractility. This suggests 
the vital role of caveolae in endothelial cells in the maintenance of vascular function.  
In addition, caveolae disruption causes impairment of vasorelaxation via potassium 
channels. In contrast, I found that incubating endothelium-intact artery rings with 
Ch-MCD for one hour, causes attenuated contraction force generated by 20 K/ Bay 
K. It is known that atherosclerosis can narrow the blood vessels and block the 
endothelial layer resulting in vascular pathogenesis (Nordestgaard, 1996, Cohen et 
al., 2004). If the atherosclerosis affects the blood vessels then the vascular function 
may be affected. 
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8.3 Future work 
To extend the TEM studies described in chapter 3, it was my original intention to 
attempt to localise BKCa channels at high resolution with immunogold staining to 
see, for example, whether the channels were localised to caveolae.  However, results 
from preliminary studies were unclear. In few samples, I have seen some BKCa 
channels stained in caveolae, but it was not clear in other samples. Therefore, it 
would be of interest to increase the n number to confirm the exact location of BKCa 
channels. 
To extend the contraction studies, it would be interesting to examine the role of 
caveolae and the BKCa channels in human arteries. Finally, in one part of my study I 
have incubated some endothelium intact artery rings with Ch-MCD, which 
attenuated the contraction force generated by 20 K/ Bay K. This might be an 
interesting area for further experiments, as it is a model of hypercholesterolemia.  
 
 
 
  
 
 204 
 
 
Figure ‎8.1. Proposed mechanisms of action of the vasodilators and basal NO on Ca2+ 
sparks, BKCa channels and MEGJ mediated hyperpolarization. A. Shows caveolae 
disruption by M-β-CD leads to inhibition of basal NO release from the EC. Also re-
distribution of the location of the BKCa channels away from the SR in cell membrane of 
SMC may occur. Absence of basal NO release leads to reduced SMC relaxation, seen as a 
vasoconstriction. B. Basal NO release leads to increased production of cGMP through 
activated GC, which in turn stimulates PKG. Activation of PKG (and PKA) have a direct 
activatory effect on the BKCa channel, increasing its open probability. PKA and PKG may 
also act on the SR to increase Ca
2+
 sparks through RyR receptors. Increased Ca
2+
 spark 
activity leads to increased activity of the BKCa channel, causing hyperpolarization, which 
lead to closure of L-type Ca
2+ 
channels. This leads to reduced cytosolic Ca
2+
 and SMC 
relaxation. In addition, hyperpolarization generated in ECs can be transmitted to the smooth 
muscle through MEGJs. Therefore, membrane hyperpolarization can cause smooth muscle 
relaxation through a decrease in VDCCs open probability. 
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